Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3028286	s-album	g/l (g/l)	9351	20970	0.00%
3028286	s-album	— (—)	1810	2379	100.00%	Distribution not available
3028286	s-alb-fr	g/l (—)	73	85	100.00%	Distribution not available
3028286	s-albumiini(valetietues-prot-fr)	g/l (—)	60	82	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Implicit bacterial Sepsis

1483

4459

3.09

321.16

2.7

2.1

35.02

38.01

g/l

48.98

1273

3786

Pain in limb

2185

5864

2.56

316.64

2.1

2.2

37.81

37.71

g/l

0.31

1940

5069

Aplastic and other anaemias

2151

5118

4.21

307.65

2.5

2.1

36.36

37.49

g/l

11.96

1862

4323

Multiple myeloma, including Hilmo

439

482

11.86

307.65

18.2

1.4

37.56

37.36

g/l

0.23

411

408

Bacterial infection, other or unspecified

2078

5634

3.27

307.65

3.0

2.0

34.93

38.49

g/l

96.02

1831

4781

Dialysis, with operation codes

643

1184

6.03

307.65

4.0

1.9

34.67

38.31

g/l

28.93

596

1032

ILD medications

3238

6008

3.01

307.65

2.7

1.6

37.25

38.49

g/l

19.47

2883

5139

Condition for Implicit Sepsis (Organ dysfunction codes)

2427

6637

2.59

307.65

2.4

2.1

36.63

38.57

g/l

36.24

2123

5782

Renal failure

2298

4895

4.49

307.65

2.4

2.1

35.55

37.78

g/l

42.99

2053

4100

Polyarthropathies

2123

4580

3.13

307.65

2.3

2.2

36.97

37.93

g/l

9.09

1912

3969

Other bacterial diseases

2903

6837

2.77

307.65

2.6

2.0

35.97

38.92

g/l

93.65

2574

5880

ILD medications: prednisolone, methylprednisolone, prednisone

3124

5989

3.00

307.65

2.1

1.6

37.15

38.48

g/l

21.60

2771

5120

Chronic kidney disease

1658

3532

5.05

307.65

2.3

2.1

35.95

37.65

g/l

20.07

1491

2933

Inflammatory bowel disease treatment related agents

3049

6910

2.53

307.65

2.0

2.2

37.12

38.33

g/l

18.50

2703

5944

Liquid cancers, helper endpoint

1993

3771

5.02

307.65

6.3

1.2

37.80

37.50

g/l

1.15

1804

3193

Other systemic involvement of connective tissue (FG)

1005

2431

4.34

307.65

1.7

2.4

36.85

37.97

g/l

5.73

866

2055

Acute renal failure

960

2411

4.30

307.65

2.6

2.1

34.15

37.88

g/l

46.60

856

2021

All chronic kidney diseases

2371

4740

4.35

307.65

2.3

2.1

35.72

38.25

g/l

55.13

2138

4017

Other anaemias

2060

4885

4.32

307.65

2.5

2.1

36.40

37.48

g/l

10.68

1782

4114

All kidney diseases

3076

6865

3.17

307.65

2.3

2.1

36.43

38.69

g/l

59.41

2747

5920

General symptoms and signs

2579

5253

2.51

307.65

2.3

1.9

37.35

38.65

g/l

17.05

2278

4557

Implicit bacterial Sepsis

1599

4736

3.05

307.65

2.6

2.1

35.06

38.04

g/l

52.08

1372

4033

Second line medication for Crohn's disease

1738

6172

2.92

307.65

4.6

1.7

37.05

38.20

g/l

12.04

1575

5373

Multiple myeloma and malignant plasma cell neoplasms

438

547

10.28

307.65

18.2

1.5

37.60

37.22

g/l

0.59

410

473

Condition for Implicit Sepsis (Organ dysfunction codes)

2413

6758

2.59

307.65

2.4

2.1

36.38

38.50

g/l

42.07

2092

5875

ILD medications: immunosuppressive drugs

2170

5270

4.00

307.65

4.1

1.6

36.86

38.64

g/l

29.43

1982

4541

Oral corticosteroids

2973

6868

2.64

307.65

2.1

2.2

36.94

38.31

g/l

22.97

2642

5906

Other bacterial diseases

2869

7064

2.82

307.65

2.7

2.0

35.76

38.77

g/l

96.06

2543

6087

Systemic connective tissue disorders

1370

3950

3.68

307.65

1.8

2.2

36.22

37.84

g/l

14.57

1196

3367

Renal tubulo-interstitial diseases

2962

6958

3.30

307.65

2.3

2.1

36.13

38.48

g/l

63.74

2616

5995

Tramadol

2234

4868

2.90

307.65

2.2

1.9

37.44

38.08

g/l

4.16

1968

4196

Malaise and fatigue

1642

4166

3.30

307.65

2.2

2.0

36.09

38.44

g/l

34.78

1406

3560

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

3832

6585

4.22

307.65

2.4

2.0

37.10

38.25

g/l

19.28

3388

5670

Fever of other and unknown origin

1704

4659

3.37

307.65

3.6

2.0

36.04

38.57

g/l

42.08

1531

4019

Primary_lymphoid and hematopoietic malignant neoplasms

1237

2823

4.81

307.65

8.1

1.4

37.28

37.46

g/l

0.42

1145

2390

Other and unspecified polyneuropathies, also in other diseases

1055

2243

5.24

307.65

2.0

2.1

38.98

37.31

g/l

13.50

915

1922

Polyneuropathies and other disorders of the peripheral nervous system

1140

2580

4.87

307.65

2.3

2.1

38.83

37.24

g/l

13.42

993

2216

Implicit Sepsis

2464

6738

2.76

307.65

2.4

2.1

36.27

38.44

g/l

44.89

2119

5854

Bacterial infection, other or unspecified

1964

5424

3.30

307.65

3.0

2.0

34.84

38.40

g/l

90.26

1726

4598

Other and unspecified anaemias

2050

4852

4.34

307.65

2.5

2.1

36.39

37.48

g/l

10.54

1773

4087

Implicit Sepsis

2360

6558

2.81

307.65

2.4

2.1

36.06

38.34

g/l

47.04

2022

5673

L04AX Other immunosuppressants

1714

6022

2.96

307.65

4.7

1.7

37.04

38.18

g/l

11.87

1553

5238

First line medication for Crohn's disease

2952

5930

2.76

307.65

2.8

1.6

37.29

38.49

g/l

17.33

2643

5077

Bacterial Sepsis

1674

4833

3.10

307.65

2.8

2.1

35.11

38.07

g/l

53.87

1444

4120

Examination and observation for other reasons

1814

3339

3.25

307.65

2.3

2.1

37.83

37.66

g/l

0.48

1650

2963

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

655

506

19.43

307.65

7.2

1.3

38.57

37.47

g/l

3.00

590

427

Heart failure, not strict

2336

5892

2.79

307.65

2.3

2.2

35.65

38.62

g/l

78.59

2069

5073

Anaemias

763

443

11.83

307.65

2.3

1.3

37.02

40.16

g/l

18.66

696

400

Metabolic disorders

2437

6330

2.41

303.53

2.3

2.0

37.45

38.11

g/l

5.09

2142

5489

Pneumonias (Asthma/COPD co-morbidities)

2540

7483

2.33

302.85

2.8

1.9

36.32

38.57

g/l

53.57

2245

6500

All pneumoniae

2548

7506

2.32

300.33

2.8

1.9

36.33

38.58

g/l

53.49

2251

6522

Pneumonia, organism unspecified

2362

7153

2.37

295.28

2.8

1.9

36.19

38.55

g/l

55.27

2072

6215

Autoimmune diseases excluding thyroid diseases

2648

6374

2.32

294.75

2.0

2.3

37.26

38.12

g/l

8.70

2370

5489

Multiple myeloma

298

273

15.16

294.48

21.9

1.5

37.21

37.08

g/l

0.11

279

226

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

298

273

15.16

294.48

21.9

1.5

37.21

37.08

g/l

0.11

279

226

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2486

7551

2.30

287.59

2.8

2.0

36.33

38.53

g/l

51.10

2196

6560

Other systemic involvement of connective tissue

1027

3051

3.56

286.71

1.8

2.2

36.86

37.81

g/l

4.57

886

2601

Autoimmune diseases excluding thyroid diseases, strict definition

2553

6162

2.32

285.01

2.0

2.3

37.28

38.12

g/l

8.12

2283

5303

Other soft tissue disorders, not elsewhere classified

2361

5953

2.38

283.95

2.2

38.02

37.72

g/l

1.39

2097

5146

Influenza and pneumonia

2573

7391

2.26

282.51

2.8

1.9

36.45

38.62

g/l

49.91

2265

6434

Glomerular diseases

778

1953

4.30

279.62

2.6

2.1

34.37

37.88

g/l

32.94

712

1711

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2301

6008

2.37

277.84

2.8

1.8

36.39

38.48

g/l

41.84

2034

5205

2301

6008

2.37

277.84

2.8

1.8

36.39

38.48

g/l

41.84

2034

5205

Gout

1036

2866

3.36

255.54

2.9

2.3

36.43

37.36

g/l

4.75

928

2435

Finngen Rheumatological endpoints

2206

5521

2.32

249.64

2.0

2.3

37.84

38.35

g/l

3.06

1965

4814

Osteopathies and chondropathies

1616

6198

2.51

241.12

2.8

2.1

37.22

37.85

g/l

3.44

1337

5370

Erysipelas

1891

6258

2.37

239.94

2.0

35.97

38.72

g/l

59.98

1666

5354

Codeine

2101

4991

2.33

238.01

2.0

1.8

38.16

38.15

g/l

0.02

1853

4313

Unspecified kidney failure

512

1057

5.35

237.07

2.4

2.0

35.00

37.76

g/l

14.97

460

885

Heart failure,strict

1616

4609

2.57

236.05

2.1

2.2

35.38

38.39

g/l

60.61

1420

3908

Nephropathy related operations

565

1269

4.88

235.98

4.1

2.0

34.47

37.83

g/l

22.75

527

1112

Disorders of lipoprotein metabolism and other lipidaemias

2131

5957

2.27

233.78

2.3

2.1

37.57

37.96

g/l

1.92

1866

5142

Heart failure and antihypertensive medication

768

1313

4.00

225.41

2.0

2.3

35.47

38.91

g/l

32.41

683

1121

Oedema, not elsewhere classified

961

3123

3.16

223.94

2.3

2.0

36.16

38.30

g/l

18.83

838

2670

Infections, IBD-co-morbidities

430

491

6.51

223.32

3.7

2.1

36.61

38.33

g/l

4.15

377

434

Opioids

2127

5015

2.24

218.01

2.3

1.8

37.98

38.16

g/l

0.55

1885

4334

Asthma, unspecified (mode), excluding more controls

1229

3406

2.77

214.68

2.1

1.8

37.52

38.98

g/l

13.64

1088

2954

Gout, FINNGEN

1036

3659

2.97

214.29

2.9

2.2

36.43

37.43

g/l

5.72

928

3098

Other and unspecified iron deficiency

1074

3868

2.89

214.06

1.9

2.2

36.35

37.69

g/l

9.25

914

3297

Nutritional anaemias

1470

5959

2.46

211.15

1.9

2.2

36.34

37.57

g/l

10.56

1241

5089

Glomerular disorders in diseases classified elsewhere

520

1196

4.74

210.52

2.7

2.2

34.32

37.78

g/l

23.30

472

1058

Hypertensive diseases (excluding secondary)

1046

2003

3.10

207.45

2.1

2.0

37.91

39.80

g/l

15.27

955

1772

Other heart diseases

951

1982

3.20

206.48

2.2

1.9

37.11

39.82

g/l

26.05

860

1762

Pure hypercholesterolaemia

1915

5727

2.24

205.70

2.2

2.1

37.43

37.88

g/l

2.28

1669

4934

Iron deficiency anaemia

1283

5077

2.58

204.86

1.9

2.2

36.26

37.59

g/l

10.67

1080

4330

Abnormal findings on examination of blood, without diagnosis

1406

5383

2.49

204.15

2.5

2.2

36.71

37.61

g/l

5.74

1239

4662

Hypertension, essential

1695

4112

2.38

203.46

2.0

2.1

37.56

38.77

g/l

10.87

1521

3576

Diseases of arteries, arterioles and capillaries (FINNGEN)

690

1264

3.93

202.89

2.3

2.1

36.15

39.53

g/l

27.78

622

1101

Care involving dialysis

400

764

5.82

202.76

2.5

2.0

34.58

38.25

g/l

18.89

366

679

Autoimmune diseases related-to ILD

2041

8456

2.11

201.40

2.0

2.2

37.03

38.07

g/l

9.75

1814

7302

Certain infectious and parasitic diseases

2141

5031

2.17

200.59

2.3

1.8

37.25

38.92

g/l

24.32

1914

4309

Implicit viral Sepsis

923

3176

3.03

200.35

2.7

2.1

36.07

38.20

g/l

17.28

798

2707

Persons encountering health services for specific procedures and health care

2424

7322

2.02

198.37

2.4

2.0

37.19

38.26

g/l

12.47

2167

6329

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

425

876

5.43

198.07

3.2

2.1

35.65

37.47

g/l

6.40

365

752

Exposure to unspecified factor

2339

8511

2.01

197.86

2.1

2.2

37.66

37.88

g/l

0.91

2032

7401

Reimbursement for rheumatic diseases

1519

6665

2.33

196.69

1.7

2.3

36.90

38.04

g/l

10.12

1370

5714

Septicaemia

1226

4576

2.59

196.09

2.7

2.0

34.92

38.31

g/l

51.22

1064

3859

Explicit Sepsis

1252

4711

2.56

195.88

2.7

2.0

34.95

38.13

g/l

46.06

1088

4018

Pain in joint

1411

3677

2.50

194.18

2.0

2.1

38.28

37.78

g/l

2.00

1240

3184

Heart failure, strict

1750

5663

2.25

192.39

2.0

2.3

35.33

37.85

g/l

47.28

1533

4786

Asthma, unspecified (mode)

1277

3850

2.56

191.67

2.1

1.8

37.45

38.62

g/l

9.46

1128

3333

Codeine or tramadol medication

2601

7408

1.95

189.77

2.1

2.2

38.00

37.76

g/l

1.03

2288

6402

Other diseases of blood and blood-forming organs, wide

764

2443

3.30

189.50

3.1

2.1

37.63

37.76

g/l

0.21

694

2115

Ulcer of lower limb, not elsewhere classified

611

1724

3.82

186.28

2.3

2.2

34.09

37.59

g/l

27.75

546

1462

Hypertensive diseases

1651

4146

2.29

182.03

2.0

2.1

37.63

38.78

g/l

9.70

1491

3604

Hypertension

1647

4145

2.28

180.59

2.0

2.1

37.63

38.78

g/l

9.68

1487

3604

Dental caries

754

2345

3.21

180.26

3.2

2.1

35.77

37.66

g/l

10.78

672

2063

All-cause Heart Failure

1696

5588

2.21

178.76

2.0

2.3

35.34

37.84

g/l

45.69

1485

4718

Diverticular disease of intestine

1882

5775

2.13

178.59

2.4

2.2

37.46

37.72

g/l

1.00

1628

4997

Codes for special purposes

1364

6008

2.33

176.11

2.8

2.0

36.47

37.95

g/l

13.26

1187

5197

Osteoporosis

904

3069

2.89

175.95

2.2

2.1

37.34

37.22

g/l

0.21

704

2595

Provisional assignment of new diseases of uncertain etiology

1362

6002

2.33

175.66

2.7

2.0

36.47

37.95

g/l

13.35

1186

5191

Erysipelas

1453

5776

2.28

175.43

2.0

35.73

38.46

g/l

45.41

1280

4929

Asthma, excluding more controls

1557

3541

2.33

175.31

2.0

1.8

37.88

39.00

g/l

10.03

1388

3081

Covid-19 confirmed case

1091

4393

2.58

174.05

2.7

2.1

35.96

37.72

g/l

14.52

945

3764

Any gastric operation

1571

3441

2.33

173.87

2.1

1.8

37.91

38.77

g/l

5.31

1390

3004

GASTRO-related operations

1571

3441

2.33

173.87

2.1

1.8

37.91

38.77

g/l

5.31

1390

3004

Other arthritis (FG)

819

2855

2.97

172.96

2.2

2.4

36.98

38.33

g/l

8.14

734

2477

Acute tubulo-interstitial nephritis

1495

5897

2.24

171.75

2.1

36.11

38.31

g/l

30.07

1278

5024

Cardiovascular diseases (excluding rheumatic etc)

1060

2252

2.75

171.58

2.2

1.9

38.00

39.94

g/l

16.26

976

2006

Cerebrovascular diseases (FINNGEN)

716

1568

3.32

168.15

2.4

2.0

37.21

39.59

g/l

17.73

634

1374

Other specific joint derangements/joint disorders

1560

4616

2.22

166.63

1.9

2.2

38.39

38.12

g/l

0.88

1368

4039

Dyspnoea

2136

8250

1.95

165.49

2.2

37.04

37.91

g/l

8.48

1860

7148

Gout, idiopatic and unspecified

875

3261

2.83

164.92

2.0

2.3

36.41

37.38

g/l

4.67

783

2788

L04AA Selective immunosuppressants

665

2158

3.22

160.25

1.7

2.1

36.33

38.15

g/l

10.03

623

1899

Autoimmune diseases

2369

6399

1.91

159.69

2.0

2.3

37.59

38.12

g/l

3.32

2100

5510

Asthma

1643

4008

2.19

159.46

2.0

1.8

37.84

38.65

g/l

6.02

1466

3480

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

324

392

6.14

158.23

2.3

2.2

36.14

37.89

g/l

3.60

299

340

Other septicaemia

1061

4222

2.50

158.04

2.4

2.0

34.70

38.25

g/l

48.32

918

3551

Medical observation and evaluation for suspected diseases and conditions

1481

3379

2.28

157.68

2.1

37.92

37.62

g/l

0.90

1265

2990

Used for control exclusion in common control thyroid runs

2228

5879

1.94

157.45

2.0

2.3

37.63

38.12

g/l

2.70

1972

5069

Caries of dentine

661

2090

3.20

157.38

3.1

2.1

35.66

37.73

g/l

11.30

585

1845

Fall on same level

2417

7154

1.87

155.92

2.2

37.49

38.16

g/l

5.13

2035

6384

Abnormalities of breathing

1867

5431

2.03

154.13

2.2

2.1

37.43

38.06

g/l

3.99

1639

4745

Diseases of oesophagus, stomach and duodenum

2349

7643

1.87

153.46

1.9

2.2

37.62

37.95

g/l

1.59

2016

6679

Asthma (mode)

1607

4043

2.16

153.24

2.0

1.8

37.89

38.65

g/l

5.18

1438

3512

Oxycodone

1020

3781

2.52

152.95

4.1

2.0

36.18

37.62

g/l

9.59

862

3211

Other specified/unspecified arthritis

735

2591

2.94

152.30

2.1

2.3

37.09

38.01

g/l

3.85

654

2232

L04AD Calcineurin inhibitors

389

917

4.54

151.83

2.3

35.72

38.23

g/l

9.17

372

824

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2478

7434

1.84

151.12

2.1

2.2

37.80

37.81

g/l

0.04

2230

6375

Disorders resulting from impaired renal tubular function

227

335

7.94

151.01

2.3

2.7

36.43

37.96

g/l

2.84

215

299

Polymyalgia rheumatica

542

1637

3.56

148.91

1.7

2.2

35.68

37.36

g/l

6.89

448

1374

Asthma (only as main-diagnosis), excluding more controls

1378

3541

2.26

148.85

2.0

1.8

37.79

39.00

g/l

10.71

1229

3081

Other disorders of skin and subcutaneous tissue

1723

7827

2.00

148.10

2.1

2.2

36.39

37.85

g/l

16.59

1501

6722

Gout, strict definition

665

2290

3.08

145.86

2.1

2.3

36.02

37.40

g/l

6.81

597

1959

Preparatory care for dialysis

255

441

6.68

145.19

2.3

2.6

35.57

37.93

g/l

5.96

236

393

Certain infectious and parasitic diseases

1526

3571

2.17

144.60

2.2

1.8

37.26

38.90

g/l

16.95

1370

3053

Disturbances of skin sensation

708

2531

2.89

142.90

1.9

2.1

39.85

38.03

g/l

14.48

636

2234

Gout, unspecified

721

2622

2.90

142.70

2.1

2.2

36.42

37.44

g/l

4.51

654

2241

Diseases of arteries, arterioles and capillaries

1749

6671

1.98

141.37

2.0

2.3

36.20

37.66

g/l

16.65

1534

5684

Coagulation defects, purpura and other haemorrhagic conditions

608

2024

3.15

140.55

2.4

2.1

37.32

37.62

g/l

0.56

547

1758

Syncope and collapse

1067

3944

2.37

140.35

2.3

2.0

37.17

38.33

g/l

7.07

891

3371

Cardiovascular diseases

903

1814

2.71

139.95

2.1

1.7

38.17

40.03

g/l

12.57

827

1624

Other heart diseases, wide

1827

5793

1.96

138.53

2.2

2.1

37.21

38.83

g/l

20.90

1634

5067

Pain in throat and chest

1754

5383

1.99

138.09

2.2

2.1

37.96

38.03

g/l

0.15

1551

4698

Continuous positive airway pressure

543

1399

3.40

137.65

2.3

35.90

38.84

g/l

19.29

466

1230

Pain, not elsewhere classified

665

2344

2.92

137.41

2.6

2.0

37.57

38.82

g/l

5.48

592

2031

Complications of surgical and medical care, not elsewhere classified

2215

8473

1.82

137.21

2.1

2.2

37.20

37.92

g/l

5.64

1921

7344

Other diseases of intestines

2139

6647

1.86

136.03

2.3

2.1

37.94

38.03

g/l

0.26

1870

5808

Diabetic nephropathy, excluding more controls

493

1183

3.64

134.95

1.7

2.1

34.85

37.70

g/l

16.15

442

999

Symptoms and signs involving the skin and subcutaneous tissue

1626

8281

1.96

134.66

2.2

38.62

37.66

g/l

8.55

1426

7155

Low back pain

1637

6010

1.99

134.25

2.5

2.0

37.93

37.67

g/l

0.92

1435

5207

Hypertensive heart and/or renal disease

771

2148

2.78

134.17

1.9

2.2

36.06

37.95

g/l

11.99

685

1793

Abnormalities of gait and mobility

478

1428

3.59

133.64

1.9

2.2

38.53

37.27

g/l

4.67

430

1239

Heart failure and bmi 25plus

968

2708

2.50

133.15

2.0

2.4

35.52

37.74

g/l

20.77

840

2252

Symptoms and signs involving cognition, perception, emotional state and behaviour

2121

8069

1.82

131.61

1.9

2.2

37.89

37.80

g/l

0.30

1821

7053

Asthma (only as main-diagnosis)

1435

4008

2.11

130.71

2.0

1.8

37.69

38.65

g/l

7.28

1277

3480

Persons encountering health services in other circumstances, wide

2511

7475

1.75

129.44

2.1

2.2

37.76

37.80

g/l

0.11

2247

6402

Viral Sepsis

613

2150

2.98

128.91

3.1

1.9

35.79

38.11

g/l

13.38

528

1830

Implicit viral Sepsis

611

2150

2.97

127.73

3.1

1.9

35.77

38.11

g/l

13.61

526

1830

Diseases of the skin and subcutaneous tissue

2076

5700

1.85

127.24

2.1

37.58

38.10

g/l

2.90

1831

4922

Headache

1238

4694

2.14

126.79

2.1

1.9

38.61

38.77

g/l

0.41

1089

4067

Non-Hodgkin lymphoma, all, including Hilmo

481

1490

3.43

126.43

2.8

1.4

36.58

37.67

g/l

2.94

447

1258

Disorders of thyroid, IBD co-morbidities

334

509

4.72

125.93

1.9

2.1

37.88

38.48

g/l

0.84

294

447

Transplanted organ and tissue status

360

928

4.15

124.80

4.2

2.0

36.48

38.33

g/l

5.48

341

820

Rheumatoid arthritis

836

3084

2.50

124.29

1.8

2.4

36.74

37.85

g/l

5.83

749

2627

Enlarged lymph nodes

440

1300

3.53

123.41

2.1

2.0

37.64

38.68

g/l

2.57

408

1135

Glomerulonephritis

366

972

4.03

121.75

2.8

2.2

34.30

37.84

g/l

14.49

342

862

Neurological diseases, wide definition

448

577

3.96

119.93

2.2

2.0

38.64

38.59

g/l

0.04

408

511

Spondylopathies

1786

5778

1.88

118.81

2.4

2.1

38.00

37.52

g/l

2.47

1574

4981

Other necrotizing vasculopathies (FG)

252

515

5.34

117.97

1.5

2.7

33.46

38.10

g/l

17.36

221

441

Small fibre neuropathy

183

284

7.58

116.41

2.4

2.2

39.13

37.15

g/l

3.29

157

249

Other disorders of fluid, electrolyte and acid-base balance

843

3439

2.41

116.28

2.4

2.1

35.73

37.57

g/l

12.41

720

2912

Benign neoplasm of colon, rectum, anus and anal canal

1600

7522

1.89

115.68

2.3

37.30

37.49

g/l

0.59

1361

6466

Other pulmonary diagnosis

1567

4049

1.97

114.66

2.4

1.8

37.51

38.65

g/l

9.28

1396

3517

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

608

1005

3.08

114.38

2.2

1.8

38.03

39.13

g/l

3.28

551

894

Non-ischemic cardiomyopathy

906

3210

2.35

113.83

2.1

2.3

35.25

37.81

g/l

24.16

784

2686

Type 2 diabetes, wide definition

1843

6578

1.83

113.65

1.9

2.4

36.61

38.03

g/l

16.97

1602

5680

Atrial fibrillation and flutter

640

1501

2.83

112.65

2.5

2.0

36.64

39.52

g/l

20.79

581

1313

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1592

7773

1.87

112.65

2.3

2.2

37.01

37.66

g/l

3.91

1394

6663

Asthma (diagnoses ohter than nonallergic)

1857

8765

1.78

112.14

2.0

2.2

37.61

37.85

g/l

0.95

1635

7574

COPD/asthma related infections

2096

6008

1.77

111.14

2.8

1.8

37.16

38.48

g/l

16.61

1857

5205

COPD/asthma/ILD related infections

2096

6008

1.77

111.14

2.8

1.8

37.16

38.48

g/l

16.61

1857

5205

Other CVD (FINNGEN)

352

709

4.04

111.05

2.8

2.1

36.51

39.28

g/l

12.09

297

601

Symptoms and signs concerning food and fluid intake

332

880

3.97

109.78

1.9

2.1

38.17

38.13

g/l

0.04

296

751

Dorsalgia

1996

6087

1.78

109.60

2.2

2.0

38.11

37.65

g/l

2.35

1748

5271

Excluding asthma or asthma-COPD overlap

1548

4049

1.94

109.40

2.4

1.8

37.54

38.65

g/l

8.86

1384

3517

Bleeding

1890

7703

1.77

108.64

2.2

36.41

37.91

g/l

19.43

1642

6638

Follow-up examination after treatment for conditions other than malignant neoplasms

958

2849

2.27

108.11

2.2

2.1

37.85

37.71

g/l

0.30

853

2533

COPD differential diagnosis

1537

4043

1.93

106.87

2.4

1.8

37.52

38.65

g/l

8.99

1378

3512

ILD differential diagnosis

1537

4043

1.93

106.86

2.4

1.8

37.52

38.65

g/l

8.99

1378

3512

Lower back pain or/and sciatica

2199

8608

1.69

105.23

2.3

2.1

37.94

37.80

g/l

0.48

1926

7464

Asthma, hospital admission 2, infections

1295

6654

1.94

104.74

2.2

36.97

37.78

g/l

5.06

1147

5703

Asthma-related infections

1295

6654

1.94

104.74

2.2

36.97

37.78

g/l

5.06

1147

5703

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

748

1913

2.51

104.52

2.0

37.23

39.72

g/l

19.37

679

1692

Nephrotic syndrome

164

257

7.24

102.55

2.5

2.7

31.67

38.15

g/l

15.22

158

229

Symptoms and signs involving the urinary system

1736

7549

1.78

102.55

2.1

2.2

37.43

37.70

g/l

0.97

1476

6530

Seropositive rheumatoid arthritis

624

2473

2.59

102.01

1.8

2.5

36.76

38.06

g/l

6.30

561

2090

Other necrotizing vasculopathies

293

758

4.19

101.77

1.7

2.5

33.51

37.82

g/l

18.27

259

662

Adjustment and management of implanted device

597

2357

2.65

100.20

2.6

2.0

36.65

37.54

g/l

2.98

536

1967

Endocrine, nutritional and metabolic diseases

1390

3656

1.95

99.89

2.0

2.1

37.78

38.67

g/l

5.09

1245

3224

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

175

304

6.70

99.55

2.1

1.3

39.28

37.45

g/l

2.97

163

255

Chronic lymphocytic leukaemia

175

304

6.70

99.55

2.1

1.3

39.28

37.45

g/l

2.97

163

255

Chronic lymphocytic leukaemia, helper endpoint

175

304

6.70

99.55

2.1

1.3

39.28

37.45

g/l

2.97

163

255

Constipation

1934

7917

1.72

98.68

2.6

2.1

37.77

37.68

g/l

0.23

1625

6903

Other and unspecified dermatitis

1153

5959

1.97

98.19

2.0

2.2

37.87

37.80

g/l

0.15

1016

5134

Disorders of mineral metabolism

295

784

4.01

98.01

3.5

2.2

36.32

37.81

g/l

2.87

248

688

Chronic gastritis

775

3466

2.31

97.91

2.1

2.3

37.00

37.37

g/l

0.86

657

2969

Soft tissue disorders

1985

5986

1.73

97.83

2.2

38.19

37.73

g/l

2.42

1755

5172

Depression medications

368

479

3.91

97.49

1.7

1.2

38.56

40.40

g/l

5.08

352

435

Osteoporosis with pathological fracture (FG)

270

678

4.29

97.43

1.6

2.4

37.47

37.68

g/l

0.21

199

552

Diabetic nephropathy

496

1788

2.89

97.31

1.7

2.0

34.81

37.12

g/l

12.05

444

1535

Purpura and other haemorrhagic conditions

419

1395

3.16

97.24

2.5

2.2

37.56

37.57

g/l

0.01

377

1220

Diaphragmatic hernia

954

4640

2.12

97.17

2.3

2.1

37.06

37.50

g/l

1.41

819

3963

Disorders of calcium metabolism

252

604

4.51

96.84

3.8

2.2

36.03

37.80

g/l

3.34

211

532

360

1096

3.42

96.45

2.2

2.1

37.22

38.26

g/l

2.08

323

963

Cardiomyopathy

505

1871

2.81

95.92

2.6

2.1

36.14

38.27

g/l

10.29

452

1591

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

17.56

95.65

11.2

1.2

37.87

37.78

g/l

0.04

Pain (limb, back, neck, head abdominally)

1443

3859

1.90

95.65

2.1

37.83

37.69

g/l

0.31

1280

3317

Dermatitis and eczema

2247

8589

1.64

95.31

1.9

2.2

38.12

37.74

g/l

2.14

1983

7431

Any reimbursement code in KELA

880

1949

2.29

95.00

2.3

1.5

38.09

39.90

g/l

12.15

810

1681

Haemorrhage from respiratory passages

864

3648

2.19

94.96

2.2

36.57

37.43

g/l

3.75

759

3110

Other dorsopathies, not elsewhere classified

1969

6092

1.71

94.29

2.1

2.0

38.36

37.65

g/l

5.10

1719

5276

Symptoms and signs involving the circulatory and respiratory systems

1866

5439

1.74

93.51

2.1

38.00

38.07

g/l

0.16

1656

4753

Other disorders of white blood cells

227

518

4.78

93.20

2.0

2.4

38.08

37.50

g/l

0.59

201

460

Parasetamol

1346

3595

1.92

92.76

2.2

1.9

37.57

38.44

g/l

4.67

1194

3188

Hypertensive Renal Disease

176

325

5.98

92.67

1.7

2.4

36.66

37.75

g/l

1.30

167

275

Asthma-related pneumonia or sepsis

908

4410

2.11

92.00

2.2

2.1

36.16

37.44

g/l

8.34

811

3706

Asthma, hospital admissions 3, pneumonia

908

4410

2.11

92.00

2.2

2.1

36.16

37.44

g/l

8.34

811

3706

Secondary hypertension

223

494

4.68

91.95

2.2

2.1

36.61

39.30

g/l

6.94

208

426

Benign neoplasm: Colon

1350

7152

1.84

91.89

2.3

37.31

37.44

g/l

0.30

1138

6159

Complications of medical and surgical care

1601

8554

1.75

91.70

2.2

37.06

37.85

g/l

5.11

1394

7388

Intestinal infectious diseases

2336

8357

1.62

91.49

2.5

2.1

37.19

37.98

g/l

7.01

2053

7229

Other antidepressants

2111

6565

1.67

91.27

2.0

2.2

38.04

37.69

g/l

1.57

1810

5744

Symptoms and signs involving the nervous and musculoskeletal systems

1294

7106

1.86

91.24

2.0

2.2

38.79

37.51

g/l

11.96

1141

6117

Asthma-related pneumonia

905

4404

2.10

91.24

2.2

2.1

36.15

37.44

g/l

8.32

808

3700

Other and unspecified diseases of blood and blood-forming organs

150

244

7.07

90.85

5.0

2.5

38.07

37.70

g/l

0.26

142

221

Other disorders of urethra and urinary system

1459

5902

1.81

90.62

2.1

2.2

37.01

37.89

g/l

5.85

1273

5090

Extracorporeal dialysis

243

598

4.42

90.45

2.4

34.20

37.94

g/l

11.87

220

537

Hyperlipidaemia, other/unspecified

955

4364

2.07

90.43

2.4

2.1

37.16

37.54

g/l

1.12

818

3714

Cardiac arrhythmias

1043

3371

2.04

90.38

2.3

2.1

37.72

39.25

g/l

11.54

940

2985

Diseases of the musculoskeletal system and connective tissue

886

2018

2.23

89.91

2.2

2.0

38.08

38.24

g/l

0.29

800

1759

Other diseases of urinary system

2019

6886

1.67

89.38

2.1

2.2

37.40

37.98

g/l

3.74

1775

6003

Intestinal infectious diseases

1900

8774

1.66

88.32

2.6

2.0

36.98

38.01

g/l

9.87

1674

7595

Valvular heart disease excluding rheumatic fever

1075

3983

1.99

88.16

2.4

2.2

36.66

38.45

g/l

17.51

932

3414

ILD medications: azathioprine

327

990

3.41

88.14

1.7

1.5

36.57

38.81

g/l

7.08

296

869

Diarrhoea and gastroenteritis of presumed infectious origin

1436

7366

1.78

87.81

2.6

2.0

36.99

37.98

g/l

7.31

1266

6357

Atrial fibrillation and flutter with reimbursement

537

1287

2.72

87.43

2.6

2.1

36.18

39.43

g/l

21.98

480

1119

Dermatitis

1311

7298

1.82

87.26

2.0

2.2

37.95

37.73

g/l

0.66

1151

6293

Diseases of liver

834

4017

2.13

87.07

1.8

2.3

36.54

37.95

g/l

7.41

711

3517

Complications of procedures, not elsewhere classified

1686

8299

1.71

87.05

2.0

2.2

37.31

37.90

g/l

3.27

1469

7185

Non-rheumatic valve diseases

1070

3978

1.98

86.72

2.4

2.2

36.68

38.45

g/l

17.16

927

3409

Malignant immunoproliferative diseases

102

116

11.95

86.58

10.0

2.3

37.42

37.22

g/l

0.10

103

Rheumatoid arthritis, including avohilmo

925

4644

2.04

86.18

1.8

2.2

36.94

37.69

g/l

3.43

827

3955

STROKE

1172

4224

1.92

85.96

2.5

2.3

37.36

38.46

g/l

7.56

1018

3652

Antihypertensive medication - note that there are other indications

847

2056

2.21

85.64

2.0

38.33

39.62

g/l

6.29

769

1812

Fracture of lumbar spine and pelvis

630

2747

2.37

84.42

2.2

2.1

36.54

37.18

g/l

1.51

485

2309

Hypertensive Heart Disease

618

2049

2.44

84.17

2.0

2.2

35.92

37.91

g/l

11.13

538

1706

Heart failure and coronary heart disease

1150

4355

1.92

83.86

1.8

2.4

35.56

37.42

g/l

19.28

1008

3654

Genitourinary diseases

1038

2596

2.03

83.47

1.9

2.1

37.68

38.72

g/l

4.84

941

2280

Lymphoid leukaemia

235

600

4.27

83.40

2.8

2.5

38.77

37.41

g/l

2.49

219

525

Non-follicular lymphoma

342

1114

3.27

83.14

2.6

2.3

36.50

37.53

g/l

2.11

319

972

Periodontitis

2004

8352

1.63

83.01

2.1

2.2

37.52

37.87

g/l

1.59

1723

7277

Cerebrovascular diseases

1697

7155

1.70

82.78

2.3

2.2

36.84

37.65

g/l

5.98

1431

6200

Spinal stenosis

1211

5032

1.86

82.69

2.0

2.1

37.92

37.27

g/l

3.22

1034

4295

Chronic periodontitis, including avohilmo

1998

8349

1.63

82.64

2.1

2.2

37.53

37.87

g/l

1.50

1716

7275

Neoplasms

1223

3459

1.89

82.21

2.5

1.2

38.28

38.33

g/l

0.09

1112

3025

Chronic lower respiratory diseases

2326

7940

1.58

81.31

2.0

2.2

37.50

38.02

g/l

3.64

2060

6875

Injuries to the abdomen, lower back, lumbar spine and pelvis

922

4663

2.00

81.20

2.3

2.1

36.97

37.66

g/l

2.44

742

3998

896

4515

2.00

80.08

2.3

2.1

37.36

37.98

g/l

2.30

795

3890

Kidney transplant status

188

416

4.87

79.96

1.7

2.4

35.52

38.73

g/l

7.58

181

378

Use of hypnotics and sedatives

2124

7726

1.60

79.50

2.4

2.2

37.75

37.87

g/l

0.36

1843

6739

Bacterial pneumoniae

938

4259

1.98

79.19

3.3

1.9

36.01

38.30

g/l

23.92

857

3643

Neurological diseases

1551

4513

1.75

79.14

2.1

2.2

38.53

37.44

g/l

8.49

1354

3966

Other external causes of accidental injury

1545

4479

1.75

79.02

2.0

2.2

37.72

38.13

g/l

1.60

1334

4004

Disorders of other endocrine glands

926

4707

1.97

78.77

2.4

2.1

37.56

37.81

g/l

0.59

804

4047

Arthropathies

1613

4796

1.72

78.70

1.9

2.2

38.11

38.06

g/l

0.11

1443

4177

Hypothyroidism (congenital or acquired)

301

466

3.69

77.79

2.4

1.2

38.31

40.28

g/l

4.60

277

422

Bacterial pneumonia, not elsewhere classified

902

4062

2.00

77.77

3.3

1.9

35.96

38.27

g/l

23.05

831

3463

Chronic apical periodontitis

2213

8109

1.57

77.39

2.2

2.1

37.66

37.91

g/l

1.03

1903

7074

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

24.87

77.20

12.7

1.1

38.05

37.83

g/l

0.07

Other disorders of kidney and ureter

402

1490

2.83

76.89

2.4

2.2

37.01

37.53

g/l

1.02

377

1302

Need for other prophylactic measures

211

528

4.29

76.56

2.2

2.3

37.29

37.84

g/l

0.55

205

468

Hypothyroidism and >3 levothyroxin purchases

298

465

3.67

76.33

2.4

1.2

38.42

40.30

g/l

4.37

274

421

Hypothyroidism, levothyroxine purchases

298

465

3.67

76.33

2.4

1.2

38.42

40.30

g/l

4.37

274

421

Amyloidosis

130

219

6.84

76.17

7.3

2.3

35.92

37.21

g/l

1.13

121

195

Amyloidosis, other/unspecified

118

181

7.71

76.10

7.8

2.4

35.86

37.31

g/l

1.23

111

160

COPD (mode)

721

2669

2.17

76.05

1.9

35.60

38.18

g/l

22.10

618

2266

Viral hepatitis, IBD co-morbidity

110

152

7.50

75.62

1.5

1.7

37.71

38.83

g/l

0.68

140

Disorders of parathyroid gland

580

2531

2.35

75.60

2.4

2.1

37.55

37.27

g/l

0.52

493

2129

Unspecified privation

322

1066

3.17

75.58

1.9

2.2

36.10

37.75

g/l

4.34

290

944

Other and unspecified disorders of white blood cells

178

397

4.93

75.51

1.9

2.5

38.56

37.53

g/l

1.07

162

352

Hypothyroidism, drug reimbursement

216

356

4.37

74.91

2.3

1.3

38.22

39.99

g/l

3.59

199

317

Other diseases of blood and blood-forming organs

243

683

3.80

74.71

4.1

2.3

38.43

37.77

g/l

0.93

221

607

Persons encountering health services for specific procedures, not carried out

242

676

3.76

74.46

2.1

2.0

37.97

38.61

g/l

0.93

224

606

Spondylosis

1181

5420

1.81

74.31

2.1

38.29

37.47

g/l

5.10

1033

4671

Falls/tendency to fall

1984

6247

1.61

74.18

2.1

2.2

37.74

38.17

g/l

2.13

1697

5594

Dizziness and giddiness

1551

7460

1.67

73.83

2.0

2.3

38.04

37.70

g/l

1.41

1333

6484

Injuries to the head

2145

8549

1.56

73.66

2.2

37.31

37.99

g/l

4.82

1826

7476

Accidents

1520

4479

1.72

73.44

2.0

2.2

37.73

38.13

g/l

1.52

1311

4004

Sulfasalazine

586

2623

2.28

73.42

1.7

2.3

37.55

38.36

g/l

2.55

529

2269

Sicca syndrome [Sjögren]

273

839

3.45

72.85

1.7

2.4

38.52

38.11

g/l

0.57

239

728

Infections of the skin and subcutaneous tissue

1141

6391

1.80

72.79

2.3

2.1

36.75

38.09

g/l

9.60

1018

5596

Injuries to the hip and thigh

1123

5714

1.81

72.65

2.0

2.2

36.73

37.45

g/l

3.00

867

4932

Other disorders of veins

908

4782

1.93

72.15

2.1

2.2

37.25

38.01

g/l

3.30

782

4130

Venous thromboembolism

1252

7044

1.75

72.14

2.4

2.2

36.46

37.57

g/l

8.25

1095

5999

Dorsopathies

1909

6096

1.61

71.91

2.2

2.0

38.40

37.66

g/l

5.32

1681

5279

Azathioprine

327

1118

3.02

71.88

1.7

2.3

36.57

38.52

g/l

5.68

296

985

Certain disorders involving the immune mechanism

477

1984

2.49

71.39

2.7

2.1

37.88

37.89

g/l

0.01

438

1740

Myalgia

494

2095

2.42

70.30

1.8

2.0

38.60

37.87

g/l

1.80

425

1824

Gastrointestinal diseases

972

2529

1.95

69.90

2.3

1.9

37.81

38.57

g/l

2.86

867

2246

SLE (Finngen)

134

249

5.85

69.87

1.8

2.2

35.56

38.45

g/l

4.42

123

225

Other joint disorders

1519

4794

1.69

69.80

1.9

2.2

38.51

38.06

g/l

1.97

1340

4175

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1317

6250

1.72

69.26

2.1

2.4

36.60

37.59

g/l

6.66

1133

5338

Malignant neoplasm

1619

5891

1.65

69.00

3.6

1.4

37.96

38.08

g/l

0.31

1454

5098

Abnormal findings on diagnostic imaging of lung

1147

6347

1.77

68.35

2.3

2.2

36.70

37.48

g/l

4.05

993

5417

Persons encountering health services for examination and investigation

1201

3379

1.80

68.31

2.0

2.1

37.93

37.62

g/l

0.83

1054

2990

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1851

7717

1.58

68.00

2.5

2.1

37.26

38.03

g/l

5.64

1609

6780

Disorders of eyelid, lacrimal system and orbit

1738

8393

1.59

67.83

2.4

2.1

38.12

37.63

g/l

2.82

1484

7273

Other diseases of pleura

1102

5506

1.79

67.77

2.4

2.2

35.84

37.45

g/l

13.79

964

4678

Peripheral artery disease

1098

4955

1.80

67.74

2.0

2.3

35.36

37.40

g/l

19.73

960

4172

Malignant neoplasm, wide definition for exclusion

1640

5962

1.63

67.56

3.5

1.4

37.90

38.10

g/l

0.60

1478

5166

2229

7622

1.53

67.25

2.9

1.9

37.53

37.94

g/l

2.32

1958

6572

Weight loss

307

1061

3.04

67.02

2.1

2.2

38.09

37.57

g/l

0.73

274

925

Cough

829

4123

1.94

66.61

2.3

2.1

38.08

37.88

g/l

0.45

720

3559

Myelodysplastic syndrome, including Hilmo

145

305

5.30

66.33

2.1

1.3

37.70

37.03

g/l

0.52

129

253

Other/unspecified dorsalgia

770

3938

1.97

66.00

2.7

2.0

37.63

37.62

g/l

0.01

664

3376

Statin medication

1156

3676

1.79

65.93

2.0

2.3

37.81

38.49

g/l

2.88

1040

3167

Chronic rhinitis, nasopharyngitis and pharyngitis

672

3310

2.07

65.92

2.0

2.2

38.44

37.94

g/l

1.43

589

2904

Explicit bacterial Sepsis

297

1017

3.05

65.58

3.9

2.0

35.66

38.17

g/l

8.09

263

877

Seronegative rheumatoid arthritis

294

1000

3.05

65.57

2.0

2.7

36.67

38.09

g/l

3.49

264

867

Exposure to other specified factors

1410

7948

1.65

65.51

2.0

2.2

37.48

38.05

g/l

2.66

1201

6991

Care involving use of rehabilitation procedures

1242

6795

1.70

65.36

2.3

2.0

37.58

38.15

g/l

2.68

1147

5849

Thrombocytopenia, unspecified

238

721

3.51

65.16

2.0

2.4

37.14

37.65

g/l

0.56

209

639

Viral infections characterized by skin and mucous membrane lesions

1645

8952

1.59

65.07

2.6

2.1

37.96

37.84

g/l

0.34

1435

7786

Intracranial trauma

965

3701

1.85

65.03

2.2

2.1

37.90

37.69

g/l

0.44

816

3267

Diarrhoea and gastroenteritis of presumed infectious origin

1933

8342

1.54

64.50

2.4

2.1

37.27

37.99

g/l

5.16

1698

7218

Mood disorders, excluding more controls

1800

6895

1.58

64.45

2.0

2.3

38.26

37.83

g/l

2.04

1551

6067

Streptococcal septicaemia

257

819

3.29

64.44

3.8

2.0

35.49

38.52

g/l

9.67

226

699

Isolated proteinuria

125

237

5.83

64.12

3.0

2.7

35.89

37.99

g/l

2.78

116

209

Abnormal weight loss

290

998

3.07

63.92

1.9

2.2

38.23

37.57

g/l

0.99

259

872

Paroxysmal tachycardia

390

1272

2.62

63.85

1.8

2.1

37.51

39.53

g/l

8.47

340

1106

Diseases of the respiratory system

1206

3468

1.76

63.71

2.4

1.8

37.54

38.51

g/l

5.90

1074

2997

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1287

7716

1.67

63.44

2.1

2.2

37.04

37.78

g/l

3.88

1123

6642

Disorders of lens

1421

5420

1.66

63.20

2.3

2.2

37.28

37.88

g/l

2.96

1225

4814

Haemolytic anaemias

143

310

5.04

62.74

3.5

2.0

38.42

37.50

g/l

0.89

132

270

Other medical care

1007

5149

1.79

62.52

3.1

2.1

35.89

37.74

g/l

16.76

896

4362

Mixed connective tissue disease

208

594

3.72

62.42

1.7

2.4

36.95

38.05

g/l

1.53

191

526

Asthma, including avohilmo

2230

8453

1.50

62.38

2.0

2.2

37.72

37.85

g/l

0.45

1972

7306

Other symptoms and signs involving cognitive functions and awareness

1046

5487

1.77

62.23

1.9

2.3

37.36

37.40

g/l

0.07

851

4710

Idiopathic gout

300

1071

2.96

61.95

2.0

2.3

35.98

37.54

g/l

3.71

262

923

Other specified/unspecified systemic involvement of connective tissue

188

504

3.97

61.90

1.8

2.6

37.28

38.25

g/l

1.17

176

444

Cystitis

1624

6107

1.60

61.87

2.1

2.2

37.63

37.89

g/l

0.94

1397

5279

Disorders of choroid and retina

1704

7828

1.57

61.41

2.3

2.2

37.06

37.65

g/l

3.56

1440

6780

Pruritus

297

1056

2.93

61.28

1.8

2.2

38.66

37.62

g/l

2.30

264

925

Speech therapy

634

3149

2.07

61.23

2.3

2.1

37.14

37.69

g/l

1.52

589

2697

Acquired haemolytic anaemia

123

241

5.75

61.21

3.8

2.1

38.03

37.53

g/l

0.35

114

211

Giant cell arteritis

175

453

4.23

61.20

1.5

2.7

33.26

37.48

g/l

11.73

149

390

Other special examinations and investigations of persons without complaint or reported diagnosis

1161

3379

1.76

61.11

2.0

2.1

38.17

37.62

g/l

2.11

1014

2990

Pulmonary heart disease, diseases of pulmonary circulation

787

4212

1.91

60.95

2.3

2.2

36.40

37.46

g/l

5.12

694

3578

Bacterial pneumonia (organism specified)

998

5177

1.78

60.78

3.5

2.0

35.92

37.72

g/l

16.47

912

4375

Systemic lupus erythematosus

134

283

5.13

60.50

1.8

1.9

35.56

38.34

g/l

4.19

123

256

DVT of lower extremities and pulmonary embolism

977

5573

1.78

60.29

2.5

2.2

36.54

37.49

g/l

5.08

849

4746

Dialysis

139

304

4.93

60.08

2.3

1.8

34.54

38.74

g/l

9.19

131

274

Atherosclerosis, excluding cerebral and coronary sclerosis

1030

4700

1.77

60.08

2.0

2.3

35.38

37.33

g/l

17.23

901

3949

Gingivitis and periodontal diseases

1981

6761

1.53

60.04

2.3

2.1

37.75

37.68

g/l

0.17

1715

5839

Any event in cancer register

1675

6328

1.58

59.90

3.4

1.5

37.97

38.06

g/l

0.22

1495

5499

Unspecified haematuria

967

4550

1.80

59.73

2.1

2.3

36.96

37.51

g/l

1.92

835

3928

Hard cardiovascular diseases

1631

6218

1.58

59.56

2.2

2.3

37.21

38.25

g/l

8.74

1445

5400

Other arthrosis

1047

4180

1.76

58.97

2.1

2.3

38.20

37.85

g/l

1.10

921

3619

Other diseases of hard tissues of teeth

1250

3853

1.70

58.56

2.1

37.90

37.32

g/l

2.49

1065

3337

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1890

8052

1.52

58.38

2.2

36.94

37.94

g/l

9.37

1654

6989

Gastro-oesophageal reflux disease

1330

7138

1.63

58.29

1.8

2.3

38.04

37.88

g/l

0.40

1105

6241

Depression or dysthymia

1344

4529

1.66

58.20

2.2

2.3

37.93

37.63

g/l

0.90

1137

4026

Implicit fungal Sepsis

215

656

3.47

58.18

2.7

2.1

35.38

38.15

g/l

6.92

183

573

Other disorders involving the immune mechanism, not elsewhere classified

124

254

5.33

58.17

2.0

2.6

35.87

38.08

g/l

2.63

116

230

Diseases of the eye and adnexa

1309

3955

1.67

57.75

2.1

2.0

38.38

38.14

g/l

0.66

1182

3522

Hernia

1795

7951

1.53

57.67

2.4

2.1

37.61

37.85

g/l

0.88

1549

6883

Obesity related asthma

711

3753

1.93

57.27

1.9

2.3

37.91

37.99

g/l

0.15

618

3286

Diabetes, varying definitions

1878

7316

1.52

57.26

1.9

2.3

37.08

38.24

g/l

11.95

1636

6350

Benign neoplasms

1754

6312

1.55

57.19

2.3

2.1

37.82

37.90

g/l

0.18

1535

5536

Non-allergic asthma (mode), excluding more controls

373

1515

2.49

57.11

1.8

1.7

37.55

38.88

g/l

4.55

329

1289

Other intervertebral disc disorders

1547

5941

1.58

57.04

2.1

2.0

38.31

37.58

g/l

4.76

1353

5133

Benzodiazepine use

1915

8863

1.50

56.92

2.0

2.2

37.81

g/l

0.01

1605

7755

Other arrhythmias

1152

5221

1.68

56.57

2.1

37.72

38.68

g/l

6.01

990

4545

Polyuria

563

2764

2.10

56.31

2.0

2.3

37.95

37.47

g/l

1.11

487

2388

Hyperparathyroidism

487

2237

2.22

56.27

2.5

2.1

37.53

37.30

g/l

0.35

416

1879

Diabetes mellitus

1878

7322

1.51

56.20

1.9

2.3

37.09

38.24

g/l

12.02

1635

6357

Nerve, nerve root and plexus disorders

2045

8523

1.48

56.07

2.1

2.2

37.99

37.71

g/l

1.21

1785

7384

Vocal cord dysfunction

248

741

3.07

55.53

2.5

2.4

38.04

39.33

g/l

2.41

209

678

Cardiomyopathy, other and unspecified

231

760

3.19

55.02

2.3

2.1

36.90

38.40

g/l

3.08

208

647

Asthma, hospital admissions , main diagnosis only

1529

8790

1.55

54.86

2.0

2.2

37.65

37.88

g/l

0.81

1350

7604

Injuries to the thorax

974

5723

1.73

54.70

2.3

2.2

37.08

37.61

g/l

1.80

814

4953

Seropositive rheumatoid arthritis, wide

624

3209

1.99

54.64

1.8

2.2

36.76

37.70

g/l

3.73

561

2739

Bronchitis

2019

8687

1.48

54.49

3.1

1.9

37.39

37.90

g/l

2.98

1772

7515

Other cataract

983

4336

1.75

54.47

2.4

2.2

37.36

37.72

g/l

1.11

842

3824

Pulmonary embolism

709

3809

1.91

54.34

2.4

2.2

36.38

37.47

g/l

4.74

624

3243

Hypercalcemia

172

479

3.90

54.15

4.4

2.4

35.74

37.48

g/l

2.57

149

414

Insulin medication

1216

6340

1.64

53.99

2.0

2.3

35.77

37.85

g/l

24.53

1058

5458

Sciatica+with lumbago

965

5203

1.73

53.88

1.9

2.1

38.10

37.71

g/l

1.25

853

4514

Type 2 diabetes

1840

7205

1.51

53.87

1.9

2.3

37.06

38.18

g/l

11.28

1601

6247

Pulmonary heart disease

709

3820

1.90

53.86

2.4

2.2

36.38

37.46

g/l

4.65

624

3252

Diseases of oral cavity, salivary glands and jaws

1245

3898

1.66

53.77

2.1

37.39

37.28

g/l

0.22

1060

3371

Gonarthrosis [arthrosis of knee](FG)

1372

5010

1.61

53.69

1.8

2.4

37.50

38.13

g/l

3.07

1196

4340

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

609

3126

2.00

53.65

1.8

2.2

36.76

37.71

g/l

3.68

547

2673

Vasculitis limited to skin, not elsewhere classified

118

250

5.22

53.47

2.5

2.7

37.24

37.63

g/l

0.25

112

221

Other/unspecified seropositive rheumatoid arthritis

617

3186

1.99

53.40

1.8

2.2

36.75

37.70

g/l

3.72

554

2722

Hypo-osmolality and hyponatraemia

431

1941

2.28

53.04

2.5

2.0

35.99

37.35

g/l

4.07

371

1612

Coxarthrosis [arthrosis of hip](FG)

1068

4496

1.69

52.81

2.1

2.5

37.86

37.98

g/l

0.28

917

3871

Factors influencing health status and contact with health services

557

1312

2.16

52.71

2.3

1.9

37.70

37.80

g/l

0.12

493

1154

Chronic periodontitis, complicated

1129

6899

1.65

52.71

2.3

37.12

37.82

g/l

3.20

982

6028

Other acute lower respiratory infections

1046

6018

1.68

52.55

3.1

2.1

36.88

37.70

g/l

4.04

934

5160

Viral pneumonia

310

1220

2.63

52.34

3.2

1.8

36.05

38.32

g/l

7.16

279

1049

Hyperkalaemia

189

569

3.52

52.33

2.4

2.1

34.78

37.39

g/l

5.71

162

479

Fracture of rib(s), sternum and thoracic spine

698

3778

1.89

52.27

2.5

2.2

37.09

37.54

g/l

1.07

580

3260

SLE, ICD10

128

294

4.71

52.23

1.8

35.69

38.30

g/l

3.71

117

265

SLE, strict definition

128

294

4.71

52.23

1.8

35.69

38.30

g/l

3.71

117

265

Other nutritional deficiencies

1177

6906

1.62

51.90

1.8

2.2

36.87

38.25

g/l

11.83

1029

6083

Acute bronchitis

845

4756

1.77

51.48

3.2

2.1

36.86

37.64

g/l

3.22

755

4040

ILD, hospital admission 2, with pulmonary infections

278

1049

2.77

51.42

2.3

1.8

35.74

38.05

g/l

7.07

254

879

Other gastritis (incl. Duodenitis)

534

2657

2.06

51.40

2.2

2.3

36.54

37.62

g/l

3.53

454

2299

Temporal arteritis

150

395

4.15

51.29

1.5

2.6

33.00

37.59

g/l

12.02

127

338

Any mental disorder

2059

7092

1.47

51.23

1.9

2.3

37.89

37.78

g/l

0.29

1768

6235

Senile cataract

1310

5065

1.61

51.16

2.4

2.2

37.27

37.79

g/l

2.23

1118

4484

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

111

231

5.23

51.12

1.8

2.6

35.34

38.19

g/l

3.65

104

208

Mycoses

1567

9080

1.52

50.65

2.1

2.2

37.85

37.88

g/l

0.06

1341

7935

IgA nephropathy (IgA glomerulonephritis)

189

5.76

50.43

1.8

2.6

35.45

38.46

g/l

3.77

168

External causes of morbidity and mortality

1162

3532

1.66

50.36

2.1

37.82

38.22

g/l

1.23

1013

3156

Other functional intestinal disorders

879

4752

1.74

50.28

2.4

2.1

37.64

37.71

g/l

0.13

740

4077

All influenza

518

2572

2.06

49.89

4.4

1.9

36.88

38.46

g/l

6.28

446

2209

Mood [affective] disorders

1859

8252

1.47

49.84

2.0

2.2

38.32

37.84

g/l

2.52

1609

7192

Mood disorders

1863

8263

1.47

49.73

2.0

2.2

38.31

37.84

g/l

2.51

1613

7199

Fracture of femur

673

3303

1.89

49.69

2.0

2.2

35.80

37.02

g/l

4.42

480

2788

Anxiety disorders, excluding more controls

1457

6189

1.55

49.29

2.1

2.2

38.86

37.97

g/l

6.53

1279

5467

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1751

7144

1.49

49.11

1.9

2.3

36.86

38.18

g/l

14.30

1524

6196

Other anxiety disorders

712

3390

1.84

49.03

1.8

2.0

38.97

38.37

g/l

1.78

634

3023

Symptoms and signs involving the digestive system and abdomen

1857

6328

1.48

48.99

2.2

2.1

37.81

37.86

g/l

0.14

1633

5469

Diseases of the digestive system

981

5921

1.68

48.98

2.2

36.15

37.56

g/l

9.21

854

5059

Other coagulation defects

200

648

3.23

48.86

2.3

2.4

36.83

37.63

g/l

1.08

180

576

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1171

7413

1.60

48.77

2.0

2.2

37.08

37.72

g/l

2.86

1020

6392

Other bacterial intestinal infections

508

2533

2.05

48.55

3.2

2.0

36.36

37.85

g/l

5.29

433

2162

Fibromyalgia

199

645

3.19

48.30

2.2

1.7

39.34

38.33

g/l

1.74

182

580

Symptoms and signs involving speech and voice

708

3947

1.83

48.12

2.5

2.1

38.08

37.61

g/l

1.44

611

3407

Arthrosis

1293

4499

1.59

48.08

2.0

2.3

37.96

37.87

g/l

0.21

1140

3898

Obesity, other/unspecified

606

3218

1.91

47.86

1.6

2.1

36.99

38.49

g/l

8.20

544

2852

Secondary and unspecified malignant neoplasm of lymph nodes

236

856

2.89

47.24

1.8

1.4

35.99

37.72

g/l

3.52

219

726

Other and unspecified vasculitis limited to skin

105

225

5.15

46.97

2.6

37.22

37.60

g/l

0.23

100

197

Non-allergic asthma (mode)

373

1655

2.28

46.79

1.8

37.55

38.60

g/l

3.08

329

1419

Hernia of abdominal wall, postoperative

352

1542

2.33

46.71

2.0

37.43

38.44

g/l

2.36

313

1362

Prurigo nodularis

106

230

5.08

46.70

1.7

3.2

38.45

37.82

g/l

0.50

201

Episodal and paroxysmal disorders

1969

6963

1.45

46.66

1.9

2.2

38.37

37.62

g/l

6.03

1704

6065

Concussion

787

3679

1.76

46.60

2.0

2.1

37.87

37.67

g/l

0.35

665

3245

Abnormal findings on examination of urine, without diagnosis

149

416

3.82

46.48

3.4

2.6

36.02

37.53

g/l

2.04

136

371

Other and unspecified coagulation defects

146

401

3.85

46.42

2.4

36.94

37.98

g/l

1.25

132

357

Depression

1679

7778

1.48

45.89

2.0

2.2

38.36

37.91

g/l

2.14

1452

6804

Shoulder lesions

1406

5597

1.54

45.70

2.1

2.2

37.95

37.61

g/l

1.24

1226

4831

Anxiety (asthma-related co-morbidities)

940

4387

1.67

45.64

1.8

2.2

38.89

38.39

g/l

1.62

837

3910

Cutaneous abscess, furuncle and carbuncle

506

2574

2.00

45.59

1.8

2.1

36.92

38.19

g/l

4.20

457

2270

Giant cell arteritis with polymyalgia rheumatica

150

429

3.81

45.56

1.5

2.5

33.00

37.54

g/l

11.93

127

370

Diabetes, insulin treatment (Kela reimbursement)

1884

7935

1.45

45.53

1.9

2.3

36.84

38.08

g/l

13.84

1646

6863

Visual disturbances and blindness

1028

6428

1.62

45.33

2.2

2.1

38.02

37.66

g/l

1.19

876

5534

Non-Hodgkin lymphoma, all

158

467

3.63

45.33

3.3

1.4

34.82

37.39

g/l

4.45

150

389

Endocarditis

122

301

4.34

45.27

1.6

2.1

33.00

38.15

g/l

11.03

112

261

Insulin, intermediate and long-acting

1107

6848

1.59

45.11

1.9

2.2

35.94

37.75

g/l

17.76

961

5918

Obesity

1091

6671

1.60

45.09

1.8

2.2

36.85

38.26

g/l

11.54

959

5873

Systemic lupus erythematosus, unspecified

109

248

4.76

45.07

1.8

1.9

35.93

38.32

g/l

2.89

100

224

Sleep disorders (combined)

2077

7712

1.43

45.00

1.9

2.2

38.15

37.66

g/l

2.93

1788

6709

Obesity and other hyperalimentation

1095

6698

1.59

44.89

1.7

2.2

36.85

38.25

g/l

11.54

961

5896

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

369

1684

2.27

44.88

1.5

2.2

34.95

37.66

g/l

10.94

320

1484

Asthma/COPD (KELA code 203)

1684

7938

1.47

44.79

2.0

2.2

37.57

38.02

g/l

2.37

1462

6874

Other abnormal findings of blood chemistry

143

398

3.82

44.73

3.2

2.3

37.87

38.03

g/l

0.11

136

353

Abdominal and pelvic pain

1824

6328

1.46

44.57

2.2

2.1

37.92

37.86

g/l

0.15

1599

5469

Amputation

289

1192

2.53

44.55

1.8

2.1

33.36

37.34

g/l

17.54

257

1007

Cardiomyopathies, Primary/intrinsic

299

1252

2.47

44.38

1.9

2.2

35.83

38.39

g/l

8.48

264

1064

Other diseases of liver

391

1832

2.19

44.27

2.0

2.2

37.75

38.01

g/l

0.34

342

1623

Secondary right heart disease

155

463

3.60

43.83

2.0

2.4

37.36

37.05

g/l

0.28

143

403

Later onset COPD, excluding more controls

501

1962

2.02

43.81

1.5

1.9

35.28

38.01

g/l

18.10

427

1622

Chronic nephritic syndrome

133

359

3.96

43.64

2.6

36.41

37.78

g/l

1.53

124

321

Cardiomyopathy (excluding other)

306

1305

2.42

43.59

1.9

2.2

35.90

38.52

g/l

9.18

270

1105

All anxiety disorders

952

4614

1.65

43.54

1.8

2.1

38.88

38.24

g/l

2.53

849

4089

Early onset COPD, excluding more controls

398

1886

2.15

43.50

2.1

1.8

36.20

38.53

g/l

10.97

351

1645

Retention of urine

774

3714

1.74

43.27

1.9

2.3

36.50

37.30

g/l

2.80

661

3196

Disorders of gallbladder, biliary tract and pancreas

1871

8309

1.43

43.20

2.1

2.2

37.09

37.87

g/l

5.88

1618

7207

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

909

5416

1.65

43.16

1.9

2.0

38.72

38.13

g/l

2.44

802

4721

Polyarthrosis

449

2070

2.06

42.96

2.2

2.4

36.77

37.65

g/l

2.07

372

1747

Osteonecrosis

182

604

3.18

42.96

6.3

1.9

36.67

37.90

g/l

1.79

161

549

Visual disturbances

946

5879

1.63

42.94

2.2

38.13

37.70

g/l

1.46

823

5078

Immunodeficiency with predominantly antibody defects

213

4.99

42.91

5.1

2.1

38.86

38.65

g/l

0.13

196

Other respiratory diseases principally affecting the interstitium

462

2336

2.04

42.86

2.4

2.1

35.92

37.29

g/l

4.88

420

1987

COPD

990

5056

1.63

42.82

1.9

2.3

35.80

37.50

g/l

14.92

856

4318

Immunodeficiencies

142

405

3.71

42.79

4.4

2.3

38.84

37.99

g/l

0.95

131

365

Fracture of shoulder and upper arm

739

4308

1.74

42.79

2.4

2.2

37.40

37.69

g/l

0.58

603

3704

Other diseases of intestine

341

1536

2.29

42.72

2.4

2.1

36.53

37.67

g/l

2.43

309

1337

Subjective visual disturbances

523

2757

1.94

42.57

2.1

38.48

37.68

g/l

2.53

458

2394

Other disorders of lacrimal gland

697

4014

1.77

42.39

2.8

2.1

38.40

37.72

g/l

2.36

593

3474

Insulin, combination of fast acting with intermediate-acting or long-acting

1216

7311

1.54

42.34

2.0

2.2

35.77

37.75

g/l

22.82

1058

6307

Soft tissue disorders related to use, overuse and pressure

548

2938

1.90

42.27

2.2

2.3

38.10

37.70

g/l

0.85

479

2547

Other diseases of pericardium

138

390

3.75

42.18

1.6

2.2

33.85

38.16

g/l

8.88

119

337

Postmenopausal osteoporosis with pathological fracture

212

776

2.90

42.15

1.7

2.1

38.25

37.31

g/l

1.55

153

661

Allergic conjunctivitis

938

5681

1.63

42.12

1.9

2.1

38.71

38.14

g/l

2.30

828

4964

Overexertion and strenuous or repetitive movements

233

889

2.71

42.09

2.4

2.2

36.87

37.96

g/l

1.75

203

802

Undetermined asthma, excluding more controls

251

991

2.59

41.94

2.0

1.5

37.83

38.91

g/l

2.25

217

849

Urticaria and erythema

638

3589

1.80

41.89

2.2

2.1

38.20

38.05

g/l

0.24

565

3142

Conjunctivitis

1270

7034

1.52

41.82

2.1

38.53

38.00

g/l

2.55

1122

6117

Zoster [herpes zoster]

1020

6391

1.59

41.80

2.8

2.2

37.62

37.59

g/l

0.06

869

5458

Ischemic heart diseases

1570

6460

1.47

41.74

2.3

37.24

38.02

g/l

5.18

1398

5570

Peripheral artery operations in Hilmo

338

1534

2.28

41.64

1.9

2.1

34.31

37.40

g/l

12.69

298

1293

Biological medication for rheuma

308

1341

2.35

41.55

1.5

2.2

37.41

38.43

g/l

1.98

285

1213

Conduction disorders

626

2820

1.83

41.55

2.2

36.68

38.18

g/l

7.61

534

2384

Dysphagia

549

2964

1.89

41.54

2.1

2.2

37.68

37.50

g/l

0.29

470

2542

Diseases of pulp and periapical tissues and dental caries

1354

4585

1.53

41.43

2.1

2.2

37.35

37.52

g/l

0.41

1154

3944

Irritable bowel syndrome

494

2576

1.95

41.35

2.4

2.1

39.16

38.07

g/l

3.77

423

2261

Unspecified fall

978

6091

1.60

41.21

2.2

37.01

37.65

g/l

2.33

799

5278

Diabetes medication

1853

7777

1.42

41.11

1.9

2.3

36.98

38.16

g/l

12.26

1603

6738

Selective serotonin reuptake inhibitors

1795

6565

1.44

41.06

2.1

2.2

37.88

37.69

g/l

0.57

1568

5744

Fibrosis and cirrhosis of liver

218

819

2.79

40.93

1.5

2.4

35.15

37.90

g/l

7.37

192

730

Other retinal disorders

1320

6905

1.51

40.82

2.3

2.2

36.94

37.52

g/l

2.80

1096

5933

Ischaemic Stroke, excluding all haemorrhages

1238

6099

1.53

40.81

2.3

2.2

36.46

37.37

g/l

5.81

1047

5223

Other CVD

498

2626

1.95

40.78

2.5

2.1

36.23

37.10

g/l

2.43

412

2197

Disorder of lipoprotein metabolism, unspecified

325

1465

2.29

40.73

1.6

2.0

36.74

37.43

g/l

1.10

287

1236

Open wound of head

1039

6433

1.58

40.63

2.1

2.2

36.72

37.69

g/l

5.09

878

5587

Stroke, including SAH

1335

6523

1.50

40.24

2.4

2.3

36.54

37.49

g/l

6.82

1132

5622

Stroke, excluding SAH

1293

6322

1.51

40.15

2.4

2.3

36.41

37.46

g/l

7.72

1094

5436

ILD, hospital admissions 3, with pneumonia sepsis

240

955

2.62

40.06

2.1

1.8

35.64

37.97

g/l

6.76

220

814

Other bacterial intestinal infections

406

2006

2.07

39.99

3.2

2.0

36.04

37.57

g/l

4.49

346

1711

Hypotension

445

2276

2.01

39.98

2.6

2.1

36.25

37.04

g/l

1.91

362

1893

Voice disturbances

548

2996

1.87

39.86

2.6

2.2

38.21

37.73

g/l

1.25

482

2598

Myelodysplastic syndrome

7.63

39.83

1.9

1.3

37.52

35.43

g/l

1.31

Injuries to the shoulder and upper arm

1566

8805

1.45

39.70

2.3

2.2

37.63

37.76

g/l

0.33

1324

7668

Coxarthrosis

973

4033

1.61

39.53

2.0

2.4

37.97

37.67

g/l

0.80

837

3468

Neurotic, stress-related and somatoform disorders

1492

7194

1.46

39.42

2.1

2.2

38.86

37.95

g/l

6.96

1316

6301

Dental caries, including avohilmo

1473

5122

1.49

39.41

2.0

2.2

37.46

37.54

g/l

0.19

1258

4424

Convulsions, not elsewhere classified

374

1775

2.11

39.21

1.7

2.0

36.54

38.84

g/l

8.22

329

1548

Other (seronegative) rheumatoid arthritis, wide

430

2187

2.02

39.13

2.0

2.1

36.59

37.67

g/l

3.23

382

1876

Abnormal involuntary movements

310

1393

2.29

39.13

2.1

2.2

38.84

37.42

g/l

3.71

272

1218

Methotrexate

290

1267

2.35

38.96

1.6

2.4

36.84

38.23

g/l

3.55

265

1094

Diffuse large B-cell lymphoma

152

483

3.35

38.87

1.6

1.4

34.29

37.40

g/l

5.67

138

414

Diffuse large B-cell lymphoma, helper endpoint

152

483

3.35

38.87

1.6

1.4

34.29

37.40

g/l

5.67

138

414

Diffuse large B-cell lymphoma, including Hilmo

152

483

3.35

38.87

1.6

1.4

34.29

37.40

g/l

5.67

138

414

Viral infections characterized by skin and mucous membrane lesions

770

4660

1.67

38.75

3.1

2.1

37.67

37.86

g/l

0.38

682

4038

Other dialysis

109

279

4.22

38.71

2.4

2.7

34.46

37.83

g/l

5.82

102

248

GI-bleeding

717

4272

1.71

38.64

2.2

35.54

37.29

g/l

9.91

622

3631

Other and unspecified immunodeficiencies with predominantly antibody defects

7.16

38.62

5.0

2.4

38.74

38.92

g/l

0.08

Coxibs

536

1481

1.93

38.46

2.0

2.2

38.17

36.89

g/l

4.30

472

1283

Seropositive rheumatoid arthritis, strict definition

347

1645

2.17

38.34

1.6

2.2

36.81

37.85

g/l

2.65

312

1435

Disorders of conjunctiva

1415

7827

1.46

38.32

2.1

38.47

37.91

g/l

3.11

1247

6795

Nausea and vomiting

537

2888

1.85

38.27

2.7

2.2

36.58

37.62

g/l

3.36

467

2435

Type 2 diabetes, definitions combined

1709

7091

1.43

38.25

1.9

2.3

37.28

38.14

g/l

6.40

1471

6138

Anxiety disorders

1505

7284

1.45

38.17

2.1

2.2

38.85

37.93

g/l

7.24

1326

6381

Abnormalities of heart beat

646

3680

1.74

37.82

2.1

37.69

37.82

g/l

0.20

546

3143

Type 2 diabetes, strict (exclude DM1)

1715

7140

1.42

37.69

1.9

2.3

37.28

38.14

g/l

6.49

1477

6182

Other diseases of anus and rectum

601

3426

1.78

37.62

2.2

2.1

37.37

37.47

g/l

0.14

490

2948

Progressive vascular leukoencephalopathy

140

433

3.48

37.59

2.1

2.3

37.40

36.76

g/l

0.57

116

364

Other diseases of the digestive system

711

4259

1.70

37.59

2.1

2.2

35.55

37.32

g/l

10.11

614

3619

Arthropathies in other diseases classified elsewhere

109

284

4.07

37.51

2.4

2.2

36.05

38.11

g/l

2.54

250

Other pulmonary heart/vessel disease

158

525

3.20

37.48

2.0

2.4

37.37

37.14

g/l

0.20

144

457

Benign neoplasm: Colon, unspecified

588

3352

1.80

37.43

2.3

2.1

37.56

37.49

g/l

0.10

477

2882

Superficial injury of head

482

2580

1.90

37.42

2.1

36.69

37.66

g/l

2.58

412

2207

Substance abuse, excluding more controls

978

5360

1.57

37.41

1.6

2.3

37.15

37.82

g/l

2.19

824

4769

Special screening examination for infectious and parasitic diseases

327

1094

2.23

37.20

2.3

2.2

39.48

38.80

g/l

1.18

288

1019

Cardiomyopathy in other diseases

10.29

37.10

7.9

2.3

36.47

37.76

g/l

0.57

Presence of cardiac and vascular implants and grafts

1018

4905

1.57

37.07

1.7

2.2

36.52

37.35

g/l

3.91

836

4238

Injury, poisoning and certain other consequences of external causes

917

2846

1.63

36.92

2.1

2.2

37.84

38.23

g/l

1.06

803

2531

Acute myeloid leukaemia and myelodysplastic syndromes

187

4.98

36.85

1.7

1.3

36.98

36.74

g/l

0.11

158

Emergency coronary revascularization (for ACS)

1646

7090

1.43

36.73

1.9

2.4

36.95

37.88

g/l

7.35

1457

6078

Other chronic obstructive pulmonary disease

934

4925

1.59

36.65

1.8

2.3

35.72

37.51

g/l

15.58

805

4201

Amputation of toe

211

826

2.68

36.61

1.8

2.3

33.15

37.44

g/l

15.16

188

720

Noninfective enteritis and colitis

822

5132

1.62

36.39

2.3

2.1

37.49

37.96

g/l

1.30

714

4474

ILD, hospital admissions

385

1945

2.04

35.98

2.3

2.2

36.07

37.36

g/l

3.76

352

1662

Acetic acid derivatives and related substances

531

1476

1.89

35.80

2.1

2.2

38.07

36.88

g/l

3.89

469

1278

Pericarditis

109

294

3.92

35.73

1.8

2.1

34.67

38.35

g/l

6.73

257

Adverse effects, not elsewhere classified

358

1759

2.08

35.71

2.1

38.37

38.19

g/l

0.24

333

1567

Undetermined asthma

251

1069

2.40

35.69

2.0

1.6

37.83

38.63

g/l

1.43

217

922

Other headache syndromes

719

4367

1.66

35.62

1.8

2.3

39.14

37.92

g/l

6.92

633

3819

Other interstitial pulmonary diseases

388

1975

2.03

35.48

2.3

2.2

36.06

37.34

g/l

3.76

355

1686

Percutaneous Coronary Intervention

1477

6333

1.44

35.46

1.9

2.3

36.99

38.00

g/l

7.73

1322

5455

Cellulitis

442

2345

1.92

35.38

2.7

2.1

36.24

37.86

g/l

5.48

395

2057

Open wound of lower leg

324

1545

2.15

35.18

2.0

36.01

37.64

g/l

4.79

277

1347

Atopic dermatitis

856

4428

1.60

35.15

1.8

2.1

38.51

38.36

g/l

0.31

752

3906

Gonarthrosis

1148

4347

1.52

35.11

1.8

2.3

37.61

37.79

g/l

0.46

1012

3757

Marginal zone B-cell lymphoma, including Hilmo

148

5.50

35.03

2.8

1.3

38.53

37.83

g/l

0.45

121

Candidiasis

526

2953

1.81

35.01

2.3

2.1

37.26

37.91

g/l

1.41

442

2558

Interstitial lung disease

388

1987

2.01

34.88

2.3

2.2

36.06

37.33

g/l

3.69

355

1696

Interstitial lung disease endpoints

388

1987

2.01

34.88

2.3

2.2

36.06

37.33

g/l

3.69

355

1696

Lumbar disc prolapse

1099

5624

1.51

34.88

2.2

2.1

38.56

37.68

g/l

5.53

971

4892

Other noninfective gastroenteritis and colitis

475

2588

1.87

34.83

2.6

2.1

37.21

37.82

g/l

1.28

412

2229

Agranulocytosis

262

1154

2.35

34.83

3.3

2.1

36.90

37.74

g/l

1.37

247

1017

Diabetic retinopathy, excluding more controls

500

1499

1.91

34.81

1.8

2.0

36.26

37.76

g/l

5.93

438

1275

Caries of dentine, including avohilmo

1530

5486

1.44

34.73

2.1

2.2

37.47

37.61

g/l

0.35

1313

4749

Primary hyperparathyroidism

284

1298

2.27

34.69

2.8

2.3

37.87

37.40

g/l

0.63

241

1108

Other neurological diseases

1420

7848

1.44

34.60

2.1

2.2

37.79

37.50

g/l

0.99

1196

6764

Urticaria

489

2693

1.84

34.59

2.2

2.0

38.41

38.18

g/l

0.35

435

2372

Reactive arthropathies, FINNGEN

149

498

3.09

34.49

2.4

2.5

37.80

38.35

g/l

0.47

130

442

Other reaction to severe stress, and adjustment disorders

532

3007

1.79

34.39

2.3

2.0

39.30

38.39

g/l

3.17

483

2680

Rash and other nonspecific skin eruption

229

957

2.47

34.32

2.0

2.2

38.38

37.71

g/l

0.98

210

838

Pleural effusion

384

1970

2.01

34.29

2.6

2.1

34.65

37.48

g/l

13.39

348

1670

Any death

1300

6443

1.46

34.23

3.0

2.1

34.55

38.22

g/l

70.85

1133

5548

Bacterial intestinal infections, IBD co-morbidities

407

2128

1.96

34.19

3.3

2.0

36.06

37.41

g/l

3.67

348

1823

Disorders of lacrimal system

807

5091

1.60

34.18

2.7

2.2

38.41

37.65

g/l

3.19

683

4387

Diseases of pulp and periapical tissues, including avohilmo

1891

7153

1.38

34.10

2.1

2.2

37.67

37.82

g/l

0.45

1630

6194

Alcohol use disorder, Swedish definition

992

6008

1.53

34.01

1.6

2.3

36.81

37.91

g/l

5.08

848

5317

Personality disorders, excluding more controls

364

1828

2.02

33.96

1.6

2.1

38.59

38.62

g/l

0.03

326

1659

Volume depletion

227

949

2.47

33.95

1.9

2.0

34.94

37.24

g/l

5.42

183

784

Rotator cuff syndrome

1116

5380

1.50

33.93

2.2

37.88

37.56

g/l

0.96

974

4647

Coronary revascularization (ANGIO or CABG)

1468

6334

1.43

33.86

2.0

2.3

37.00

38.00

g/l

7.58

1316

5456

Diseases of the myoneural junction and muscle

292

1361

2.21

33.83

1.6

2.1

36.88

37.44

g/l

0.72

240

1181

Recurrent or chronic depression

630

2595

1.73

33.79

1.9

2.2

38.53

38.31

g/l

0.36

555

2357

Malignant neoplasm of skin

993

4473

1.54

33.43

2.6

1.4

37.63

37.64

g/l

0.02

845

3805

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

978

4347

1.55

33.35

2.6

1.4

37.62

37.64

g/l

0.04

839

3695

Type 2 diabetes, definitions combined, including avohilmo

1678

7062

1.39

33.05

1.9

2.3

37.27

38.16

g/l

6.86

1448

6120

1034

6265

1.51

32.95

1.6

2.3

36.77

37.94

g/l

5.97

887

5546

Trochanteric bursitis

298

1415

2.16

32.77

2.1

38.29

37.60

g/l

1.20

256

1216

Other and unspecified effects of external causes

451

2468

1.85

32.63

2.0

2.1

38.38

38.20

g/l

0.25

413

2190

Isolated proteinuria with specified morphological lesion

6.66

32.58

4.3

2.8

36.28

38.41

g/l

1.63

Injuries to the knee and lower leg

2073

8605

1.35

32.52

2.0

2.2

37.63

37.88

g/l

1.02

1776

7507

Major coronary heart disease event

1573

6822

1.40

32.40

2.0

2.3

37.02

37.98

g/l

7.45

1398

5874

Psychiatric diseases

1759

6406

1.38

32.36

2.1

2.3

37.87

37.74

g/l

0.34

1506

5656

1073

6402

1.49

32.35

1.6

2.3

36.91

37.94

g/l

5.00

920

5670

Other inflammation of eyelid

300

1439

2.14

32.21

2.7

2.2

38.53

37.67

g/l

1.80

246

1263

AV-block

402

1863

1.93

31.91

2.3

2.1

36.81

38.03

g/l

3.71

339

1541

Cirrhosis of liver, NAS

157

571

2.90

31.61

1.6

2.5

34.45

37.55

g/l

6.90

141

504

Sleep apnoea

1690

8006

1.38

31.53

2.0

2.2

38.00

37.79

g/l

0.75

1475

7012

ILD, hospital admissions 1, main diag only

344

1752

2.03

31.53

2.4

2.2

35.99

37.47

g/l

4.36

314

1498

Sequelae of cerebrovascular disease

783

4321

1.59

31.10

2.1

2.2

36.55

37.27

g/l

2.59

623

3690

Secondary uncertain malignant neoplasm

297

1440

2.12

31.04

1.9

1.4

35.66

37.59

g/l

5.16

269

1204

Ischaemic heart disease, wide definition

1479

6572

1.41

31.01

2.4

2.3

37.10

37.80

g/l

4.19

1311

5650

Migraine with aura

357

1848

1.96

30.62

1.5

2.1

39.50

38.34

g/l

3.36

320

1655

Tumor necrosis factor alpha inhibitors

258

1189

2.21

30.51

1.3

2.2

37.48

38.45

g/l

1.56

238

1079

Other diseases of upper respiratory tract

1984

7754

1.34

30.28

2.1

2.2

37.96

37.62

g/l

1.61

1732

6700

Asthma and allergy, excluding more controls

171

648

2.64

30.19

1.8

1.4

39.21

39.64

g/l

0.41

149

580

Other (not insulin) diabetes medications

1731

7577

1.37

30.18

1.9

2.3

37.13

38.07

g/l

7.76

1490

6551

Type 1 diabetes

428

2366

1.83

29.88

1.8

2.2

35.88

38.34

g/l

13.68

387

2085

Other chronic obstructive pulmonary disease, including avohilmo

1101

6291

1.46

29.87

1.8

2.3

36.05

37.55

g/l

13.37

952

5411

Other degenerative diseases of the nervous system

539

2351

1.74

29.84

1.9

2.2

37.80

37.09

g/l

1.67

424

2018

Lichen simplex chronicus and prurigo

163

622

2.73

29.76

1.8

2.6

37.99

37.80

g/l

0.16

144

545

Hypertrophic cardiomyopathy

126

422

3.16

29.51

2.7

36.15

37.51

g/l

1.48

115

373

Insulin, fast-acting

662

4142

1.62

29.37

1.8

2.2

35.76

38.00

g/l

16.19

586

3594

Osteomyelitis

164

632

2.70

29.35

2.0

1.9

34.34

37.71

g/l

7.46

144

569

Chronic sinusitis

735

4712

1.58

29.26

2.2

38.30

37.90

g/l

1.00

652

4118

Injuries to unspecified part of trunk, limb or body region

227

1014

2.31

29.23

1.6

2.2

36.06

37.79

g/l

3.28

197

892

Somatoform disorder

299

1483

2.06

29.22

2.4

2.2

38.97

37.87

g/l

2.65

259

1315

Other abnormalities of plasma proteins

140

5.11

29.02

4.9

3.0

34.26

38.14

g/l

3.38

119

Other and unspecified types of non-Hodgkin lymphoma, hilmo

130

448

3.07

29.00

3.3

2.4

35.84

37.20

g/l

1.45

119

393

Calcific aortic valvular stenosis

679

4165

1.61

28.94

2.2

2.1

35.96

36.99

g/l

4.52

588

3468

Calcific aortic valvular stenosis, operated

679

4165

1.61

28.94

2.2

2.1

35.96

36.99

g/l

4.52

588

3468

Calcific aortic valvular stenosis, including rheumatic fever

680

4171

1.61

28.86

2.2

2.1

35.96

36.99

g/l

4.44

589

3473

Operations 2 for CAVS

678

4162

1.61

28.80

2.2

2.1

35.96

36.99

g/l

4.45

587

3465

Calcific aortic valvular stenosis, diagnosis (helper)

678

4162

1.61

28.80

2.2

2.1

35.96

36.99

g/l

4.45

587

3465

Nonalcoholic fatty liver disease

208

901

2.38

28.80

2.1

2.4

38.48

38.06

g/l

0.41

184

809

Need for immunization against other single viral diseases

153

4.80

28.64

2.8

2.6

36.47

38.22

g/l

1.35

137

Cardiodefibrillation

779

5091

1.55

28.58

2.2

36.19

37.34

g/l

5.90

697

4338

Zoster [herpes zoster]

402

2222

1.85

28.53

3.5

2.1

37.50

37.49

g/l

0.01

343

1888

Decubitus ulcer and pressure area

166

654

2.65

28.47

1.6

2.4

33.88

37.38

g/l

7.90

136

558

Sequelae of external causes of morbidity and mortality

516

3062

1.72

28.46

2.4

2.2

36.63

37.68

g/l

3.23

473

2650

Reactive arthropathies

173

692

2.57

28.45

2.3

2.4

37.81

37.99

g/l

0.14

150

610

Injuries to the elbow and forearm

1198

7465

1.42

28.41

2.0

2.2

37.84

37.94

g/l

0.21

1003

6496

Dental operations

1248

4507

1.44

28.28

2.1

37.47

37.34

g/l

0.27

1063

3897

Biguanides

1707

7748

1.35

28.22

1.9

2.3

37.11

37.98

g/l

6.65

1479

6704

Fungal Sepsis

117

385

3.20

28.21

2.8

2.1

34.05

38.32

g/l

6.66

103

342

In situ neoplasms

746

4850

1.56

28.20

2.2

37.31

37.40

g/l

0.15

644

4107

Injuries to the ankle and foot

1078

6683

1.44

27.95

2.0

2.1

38.01

38.18

g/l

0.38

947

5915

Enterocolitis due to Clostridium difficile

255

1222

2.15

27.60

3.6

2.1

35.21

37.35

g/l

5.64

223

1049

Heart failure and hypertrophic cardiomyopathy

189

4.36

27.50

3.1

2.8

34.87

37.40

g/l

2.25

163

Iron deficiency anaemia secondary to blood loss (chronic)

345

1839

1.92

27.48

1.9

2.2

35.76

37.44

g/l

5.02

275

1576

Asthma and allergy

171

680

2.52

27.38

1.8

1.5

39.21

39.48

g/l

0.23

149

603

Superficial injury of lower leg

433

2472

1.78

27.34

1.8

2.1

37.64

38.00

g/l

0.60

363

2153

Other malignant neoplasms of skin (=non-melanoma skin cancer)

904

4173

1.50

27.31

2.6

1.4

37.50

37.61

g/l

0.22

766

3535

Abnormal serum enzyme levels

612

3737

1.62

27.17

2.0

2.3

37.00

37.50

g/l

1.23

546

3254

Migraine

699

3628

1.58

27.16

1.8

2.2

39.22

38.18

g/l

5.16

625

3225

Cerebral palsy and other paralytic syndromes

235

1099

2.19

27.01

1.9

2.1

37.51

37.87

g/l

0.35

206

974

Obesity due to excess calories

739

4844

1.54

26.76

1.8

2.3

36.64

38.33

g/l

10.51

647

4282

Basal cell carcinoma, including avohilmo

898

4181

1.50

26.67

2.4

1.4

37.51

37.61

g/l

0.19

763

3540

Disorders of continuity of bone

191

824

2.38

26.67

3.2

2.0

38.10

38.01

g/l

0.06

166

745

Gastroduodenal ulcer

546

3337

1.66

26.59

1.9

2.2

35.97

37.24

g/l

4.45

471

2859

Other diseases of arteries and capillaries

207

928

2.30

26.53

1.8

2.3

36.00

37.81

g/l

3.49

176

806

Implicit fungal Sepsis

108

352

3.23

26.51

2.9

2.0

34.55

38.33

g/l

5.47

313

Peripheral arterial reconstruction

404

2291

1.81

26.44

1.8

2.2

35.07

37.15

g/l

8.31

351

1936

Drug-induced osteoporosis with pathological fracture

182

4.38

26.39

1.6

2.2

35.21

37.20

g/l

1.74

158

Acute upper respiratory infections of multiple and unspecified sites

1223

6509

1.40

26.23

3.3

1.9

37.97

37.87

g/l

0.20

1078

5661

Hypokalaemia

249

1205

2.12

26.20

2.7

2.0

36.03

37.68

g/l

3.64

211

1019

Motor neuron disease

143

4.71

26.19

1.2

1.7

40.22

37.44

g/l

3.10

126

Diseases of spleen

148

4.68

26.10

1.9

2.2

37.36

37.53

g/l

0.06

131

Phlebitis and thrombophlebitis (not including DVT)

438

2546

1.75

26.09

2.4

2.2

36.86

37.88

g/l

2.88

385

2202

Acute sinusitis

795

4913

1.51

26.06

3.1

1.9

38.29

38.13

g/l

0.35

704

4320

Mixed and other personality disorders

138

516

2.74

26.02

1.6

2.1

38.78

38.67

g/l

0.06

128

475

L01XX Other antineoplastic agents

167

692

2.53

25.92

3.3

2.3

38.90

37.44

g/l

2.37

151

608

Solid cancers, helper endpoint

1362

5855

1.38

25.87

2.2

1.4

37.82

38.07

g/l

0.75

1207

5065

Eosinophilic disease (BM)

5.72

25.86

2.5

1.2

36.16

37.78

g/l

0.89

Allergic asthma (mode), excluding more controls

297

1497

1.96

25.80

1.9

1.6

38.42

39.43

g/l

2.17

270

1318

Motor neuron disease (with DMD)

145

4.63

25.72

1.2

1.7

40.22

37.48

g/l

3.04

128

Phobic anxiety disorders

171

711

2.44

25.63

1.9

2.0

38.55

38.73

g/l

0.13

159

649

Substance abuse

978

6417

1.44

25.56

1.6

2.3

37.15

37.96

g/l

3.07

824

5680

Viral pneumonia (unknown virus, not influenza)

149

588

2.62

25.36

2.3

2.4

36.07

37.72

g/l

2.13

137

524

Persons with potential health hazards related to communicable diseases

489

2918

1.68

25.26

2.0

1.9

37.86

38.65

g/l

2.08

457

2631

Benign neoplasm of other and ill-defined parts of digestive system

384

2174

1.81

25.25

2.1

37.22

37.50

g/l

0.41

337

1879

Diabetic neuropathy

263

1314

2.06

25.20

2.0

36.43

37.06

g/l

0.80

230

1132

Idiopathic thrombocytopenic purpura

266

3.54

25.19

2.5

2.4

38.72

37.54

g/l

1.12

230

Other metabolic disorders

230

1095

2.14

25.17

3.1

2.0

37.82

38.22

g/l

0.48

218

960

Myeloproliferative diseases

206

944

2.26

25.16

2.8

2.2

38.63

37.63

g/l

1.55

177

829

Basal cell carcinoma

865

4066

1.49

25.12

2.5

1.4

37.44

37.56

g/l

0.23

732

3439

Insulin, fast-acting or short human

664

4314

1.56

25.10

1.8

2.2

35.75

37.90

g/l

15.14

588

3736

Artrosis, including avohilmo

1437

5792

1.37

25.09

1.9

2.3

38.03

37.76

g/l

0.88

1249

5080

COPD, early/later onset

943

5526

1.46

25.06

1.8

2.3

35.73

37.47

g/l

15.05

811

4733

Mental and behavioural disorders due to psychoactive substance use

1004

6551

1.43

25.01

1.6

2.3

37.21

37.97

g/l

2.87

848

5788

Essential (haemorrhagic) thrombocythaemia

109

370

3.11

24.99

2.4

1.4

39.02

37.93

g/l

1.10

317

Gastric ulcer

383

2173

1.80

24.93

1.8

2.3

36.03

37.37

g/l

3.52

326

1855

Memory loss

232

1119

2.15

24.89

2.0

2.3

37.16

37.36

g/l

0.19

194

981

Superficial injury of hip and thigh

304

1606

1.93

24.88

1.8

2.2

37.13

37.38

g/l

0.27

249

1388

L04AC Interleukin inhibitors

118

418

2.92

24.78

1.7

2.3

37.61

38.40

g/l

0.61

110

382

Spondyloarthritis

318

1705

1.90

24.77

2.0

2.1

36.31

37.93

g/l

3.94

289

1480

Complications of internal orthopaedic prosthetic devices, implants and grafts

480

2905

1.68

24.73

1.8

2.2

36.52

37.41

g/l

2.21

403

2441

Sleep apnoea, including avohilmo

1722

8114

1.32

24.72

1.9

2.2

38.05

37.78

g/l

1.05

1495

7102

Other disorders of eye and adnexa

262

1324

2.02

24.44

2.0

2.1

38.29

37.92

g/l

0.47

238

1169

Other specified and unspecified disorders of eye and adnexa

105

353

3.12

24.43

2.3

2.4

38.34

38.15

g/l

0.12

312

Nonorganic sleeping disorders, excluding more controls

290

1515

1.94

24.39

1.5

2.2

39.30

38.20

g/l

2.68

258

1358

Charcot foot

144

4.56

24.22

2.6

2.8

35.24

38.22

g/l

2.67

127

Other peripheral vascular diseases

180

792

2.34

24.16

1.6

2.2

38.15

37.90

g/l

0.20

161

700

Other diseases of lip and oral mucosa

696

4611

1.53

24.14

2.3

2.2

38.66

37.84

g/l

3.30

593

4021

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

575

3655

1.59

24.06

2.4

2.1

37.77

37.84

g/l

0.11

502

3182

Coronary atherosclerosis

1230

5661

1.39

24.02

2.2

2.3

36.91

37.80

g/l

5.59

1095

4843

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

188

845

2.29

23.94

3.1

2.1

37.39

37.90

g/l

0.52

171

749

Pyogenic arthritis

146

587

2.56

23.92

2.5

2.3

36.03

37.70

g/l

2.13

130

505

Major coronary heart disease event excluding revascularizations

1185

5723

1.39

23.90

2.2

2.4

36.50

37.73

g/l

9.06

1021

4886

Other general symptoms and signs

300

3.23

23.88

1.5

2.4

38.08

38.11

g/l

0.02

266

Papulosquamous disorders

699

4648

1.52

23.84

2.1

2.2

37.74

37.85

g/l

0.19

614

4065

Other encephalitis

217

3.75

23.82

1.8

2.7

37.10

38.22

g/l

0.59

195

Myeloproliferative diseases (CML excluded)

189

857

2.29

23.74

3.0

2.3

38.62

37.66

g/l

1.41

163

754

Other pleural conditions

249

1253

2.05

23.74

3.2

2.2

34.80

37.34

g/l

8.63

219

1063

Sequelae of other external causes

134

521

2.67

23.63

2.8

2.4

37.25

37.59

g/l

0.25

127

460

Missing teeth due to accident, extraction or parodontitis

1116

7630

1.39

23.53

2.0

2.3

37.36

37.63

g/l

0.72

878

6679

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

262

3.42

23.50

1.5

2.0

39.03

38.31

g/l

0.57

240

Disorders of adult personality and behaviour

387

2234

1.75

23.49

1.7

2.0

38.76

38.63

g/l

0.17

347

2024

Postprocedural endocrine and metabolic disorders, not elsewhere classified

215

1026

2.14

23.44

3.0

2.0

37.99

38.20

g/l

0.21

203

905

Migraine without aura

253

1278

2.00

23.43

2.1

39.52

38.65

g/l

1.69

231

1159

COPD, hospital admissions

925

5496

1.44

23.25

1.8

2.3

35.81

37.45

g/l

13.42

795

4703

Rheumatism, unspecified

257

1314

2.00

23.23

2.1

38.31

37.66

g/l

1.00

234

1130

Deforming dorsopathies

460

2793

1.67

23.22

2.2

2.1

38.34

37.64

g/l

1.66

399

2410

COPD related to multimorbidity

836

4874

1.47

23.20

1.8

2.3

35.62

37.42

g/l

14.26

711

4161

Disorders of muscles

191

875

2.23

23.15

1.6

1.9

38.04

37.66

g/l

0.38

173

774

Herpesviral [herpes simplex] infections

385

2233

1.75

23.07

2.7

2.1

38.43

38.27

g/l

0.20

344

1967

Haemorrhage, not elsewhere classified

102

349

3.06

23.00

2.9

2.5

36.56

37.50

g/l

0.79

299

Idiopathic urticaria

145

4.38

22.99

1.2

2.0

39.55

38.65

g/l

0.45

135

Type 1 diabetes, wide definition, subgroup 1

326

1801

1.83

22.99

1.8

2.1

36.03

38.46

g/l

10.46

290

1606

Acute upper respiratory infections

1799

8567

1.30

22.97

3.0

2.0

38.03

37.71

g/l

1.39

1579

7401

Hypoparathyroidism

108

385

2.96

22.75

1.6

2.2

37.61

37.70

g/l

0.05

339

Intracranial injury

986

6665

1.41

22.69

2.1

37.59

37.79

g/l

0.45

819

5768

Other/unspecified reactive arthropathies

139

561

2.56

22.65

2.5

2.4

37.77

38.07

g/l

0.22

122

507

Metatarsalgia

183

832

2.25

22.64

2.4

2.0

38.23

38.04

g/l

0.15

164

738

Other enthesopathy of foot (+metatarsalgia)

190

877

2.22

22.62

2.3

2.0

38.20

38.01

g/l

0.15

170

777

Invasive ventilation

170

753

2.33

22.56

2.3

2.2

34.66

37.73

g/l

6.85

151

662

Myocardial infarction

965

4808

1.43

22.53

2.1

2.3

36.30

37.64

g/l

9.01

826

4087

Mycoses

479

2964

1.64

22.53

2.6

2.1

37.06

37.86

g/l

1.98

417

2573

Oter anti-inflammatory and antirheumatic agents, non-steroids

428

1379

1.74

22.44

2.2

37.02

36.64

g/l

0.58

370

1184

DVT of lower extremities

385

2256

1.74

22.42

2.5

2.1

36.78

37.67

g/l

2.01

326

1947

Oxicams

427

1418

1.73

22.39

2.1

2.2

37.93

36.72

g/l

3.01

367

1222

Encephalitis

232

3.53

22.23

1.8

2.6

37.08

38.32

g/l

0.69

209

Fenamates

276

972

1.96

22.11

2.0

2.1

37.69

37.08

g/l

0.87

244

837

Non-selective monoamine reuptake inhibitors

669

4312

1.51

22.09

2.1

2.3

38.09

37.67

g/l

1.05

582

3720

Hypocalcemia

210

3.71

22.05

3.9

2.6

35.81

38.36

g/l

2.20

192

Psoriasis

497

3120

1.62

22.02

1.9

2.3

37.48

38.03

g/l

1.17

440

2743

Alcoholic liver disease

216

1061

2.09

22.01

1.3

2.3

34.61

37.84

g/l

7.83

177

945

Discitis, unspecified

147

4.33

21.90

2.9

1.9

32.97

37.31

g/l

4.73

129

Diseases of external ear

601

3944

1.54

21.89

1.8

2.2

37.99

37.73

g/l

0.46

467

3439

Chronic ulcer of skin, not elsewhere classified

164

727

2.33

21.75

2.3

35.27

37.80

g/l

4.81

142

633

Abnormal findings on diagnostic imaging of other body structures

284

1537

1.89

21.74

2.5

2.2

37.23

37.79

g/l

0.84

255

1344

Cramp and spasm

108

393

2.86

21.73

2.4

2.3

38.74

37.74

g/l

0.93

355

Viral haemorrhagic fevers, not elsewhere classified/unspecified

296

1621

1.86

21.70

2.4

2.1

37.48

37.78

g/l

0.39

272

1431

Functional dyspepsia

454

2798

1.64

21.68

2.3

2.2

38.46

37.87

g/l

1.37

402

2453

Bipolar affective disorders

263

1385

1.92

21.66

1.8

2.1

38.44

38.37

g/l

0.07

234

1252

Allergic asthma (mode)

297

1588

1.85

21.65

1.9

1.6

38.42

39.13

g/l

1.24

270

1396

Other and unspecified aplastic anaemias

5.31

21.61

1.6

2.8

36.81

38.17

g/l

0.72

Fracture of foot, except ankle

382

2256

1.72

21.48

2.2

2.1

38.38

38.21

g/l

0.22

334

2014

Noninfectious colitis NAS

257

1352

1.94

21.40

2.7

2.1

37.15

37.83

g/l

0.94

224

1179

Persistent mood disorders

330

1875

1.79

21.36

2.0

2.1

37.96

37.85

g/l

0.11

295

1646

Spondylopathies (FG)

202

975

2.11

21.35

1.8

2.5

37.90

38.55

g/l

0.72

187

862

Generalized anxiety disorder

202

978

2.09

21.12

1.7

2.2

39.87

38.67

g/l

2.44

181

882

Paracetamol or NSAID medication

241

594

2.06

20.94

2.5

1.9

37.82

37.18

g/l

0.69

213

528

Cervicalgia

357

2087

1.74

20.91

2.1

2.2

38.48

37.44

g/l

2.34

305

1806

Enthesopathies of lower limb, excluding foot

360

2109

1.73

20.89

2.3

2.1

38.67

37.86

g/l

1.61

318

1847

Other viral hepatitis

107

395

2.78

20.80

1.7

1.9

37.73

38.74

g/l

0.71

363

Other enthesopathies

472

2967

1.61

20.76

1.9

2.2

38.39

37.92

g/l

0.94

413

2593

Valvular operations

279

1524

1.87

20.70

1.6

2.1

36.79

38.14

g/l

3.44

246

1276

Other viral diseases

502

3175

1.58

20.69

2.8

2.0

37.73

38.48

g/l

1.85

468

2827

Etanercept

122

483

2.60

20.68

1.4

2.2

37.35

38.36

g/l

0.97

116

440

Elevated blood glucose level

168

767

2.25

20.68

1.7

2.0

36.64

38.04

g/l

1.69

139

683

Hypothyroidism, strict autoimmune

1119

5406

1.37

20.65

1.9

2.3

37.91

38.02

g/l

0.23

962

4625

Personality disorders

364

2152

1.71

20.36

1.6

2.0

38.59

38.60

g/l

0.01

326

1948

Injury of unspecified body region

167

768

2.24

20.24

1.6

2.3

35.62

37.68

g/l

3.11

142

679

Infection of intervertebral disc (pyogenic)

130

4.46

20.20

1.4

2.1

32.48

37.27

g/l

4.39

113

Other embolism and thrombosis

260

1401

1.90

20.20

2.6

2.1

36.09

37.69

g/l

3.25

235

1206

Pain in thoracic spine

252

1342

1.91

20.17

2.7

2.1

38.95

37.56

g/l

3.24

227

1168

Substance use, excluding alcohol

305

1724

1.79

20.09

1.5

2.1

38.05

38.37

g/l

0.37

246

1568

Budesonide

220

1121

2.00

20.08

2.0

2.2

37.63

38.53

g/l

1.20

192

981

Covid-19 suspected case

319

1827

1.77

20.05

2.6

2.1

38.01

38.50

g/l

0.74

285

1629

Arthropod-borne viral fevers and viral haemorrhagic fevers

327

1889

1.76

20.05

2.5

2.1

37.36

37.79

g/l

0.67

303

1660

Psoriatic and enteropathic arthropathies

183

874

2.13

19.97

1.7

2.5

37.95

38.55

g/l

0.62

162

776

Adalimumab

154

687

2.29

19.96

1.3

2.3

37.90

38.47

g/l

0.54

142

627

Other disorders of bone

310

1765

1.78

19.94

3.5

1.8

38.10

38.28

g/l

0.21

271

1595

Atopic dermatitis, strict definition with reimbursement

358

2042

1.71

19.92

1.8

2.0

38.40

38.71

g/l

0.43

316

1838

Cholelithiasis, broad definition with cholecystitis

1513

7871

1.30

19.77

2.1

2.2

37.23

37.84

g/l

3.41

1303

6796

Disorders of skin appendages

717

4967

1.45

19.76

2.2

37.89

38.18

g/l

0.70

644

4364

Abnormal findings in nipple discharge synovial fluid wound secretions

115

4.57

19.63

3.6

2.2

36.50

38.51

g/l

1.30

103

Other and unspecified myopathies

195

964

2.08

19.62

1.7

2.2

36.43

37.38

g/l

1.12

154

833

Dermatophytosis

1007

7404

1.37

19.62

2.1

2.2

38.15

37.83

g/l

0.93

861

6472

Amputation of foot

274

3.18

19.53

1.5

2.6

33.23

37.09

g/l

5.68

235

All influenza (not pneumonia)

249

1337

1.89

19.45

4.6

1.8

37.25

38.56

g/l

2.50

213

1171

Caries of enamel

1363

7521

1.31

19.44

2.4

2.1

38.64

38.07

g/l

2.95

1195

6635

Open wound of ankle and foot

189

925

2.09

19.41

2.2

35.24

38.02

g/l

6.35

164

832

Other extrapyramidal and movement disorders in other diseases

447

2826

1.61

19.38

2.2

38.83

37.53

g/l

5.14

382

2446

Chronic viral hepatitis

305

2.96

19.28

1.5

1.8

38.46

39.00

g/l

0.27

287

Thoracic aortic aneurysm

296

1687

1.79

19.21

2.2

2.3

37.01

37.83

g/l

1.51

253

1480

Extrapyramidal and movement disorders

714

4984

1.45

19.19

2.1

2.2

38.75

37.32

g/l

9.29

602

4271

Amiodarone users

233

1236

1.94

19.19

2.0

2.1

35.77

37.36

g/l

3.35

212

1074

Chronic pancreatitis

250

1356

1.89

19.09

1.8

2.2

35.48

37.80

g/l

5.54

222

1195

Type 1 diabetes, wide definition

336

1980

1.72

19.03

1.8

2.1

35.99

38.33

g/l

10.02

299

1756

Disease of hard tissues of teeth, NOS

970

3671

1.39

18.97

2.1

38.45

37.44

g/l

5.89

846

3195

Fracture of forearm

911

6068

1.39

18.96

1.9

2.2

37.76

37.87

g/l

0.21

755

5238

Viral hepatitis

125

522

2.45

18.91

1.6

2.1

37.59

38.38

g/l

0.58

111

474

Benign neoplasm: Transverse colon

242

1309

1.90

18.76

2.7

2.2

36.86

37.58

g/l

1.11

201

1142

General examination and investigation of persons without complaint and reported diagnosis

903

3372

1.41

18.72

2.0

2.1

38.04

37.62

g/l

1.00

747

2987

Congenital malformations, deformations and chromosomal abnormalities

917

6160

1.38

18.72

1.8

2.2

38.35

38.23

g/l

0.24

812

5432

Other overlap syndromes

146

4.01

18.69

1.9

2.5

36.26

38.34

g/l

1.57

131

Other viral diseases

403

2494

1.63

18.69

2.9

2.0

37.47

38.40

g/l

2.09

377

2225

Carcinoma in situ of skin of scalp and neck

304

3.03

18.63

1.8

2.5

37.17

36.75

g/l

0.27

262

Other diseases of the respiratory system

416

2612

1.62

18.62

2.0

2.1

36.42

37.31

g/l

2.09

353

2218

Other respiratory disorders and diseases

416

2612

1.62

18.62

2.0

2.1

36.42

37.31

g/l

2.09

353

2218

Benign neoplasm: Sigmoid colon

395

2454

1.64

18.54

2.3

2.2

37.45

37.53

g/l

0.09

344

2119

Disorders of sclera, cornea, iris and ciliary body

895

6528

1.38

18.53

2.1

37.91

37.86

g/l

0.09

787

5676

Nonischemic cardiomyopathy

209

1081

1.98

18.44

2.3

2.1

35.89

37.82

g/l

4.10

185

926

Benign neoplasm: Ascending colon

303

1762

1.76

18.39

2.1

2.2

37.08

37.42

g/l

0.40

255

1517

Pacemaker

689

4621

1.45

18.26

2.1

2.2

36.35

37.09

g/l

2.41

569

3874

Radiculopathy

310

1815

1.74

18.21

2.3

2.1

38.50

37.24

g/l

3.29

275

1557

Diseases of salivary glands

526

3495

1.52

18.16

2.0

2.2

38.08

37.87

g/l

0.32

442

3057

5-aminosalicylic acid

291

1673

1.76

18.09

1.8

2.1

37.99

38.62

g/l

0.95

259

1471

Panic disorder

186

931

2.02

17.85

1.5

2.3

38.95

38.56

g/l

0.35

166

840

Disorders of the thyroid gland

1570

8041

1.28

17.83

2.0

2.2

37.94

37.74

g/l

0.60

1364

6972

Migraine with aura and triptan purchases

194

987

1.99

17.79

1.4

1.8

39.75

38.83

g/l

1.41

180

877

Dilated cardiomyopathy

253

1410

1.84

17.79

1.8

2.2

35.60

37.57

g/l

4.66

222

1237

Other and unspecified drugs and medicaments

170

830

2.10

17.70

2.9

2.2

37.21

37.77

g/l

0.53

153

731

Fracture of lower leg, including ankle

910

6636

1.37

17.67

2.0

2.2

37.74

37.93

g/l

0.44

769

5769

Myocardial infarction, without ST-elevation

818

5402

1.40

17.58

2.0

2.2

36.22

37.15

g/l

4.20

689

4578

Aortic aneurysm

464

2968

1.56

17.57

2.1

2.3

36.56

37.52

g/l

2.72

394

2546

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

339

2038

1.67

17.56

1.8

2.1

38.53

38.44

g/l

0.10

292

1843

COPD, hospital admissions 3, with asthma pneumonia sepsis

570

3307

1.49

17.44

1.9

2.3

34.91

37.28

g/l

16.96

487

2794

Other hammer toe(s) (acquired)

319

1752

1.71

17.42

1.8

2.5

37.30

37.51

g/l

0.22

262

1467

COPD, hospital admission 2, with asthma infections

651

3888

1.45

17.42

1.9

2.2

35.17

37.37

g/l

17.00

557

3313

Cholelithiasis

1442

7782

1.29

17.22

2.1

2.2

37.26

37.81

g/l

2.78

1240

6715

Neuromuscular dysfunction of bladder

179

901

2.03

17.14

2.1

2.5

37.38

37.84

g/l

0.42

160

789

Crystal arthropathies, rheuma endpoint

170

3.63

17.09

1.7

3.0

35.76

37.33

g/l

0.97

142

Myocardial infarction, strict

882

4601

1.38

17.06

2.0

2.3

36.34

37.61

g/l

7.50

759

3906

Vasomotor and allergic rhinitis

513

3372

1.51

16.94

2.1

38.73

38.19

g/l

1.22

447

2980

Fissure and fistula of anal and rectal regions

391

2472

1.60

16.94

2.0

2.1

38.31

37.91

g/l

0.64

335

2175

Transient ischemic attack

1003

6091

1.35

16.94

2.2

37.56

37.40

g/l

0.37

841

5215

Stomatitis and related lesions

325

1967

1.68

16.85

2.4

2.1

37.98

37.90

g/l

0.09

285

1724

Mental and behavioural disorders due to alcohol

826

5805

1.38

16.80

1.6

2.2

37.07

37.93

g/l

2.92

707

5148

Scoliosis

140

646

2.21

16.80

1.8

2.1

38.30

37.36

g/l

0.94

121

562

Nonorganic sleeping disorders

290

1703

1.72

16.79

1.5

2.1

39.30

38.23

g/l

2.60

258

1531

Paralytic ileus and intestinal obstruction

456

2990

1.54

16.78

2.4

2.1

36.75

37.41

g/l

1.28

393

2567

Fall on and from stairs and steps

447

2921

1.55

16.78

2.2

2.1

37.92

37.70

g/l

0.34

376

2537

Meniscus derangement

868

4274

1.38

16.77

2.2

2.3

38.09

37.87

g/l

0.53

754

3710

Thyrotoxicosis

422

2723

1.57

16.76

1.7

2.1

37.43

37.84

g/l

0.80

366

2353

Mucosal proctocolitis

199

1048

1.93

16.60

2.3

2.2

38.01

38.08

g/l

0.06

187

945

Respiratory insufficiency

159

774

2.10

16.54

1.5

1.6

36.63

38.21

g/l

2.52

131

645

Migraine without aura and triptan purchases

189

979

1.95

16.47

1.5

1.9

39.58

38.99

g/l

0.76

174

881

Agoraphobia

130

3.87

16.45

1.8

1.7

38.36

39.30

g/l

0.41

122

Other disorders of eyelid

840

5889

1.37

16.43

2.1

2.2

37.87

37.31

g/l

2.03

714

5026

Other and unspecified injuries of head

140

654

2.20

16.39

1.6

2.1

36.82

37.85

g/l

1.06

115

571

Other infectious diseases

184

951

1.98

16.37

2.5

2.1

35.22

37.62

g/l

4.80

165

835

Gonarthrosis,primary

1623

7976

1.26

16.35

1.9

2.3

37.35

37.66

g/l

1.23

1391

6897

Abnormal spermatozoa

1577

0.32

16.24

1.9

2.4

35.82

37.48

g/l

0.95

1377

Oesophageal varices

403

2.55

16.09

1.5

2.4

33.97

37.96

g/l

7.21

357

Faecal incontinence

195

1035

1.93

16.05

1.5

2.3

38.04

37.38

g/l

0.76

173

883

Anaemia in chronic diseases classified elsewhere

218

3.19

16.03

1.8

2.8

35.34

37.48

g/l

1.97

189

Pneumonia derived septicemia

316

2.77

16.01

4.6

2.4

36.93

37.57

g/l

0.41

275

Other and unspecified acquired haemolytic anaemias

4.63

15.99

3.3

1.5

35.85

37.60

g/l

0.81

Mental and behavioural disorders due to alcohol, excluding acute intoxication

724

5215

1.39

15.82

1.6

2.2

37.05

37.94

g/l

2.83

615

4626

KRA_PSY_EATING, excluding more controls

276

2.81

15.65

1.4

1.7

39.28

39.66

g/l

0.26

252

Thyrotoxicosis, other and/or unspecified

327

2024

1.64

15.55

1.8

2.1

37.49

37.97

g/l

0.81

288

1765

Congenital malformations, deformations and chromosomal abnormalities

799

5604

1.37

15.48

1.8

2.1

38.45

38.27

g/l

0.37

709

4946

Retinal detachments and breaks

666

4778

1.41

15.48

2.4

2.3

37.10

37.49

g/l

0.87

576

4116

Spirochaetal infections, other/unspecified

176

916

1.97

15.41

2.4

2.3

38.20

37.69

g/l

0.47

136

805

Fracture of skull and facial bones

344

2161

1.61

15.38

2.5

2.1

37.71

38.04

g/l

0.41

296

1923

Use of pramipexole

421

2775

1.54

15.32

1.8

2.2

37.95

37.48

g/l

0.90

347

2384

Hallux valgus (acquired)

519

2537

1.48

15.31

1.9

2.4

37.49

37.93

g/l

0.85

430

2168

Ptosis of eyelid

232

1320

1.80

15.29

2.6

2.3

38.33

37.34

g/l

2.18

212

1148

Acute pancreatitis

355

2252

1.60

15.29

1.9

2.2

36.39

37.68

g/l

3.22

313

1954

Raynaud syndrome

153

759

2.06

15.29

1.5

2.3

39.01

37.99

g/l

1.19

136

679

Bronchiectasis

180

949

1.95

15.22

2.8

2.3

36.71

37.63

g/l

1.22

161

808

Degeneration of macula and posterior pole

948

5712

1.33

15.10

2.2

37.21

37.24

g/l

0.04

765

4840

Benign neoplasm of other and unspecified endocrine glands

248

1442

1.75

15.09

2.1

37.32

37.75

g/l

0.48

208

1281

Atopic dermatitis, strict definition

334

2046

1.61

15.06

1.8

1.9

38.35

38.76

g/l

0.58

300

1854

Collagenous colitis

179

945

1.94

15.00

3.0

2.2

37.33

37.70

g/l

0.33

157

831

Other disorders of skin and subcutaneous tissue, not elsewhere classified

265

1571

1.72

15.00

2.2

2.1

35.86

37.66

g/l

4.37

214

1352

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

278

1672

1.69

14.92

2.1

1.4

36.33

37.80

g/l

3.34

255

1429

Other complications of surgical and medical care, not elsewhere classified

178

940

1.93

14.86

2.7

2.1

37.25

37.89

g/l

0.65

154

831

Biomechanical lesions, not elsewhere classified

111

493

2.33

14.84

2.4

2.5

38.90

37.64

g/l

1.71

103

437

Other and unspecified urticaria

291

1770

1.66

14.84

2.5

2.0

37.89

37.99

g/l

0.10

256

1566

Localized swelling, mass and lump of skin and subcutaneous tissue

510

3514

1.47

14.81

2.1

2.2

37.82

37.60

g/l

0.33

443

3044

Alcohol induced polyneuropathy

4.50

14.79

1.2

1.9

35.97

37.65

g/l

0.58

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

256

1462

1.72

14.73

1.6

2.1

37.71

38.01

g/l

0.31

227

1299

Protozoal diseases

296

2.76

14.73

5.0

2.5

35.26

37.87

g/l

2.67

262

Carcinoma in situ of skin of other and unspecified parts of face

204

1133

1.85

14.71

2.0

2.3

36.91

36.85

g/l

0.05

180

957

Fibroblastic disorders

401

2638

1.54

14.67

2.5

2.2

38.01

37.40

g/l

1.23

346

2267

Pneumococcal septicemia

308

2.70

14.62

4.8

2.5

37.04

37.82

g/l

0.53

270

Guillain-Barre syndrome

138

3.69

14.61

2.2

37.85

37.44

g/l

0.14

123

Delirium, not induced by alcohol and other psychoactive substances

253

1491

1.73

14.61

1.8

2.3

35.02

37.27

g/l

5.48

204

1282

Sub-endpoint used in defining T1D endpoints

457

3039

1.49

14.56

1.8

2.0

35.88

37.78

g/l

9.27

409

2632

Congenital malformations of the urinary system

109

483

2.31

14.56

2.0

2.5

37.21

38.02

g/l

0.67

103

435

Eosinophilia

149

3.57

14.43

2.5

2.3

36.16

37.67

g/l

0.93

135

Allergic rhinitis

370

2368

1.56

14.43

2.1

1.9

38.76

38.53

g/l

0.29

325

2127

Other spirochaetal diseases

506

3501

1.46

14.42

2.7

2.2

38.77

37.84

g/l

2.98

428

3069

Other crystal arthropathies

190

3.23

14.37

1.7

2.1

35.76

36.92

g/l

0.64

159

Sequelae of injuries of lower limb

162

839

1.97

14.34

2.2

2.3

38.69

38.05

g/l

0.85

147

753

Myeloid leukaemia

266

2.84

14.33

1.5

2.7

37.32

37.61

g/l

0.14

233

Vitamin B12 deficiency anaemia

211

1192

1.81

14.24

1.8

2.2

36.66

37.45

g/l

1.11

182

1021

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

237

1336

1.74

14.23

1.6

2.1

37.74

37.93

g/l

0.16

211

1194

Psoriatic arthropathies

159

820

1.97

14.22

1.8

2.2

37.45

38.14

g/l

0.66

138

724

Psoriasis vulgaris

313

1962

1.62

14.22

1.8

2.1

37.35

37.93

g/l

0.84

275

1748

Thyroiditis, ILD-related definition

178

954

1.90

14.17

2.4

2.2

39.09

38.24

g/l

1.15

157

837

Disorders of synovium and tendon

774

5036

1.35

14.12

1.8

2.2

38.27

37.79

g/l

1.35

674

4366

Sequelae with surgical and medical care as external cause

378

2480

1.55

14.10

2.1

36.40

37.55

g/l

2.83

342

2134

Pemphigoid

298

2.72

14.04

1.6

2.4

38.22

36.67

g/l

1.47

255

Primary biliary cholangitis (PBC)

187

3.20

14.03

1.4

1.9

37.38

38.43

g/l

0.57

168

Poisoning by drugs, medicaments and biological substances

314

1974

1.61

14.00

1.9

2.1

38.29

38.41

g/l

0.13

273

1789

Spirochaetal infections, other/unspecified

499

3465

1.46

13.97

2.7

2.3

38.76

37.84

g/l

2.91

422

3037

Benign neoplasm: Stomach

205

1157

1.81

13.96

2.3

2.2

37.08

37.62

g/l

0.68

177

1010

Traumatic subarachnoid haemorrhage

286

2.71

13.91

2.4

1.9

37.75

37.28

g/l

0.25

254

Chronic tubulo-interstitial nephritis

333

2.58

13.91

2.1

1.9

35.65

38.47

g/l

3.01

294

Striking against or struck by other objects

468

3209

1.47

13.86

1.8

2.1

37.86

38.20

g/l

0.56

395

2861

Other spirochaetal diseases

499

3471

1.45

13.85

2.7

2.3

38.77

37.85

g/l

2.89

422

3042

Lyme disease

495

3440

1.45

13.81

2.7

2.3

38.78

37.86

g/l

2.88

418

3015

Traumatic subdural haemorrhage

251

1438

1.70

13.79

2.3

2.2

37.02

36.61

g/l

0.46

202

1234

Personal history of malignant neoplasm

137

682

2.06

13.67

2.8

1.8

37.25

38.18

g/l

0.87

122

604

Malignant melanoma, including Hilmo

316

2006

1.60

13.67

2.2

1.4

37.94

37.65

g/l

0.39

266

1708

Herpesviral [herpes simplex] infections

196

1096

1.82

13.66

3.3

2.2

37.56

37.91

g/l

0.34

177

970

Early onset COPD

398

2658

1.52

13.65

2.1

2.3

36.20

37.94

g/l

6.79

351

2323

Intestinal malabsorption

403

2.40

13.64

1.7

2.5

37.13

37.95

g/l

0.58

357

Other and unspecified visual disturbances

186

1026

1.85

13.61

2.3

2.0

38.15

37.60

g/l

0.64

168

906

Cervical disc disorders

583

4183

1.41

13.55

2.1

38.50

37.57

g/l

3.29

500

3626

Poisoning by medicine

283

1751

1.63

13.50

2.0

2.1

38.40

38.47

g/l

0.07

248

1588

Diabetic retinopathy

623

2790

1.41

13.50

1.8

2.0

36.27

36.95

g/l

2.00

543

2412

Congenital malformations of the urinary system

101

448

2.31

13.50

2.1

2.4

37.07

38.02

g/l

0.78

404

Other disorders of glucose regulation and pancreatic internal secretion

150

774

1.98

13.46

2.1

2.2

35.71

37.61

g/l

2.94

131

683

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

799

5853

1.34

13.41

2.2

38.58

37.83

g/l

2.90

696

5133

Alcohol-induced chronic pancreatitis

126

614

2.11

13.35

1.9

2.4

35.82

37.94

g/l

2.42

107

557

Other infectious diseases

156

820

1.95

13.32

2.7

2.1

34.84

37.56

g/l

4.94

140

720

Lung cancer and mesothelioma

335

1848

1.57

13.26

2.1

1.9

36.19

38.15

g/l

6.96

296

1558

Bullous disorders

130

644

2.08

13.23

1.9

2.3

37.82

37.35

g/l

0.39

119

566

Juvenile arthritis (FINNGEN)

192

3.02

13.22

1.8

1.9

38.64

38.93

g/l

0.12

176

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

201

1146

1.79

13.21

1.9

1.4

36.02

37.69

g/l

3.10

178

966

Conjunctivitis (acute, non atopic)

393

2626

1.50

13.11

2.6

2.0

38.11

38.03

g/l

0.09

350

2311

Vascular disorders of the intestines

146

755

1.98

13.10

2.2

1.9

35.67

37.22

g/l

2.15

129

638

Other viral diseases, not elsewhere classified

342

2216

1.55

13.06

2.8

2.0

37.56

38.35

g/l

1.48

318

1972

Lesion of lateral popliteal nerve

443

2.30

13.02

2.0

2.2

38.04

37.66

g/l

0.21

394

Cardiomyopathy, Hypertrophic obstructive

159

3.31

12.99

1.5

2.3

37.16

38.52

g/l

0.74

141

Inflammatory bowel disease

461

3197

1.45

12.98

2.2

37.69

38.18

g/l

0.89

404

2832

COPD-related respiratory insufficiency

248

1506

1.68

12.97

2.0

2.2

34.97

37.44

g/l

8.62

203

1267

Alcohol use disorder, ICD-based

654

4823

1.37

12.86

1.6

2.2

37.12

37.91

g/l

2.18

561

4275

Benign neoplasm: Caecum

223

1321

1.73

12.85

2.6

2.1

37.38

37.46

g/l

0.08

191

1157

Other or unspecified ileus, impaction or obstruction

322

2082

1.57

12.82

2.2

2.1

36.81

37.45

g/l

0.88

275

1789

Demyelinating diseases of the central nervous system

127

629

2.05

12.79

1.6

2.0

39.43

38.25

g/l

1.22

115

568

Macular pucker

319

2067

1.57

12.75

1.7

2.4

37.69

37.39

g/l

0.38

260

1770

Inflammatory diseases of the central nervous system

146

763

1.95

12.66

2.1

2.3

36.53

37.76

g/l

1.14

121

676

Restless leg syndrome

239

1449

1.68

12.54

2.1

38.72

37.67

g/l

1.84

202

1278

Artificial opening status

121

596

2.09

12.53

3.0

2.1

35.95

37.80

g/l

2.03

108

530

Diagnoses used for exclusion with ILD

456

3182

1.45

12.52

2.1

37.37

37.52

g/l

0.22

388

2744

807

5647

1.32

12.51

2.6

2.2

37.01

37.14

g/l

0.25

671

4755

Acute pancreatitis (for exclusion)

355

2361

1.52

12.47

1.9

2.2

36.39

37.58

g/l

2.84

313

2056

Drug-induced polyneuropathy

4.38

12.45

15.1

1.3

37.99

37.32

g/l

0.32

Malignant melanoma

262

1629

1.63

12.43

2.3

1.4

37.84

37.64

g/l

0.21

217

1378

Internal derangement of knee

527

3753

1.41

12.43

1.7

2.3

38.28

37.95

g/l

0.66

447

3278

Ascites

152

814

1.91

12.31

1.5

2.3

34.08

37.62

g/l

7.48

137

706

Exposure to other and unspecified inanimate mechanical forces

121

598

2.06

12.31

2.3

37.99

37.98

g/l

0.01

115

531

Other viral diseases, not elsewhere classified

256

1580

1.63

12.27

2.9

2.1

37.18

38.07

g/l

1.33

240

1406

Recurrent aphthous stomatitis , including avohilmo

235

1426

1.67

12.26

2.4

2.2

38.05

37.71

g/l

0.39

207

1252

Transport accidents

597

3747

1.38

12.25

1.8

2.2

38.37

38.25

g/l

0.17

520

3378

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

366

2.36

12.13

1.5

1.8

38.67

38.81

g/l

0.06

343

Open wound of forearm

156

846

1.88

12.08

2.1

36.75

37.60

g/l

0.86

134

751

Other diseases of pancreas

165

915

1.85

11.99

2.0

2.3

37.19

37.68

g/l

0.44

142

802

Superficial injury of abdomen, lower back and pelvis

233

1419

1.66

11.96

2.1

37.78

37.82

g/l

0.03

206

1252

Actinic keratosis

755

5324

1.33

11.95

2.7

2.2

36.93

37.09

g/l

0.32

627

4472

Behavioural syndromes associated with physiological disturbances and physical factors

1391

8036

1.23

11.95

1.9

2.2

38.56

37.88

g/l

3.95

1207

7004

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

442

3075

1.44

11.91

2.1

38.77

38.59

g/l

0.27

389

2771

Other and unspecified mood [affective] disorders

382

2.31

11.87

1.6

2.1

37.99

38.83

g/l

0.63

347

Pollen allergy

193

1103

1.74

11.87

2.5

2.0

38.54

38.89

g/l

0.35

165

1016

Cutaneous lupus erythematosus

223

2.81

11.86

2.3

2.1

37.99

38.21

g/l

0.11

198

Other inflammatory liver diseases

124

628

2.02

11.85

1.7

2.5

35.50

37.96

g/l

3.30

103

560

Specific personality disorders

284

1817

1.58

11.83

1.7

2.0

38.59

38.62

g/l

0.02

252

1646

Ankylosing spondylitis

139

731

1.93

11.83

1.6

2.0

37.96

37.53

g/l

0.32

129

656

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

183

1052

1.77

11.74

3.0

2.3

36.94

37.63

g/l

0.73

161

936

Sequelae of injuries, of poisoning and of other consequences of external causes

361

2439

1.50

11.73

2.6

2.1

38.21

38.04

g/l

0.23

310

2172

Skin changes due to chronic exposure to nonionizing radiation

768

5424

1.32

11.69

2.7

2.2

36.99

37.10

g/l

0.19

639

4558

Other and unspecified local infections of skin and subcutaneous tissue

165

922

1.82

11.63

2.8

2.2

35.47

37.84

g/l

4.86

144

822

Hallux rigidus

233

1432

1.65

11.60

2.2

2.4

38.18

37.68

g/l

0.59

191

1230

Diabetic maculopathy, excluding more controls

187

1085

1.75

11.57

1.3

2.2

35.47

37.86

g/l

5.94

164

951

Allergic urticaria

126

646

1.98

11.57

1.8

2.2

38.43

38.02

g/l

0.32

112

579

Mental and behavioural disorders due to sedatives or hypnotics

104

498

2.13

11.53

1.4

2.1

38.95

38.23

g/l

0.52

451

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

242

1501

1.64

11.53

2.5

1.4

37.01

37.11

g/l

0.10

202

1226

Other local infections of skin and subcutaneous tissue

175

998

1.78

11.52

2.7

2.2

35.64

37.86

g/l

4.53

150

890

Speech disturbances, not elsewhere classified

173

985

1.79

11.50

2.0

2.3

37.82

37.31

g/l

0.50

139

863

Ulcerative colitis

359

2432

1.49

11.50

2.3

2.1

37.85

38.14

g/l

0.39

313

2155

Fall involving bed

347

2.40

11.47

2.5

2.4

36.17

36.95

g/l

0.60

295

Other localized connective tissue disorders

177

3.02

11.46

2.7

2.0

36.73

38.18

g/l

0.88

158

Other/unspecified enthesopathies of lower limb, excluding foot

114

567

2.05

11.42

1.8

2.1

38.63

37.64

g/l

0.86

105

507

Parkinson's disease, excluding more controls

248

1462

1.62

11.39

2.0

2.2

38.32

36.74

g/l

4.53

204

1258

Exclusions for E4_PCOS_BROAD

249

1561

1.61

11.36

3.0

2.0

37.44

38.08

g/l

0.84

225

1394

Benign neoplasm: Rectum, anus and anal canal

380

2616

1.47

11.33

2.2

37.15

37.49

g/l

0.49

336

2254

Suppurative and necrotic conditions of lower respiratory tract

116

585

2.04

11.29

2.7

2.3

33.86

37.61

g/l

7.43

105

512

Emotionally unstable personality disorder

133

699

1.92

11.29

1.5

1.8

39.19

38.91

g/l

0.22

119

646

Spondylolisthesis/Spondylolysis

287

1869

1.55

11.16

2.5

2.1

38.22

37.52

g/l

1.16

249

1621

Anti-inflammatory and antirheumatic products, non-steroids

430

1490

1.46

11.16

2.6

2.2

37.59

36.91

g/l

1.33

380

1292

Vitreous haemorrhage

187

1098

1.74

11.15

1.9

2.2

35.94

37.65

g/l

3.28

170

966

Candidiasis

223

1370

1.65

11.14

3.0

2.1

36.37

37.84

g/l

2.34

187

1200

Hydronephrosis

190

1120

1.72

11.12

1.8

2.0

35.94

38.07

g/l

4.71

172

970

Infections with a predominantly sexual mode of transmission

342

2306

1.49

11.09

1.8

1.9

38.33

38.83

g/l

0.75

301

2086

Coxarthrosis, primary

1096

7460

1.25

11.08

2.1

2.3

37.62

37.36

g/l

0.78

929

6373

Benign neoplasm: Adrenal gland

155

866

1.83

11.04

1.8

2.4

36.58

37.82

g/l

1.47

131

768

Impacted cerumen

195

1162

1.71

11.04

1.7

2.3

37.52

37.40

g/l

0.08

121

1017

Carbimazole or st.post thyroidectomy, condition for graves disease

315

2098

1.52

11.02

2.4

2.1

37.75

38.01

g/l

0.34

277

1839

Artificial joint re-operation

153

854

1.84

10.98

1.8

2.4

36.42

37.58

g/l

1.44

136

738

Benign neoplasm: Rectum

343

2332

1.49

10.94

2.2

37.05

37.52

g/l

0.73

304

2012

Sarcoidosis

227

1409

1.64

10.91

2.0

2.1

38.34

37.84

g/l

0.66

205

1252

Carpal tunnel syndrome

977

6848

1.26

10.89

2.2

38.06

37.77

g/l

0.83

874

5922

Unspecified acute lower respiratory infection

236

1479

1.62

10.86

2.6

2.1

36.32

37.75

g/l

2.61

211

1296

Propionic acid derivatives

428

1490

1.45

10.86

2.4

2.2

38.15

36.91

g/l

3.52

375

1292

Other congenital malformations

166

948

1.77

10.82

1.7

2.2

38.43

38.24

g/l

0.14

152

854

Other bursopathies

221

1368

1.64

10.73

2.3

2.0

37.64

37.50

g/l

0.12

197

1190

Insomnia

1276

7599

1.23

10.73

1.8

2.2

38.73

37.92

g/l

5.05

1107

6637

Viral pneumonia (known virus, not influenza)

253

2.59

10.70

6.2

2.6

35.03

37.41

g/l

2.19

218

Sleep disorders

1319

7819

1.22

10.69

1.8

2.2

38.68

37.91

g/l

4.62

1145

6823

Iridocyclitis

356

2448

1.47

10.64

2.4

2.0

37.85

37.84

g/l

0.01

314

2136

Parkinson's disease, strict definition, excluding more controls

232

1387

1.62

10.57

1.9

2.2

38.46

36.77

g/l

4.75

192

1199

Mixed hyperlipidaemia

391

2.24

10.57

1.7

2.1

36.74

37.63

g/l

0.68

349

Social phobias

376

2.23

10.54

1.3

1.9

38.81

38.87

g/l

0.03

349

Hypoglycaemia, other or unspecified

117

607

1.97

10.46

1.7

2.2

35.83

37.62

g/l

2.24

105

539

Intestinal adhesions without obstruction

156

887

1.79

10.45

3.1

2.0

37.47

37.69

g/l

0.15

132

770

Disorders of vitreous body and globe

883

6712

1.27

10.43

2.1

2.3

37.62

37.60

g/l

0.04

765

5782

Ocular pain

132

713

1.88

10.43

1.7

2.2

38.51

38.09

g/l

0.40

120

632

Pain and other conditions associated with female genital organs and menstrual cycle

234

1353

1.60

10.41

1.8

39.98

38.35

g/l

4.70

201

1198

Hypermobility syndrome

267

2.48

10.37

2.2

1.8

40.02

38.48

g/l

1.30

256

Acute posthaemorrhagic anaemia

324

2.35

10.36

2.9

2.5

35.18

37.40

g/l

1.96

278

Abnormal results of function studies

145

809

1.82

10.34

2.4

2.3

38.22

37.97

g/l

0.22

126

731

Other and unspecified glaucoma

153

870

1.80

10.32

2.1

2.4

36.80

37.14

g/l

0.28

126

734

Special screening examination for neoplasms

101

500

2.06

10.32

3.3

2.1

37.46

37.31

g/l

0.09

449

Infections with a predominantly sexual mode of transmission

413

2727

1.42

10.27

1.8

1.9

38.52

38.85

g/l

0.49

366

2464

Hyperplasia of prostate

634

2704

1.34

10.27

2.3

2.4

37.72

37.35

g/l

0.73

557

2392

Other shoulder lesions

140

774

1.84

10.25

1.5

1.8

38.26

38.00

g/l

0.18

125

691

Gingival hyperplasia

301

2.40

10.22

2.8

35.06

37.94

g/l

2.59

267

Lesion of ulnar nerve

227

1432

1.61

10.22

1.7

2.0

37.69

37.77

g/l

0.07

204

1280

Neuralgia and neuritis, unspecified

422

2.16

10.21

2.5

1.9

38.23

37.68

g/l

0.37

377

Squamous cell neoplasms and carcinomas of the skin

167

975

1.75

10.21

2.5

1.4

37.17

37.21

g/l

0.03

139

792

Alcohol abuse, main dg, excluding more controls

210

1299

1.64

10.21

1.2

2.3

37.27

38.17

g/l

0.98

180

1172

Other diseases of stomach and duodenum

127

684

1.90

10.20

2.1

2.4

36.50

37.64

g/l

1.13

113

604

Colonic or urogenital fistula

423

3028

1.41

10.15

2.2

38.16

37.86

g/l

0.46

362

2656

Dislocation, sprain and strain of joint and ligaments of hip

379

2.23

10.13

1.5

2.3

36.67

37.13

g/l

0.24

337

Cardiac arrest

103

438

2.04

10.07

2.1

35.30

39.35

g/l

7.21

370

Alcohol-induced acute pancreatitis

322

2.34

10.06

2.3

2.7

36.61

38.04

g/l

0.89

292

Exclusions for E4_PCOS_CONSORTIUM

983

4921

1.26

9.98

2.2

2.1

37.75

38.16

g/l

1.29

841

4273

Drug-induced cataract

203

2.72

9.93

2.4

2.6

37.95

37.96

g/l

0.00

182

Heartburn

176

1052

1.70

9.84

1.8

2.2

38.67

37.87

g/l

1.10

145

912

Algoneurodystrophy

215

2.63

9.81

1.3

1.8

39.77

38.45

g/l

0.98

200

Other specified and unspecified personality disorders

119

634

1.90

9.80

1.6

2.1

38.51

g/l

0.00

106

576

Disorders of vitreous body

854

6555

1.27

9.80

2.1

2.3

37.61

37.62

g/l

0.01

741

5651

Keratitis

528

3938

1.35

9.79

2.0

2.1

38.03

37.92

g/l

0.15

459

3436

Speech and linguistic disorders, excluding more controls

339

2.22

9.79

2.5

2.2

38.28

38.40

g/l

0.06

296

Hemiplegia

479

2.05

9.66

1.6

2.3

38.06

37.64

g/l

0.23

421

Problems related to lifestyle

138

774

1.81

9.64

1.4

2.3

37.15

38.18

g/l

0.94

122

686

Injuries to the neck

311

2126

1.48

9.61

2.7

2.0

38.58

38.09

g/l

0.67

267

1891

Bullous pemphigoid

243

2.55

9.60

1.5

2.6

38.08

36.68

g/l

1.03

206

Pyothorax

434

2.11

9.58

2.9

2.4

34.10

37.51

g/l

4.89

382

Other lack of coordination

145

3.03

9.58

1.8

3.0

39.45

37.45

g/l

1.21

128

Cervicobrachial syndrome

307

2095

1.48

9.57

2.0

2.1

39.11

37.76

g/l

3.99

282

1816

Other disorders of the musculoskeletal system and connective tissue

257

1697

1.54

9.51

2.2

37.63

37.60

g/l

0.02

233

1489

Hypothyroidism, other/unspecified

1382

7573

1.20

9.49

2.0

2.2

37.94

37.76

g/l

0.51

1195

6557

Disorders of vestibular function (Vertigo)

790

6146

1.27

9.46

1.9

2.2

38.27

37.48

g/l

3.54

661

5253

Carcinoma in situ of skin

179

1090

1.68

9.46

1.7

2.3

36.63

37.28

g/l

0.67

158

936

Anogenital herpesviral [herpes simplex] infection

115

613

1.90

9.44

1.8

2.0

38.64

38.87

g/l

0.18

103

565

Systemic atrophies primarily affecting the central nervous system

437

2.10

9.43

1.3

2.6

39.68

37.58

g/l

3.18

384

Epilepsy

460

3371

1.37

9.39

1.8

2.3

37.35

37.48

g/l

0.15

380

2938

Erosion of teeth , including avohilmo

310

2128

1.47

9.38

2.2

2.0

38.86

38.41

g/l

0.72

275

1911

Abscess of anal and rectal regions

124

680

1.85

9.37

1.3

2.0

37.13

38.25

g/l

1.25

111

619

Asthma and opportunity respiratory infection

103

535

1.98

9.34

2.5

2.6

36.52

37.24

g/l

0.58

458

Synovial cyst of popliteal space [Baker]

130

727

1.82

9.27

2.7

1.9

37.76

37.51

g/l

0.19

117

633

Secondary thrombocytopenia

111

3.33

9.26

4.2

1.5

36.04

37.57

g/l

0.85

Emphysema

144

831

1.77

9.25

2.8

2.3

35.38

37.48

g/l

3.78

129

715

Mental and behavioural disorders due to opioids

186

2.69

9.25

1.7

1.9

39.00

38.90

g/l

0.03

175

Intestinal stricture

533

4021

1.34

9.23

2.4

2.2

36.63

37.47

g/l

2.16

455

3436

Other orthopaedic follow-up care

101

522

1.98

9.21

1.8

2.0

37.75

38.50

g/l

0.56

460

Monoamine oxidase A inhibitors

186

1148

1.64

9.21

1.8

2.3

38.18

37.77

g/l

0.41

165

1009

Superficial injury of thorax

235

1533

1.55

9.18

1.4

2.2

37.36

37.61

g/l

0.24

192

1348

Colectomy operation

304

2096

1.47

9.11

2.5

2.1

36.36

37.38

g/l

1.93

261

1796

Crushed, pushed or stepped on by crowd or human stampede

468

2.02

9.09

2.6

2.2

37.92

38.21

g/l

0.16

423

Carcinoma in situ of other and unspecified digestive organs

357

2.20

9.09

1.8

2.7

37.02

37.27

g/l

0.13

311

Diplopia

218

1403

1.58

9.08

2.1

2.0

37.85

37.58

g/l

0.28

190

1231

Paraplegia, diplegia of upper limbs

195

2.66

9.07

1.9

2.6

35.56

37.74

g/l

1.29

174

Calculus of kidney and ureter

504

3783

1.34

9.05

2.0

2.2

37.58

37.60

g/l

0.02

446

3294

Other demyelinating diseases of the central nervous system

236

2.47

9.04

1.6

1.8

39.26

38.91

g/l

0.15

219

Ankylosing spondylitis, ICD10

133

756

1.79

8.96

1.6

2.3

38.02

38.01

g/l

0.01

123

685

Vitamin deficiency, wide

425

2.07

8.92

2.5

2.3

36.96

37.73

g/l

0.60

374

Vitamin deficiency

425

2.07

8.92

2.5

2.3

36.96

37.73

g/l

0.60

374

Total colectomy

352

2.18

8.92

2.4

2.6

36.96

37.94

g/l

0.52

317

Total colectomy operation

352

2.18

8.92

2.4

2.6

36.96

37.94

g/l

0.52

317

Insulin, fast-acting (human)

189

1180

1.62

8.91

1.8

2.0

36.19

38.20

g/l

4.79

168

1061

Temporomandibular joint disorders, including avohilmo

523

3894

1.33

8.89

2.0

2.1

39.16

38.35

g/l

2.85

459

3445

Thyrotoxicosis with toxic multinodular goitre

123

687

1.83

8.89

1.5

2.2

36.38

37.56

g/l

1.61

102

591

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

197

1243

1.60

8.87

1.8

2.2

38.78

38.48

g/l

0.28

170

1137

Other/unspecified rheumatoid arthritis

225

1469

1.56

8.83

1.7

2.1

36.39

37.38

g/l

1.68

195

1249

Diseases of male genital organs

774

3072

1.28

8.76

2.0

2.3

37.86

37.70

g/l

0.26

695

2737

Benign neoplasm: Rectosigmoid junction

457

2.03

8.74

2.0

2.6

38.23

37.36

g/l

0.74

401

Adhesive capsulitis of shoulder

257

1729

1.50

8.70

1.8

2.1

38.09

37.62

g/l

0.58

225

1506

Carcinoma in situ of colon

212

2.57

8.69

1.8

2.9

36.68

37.25

g/l

0.26

184

Other skin changes

311

2174

1.45

8.67

2.8

2.2

37.11

37.31

g/l

0.23

255

1876

Olecranon bursitis

105

562

1.91

8.65

2.0

1.9

37.12

37.43

g/l

0.18

498

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

339

2403

1.42

8.64

1.8

2.0

38.53

38.48

g/l

0.05

292

2176

Tubulo-interstitial nephritis, not specified as acute or chronic

114

627

1.85

8.60

2.4

1.9

36.10

38.16

g/l

2.40

549

Eating disorder

368

2.11

8.59

1.4

1.6

39.28

39.47

g/l

0.12

343

Microscopic polyangiitis

3.98

8.59

1.5

1.9

30.59

37.48

g/l

3.10

Other symptoms and signs involving the nervous and musculoskeletal systems

605

4688

1.30

8.59

1.9

2.2

39.11

37.72

g/l

6.67

529

4066

Alzheimer disease, excluding more controls

321

1473

1.45

8.57

1.9

2.3

36.87

36.81

g/l

0.05

240

1258

Otitis externa

322

2273

1.43

8.47

1.9

2.1

38.86

37.80

g/l

2.57

261

2015

Dermatographic urticaria

509

1.94

8.46

1.8

2.3

39.22

38.18

g/l

0.94

464

Disorders of orbit

400

2.07

8.45

3.7

2.4

38.16

37.91

g/l

0.17

358

Primary gonarthrosis, bilateral

909

6330

1.24

8.45

1.8

2.3

37.31

37.53

g/l

0.52

775

5418

Bacterial, viral and other infectious agents

127

725

1.78

8.45

2.7

2.2

37.39

38.01

g/l

0.50

116

660

Anogenital herpesviral [herpes simplex] infection

352

2.13

8.45

1.7

1.8

38.78

38.84

g/l

0.03

322

Folate deficiency anaemia

3.41

8.44

2.2

1.7

35.23

37.42

g/l

0.71

Retinal vascular occlusion

230

1526

1.53

8.42

2.3

2.2

36.47

37.20

g/l

0.98

200

1290

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

160

976

1.67

8.41

2.1

2.2

38.61

37.73

g/l

1.13

131

854

Other/unspecified disorders of vestibular function

429

2.04

8.40

1.6

2.5

37.45

37.71

g/l

0.15

380

Anosmia

3.31

8.38

3.1

1.4

37.39

39.40

g/l

0.77

D07AA Corticosteroids, weak (group I)

192

1220

1.59

8.37

1.7

2.2

38.28

38.21

g/l

0.06

163

1093

COPD, hospital admissions 1, only main diagnosis

636

4260

1.29

8.30

1.9

2.2

35.62

37.39

g/l

11.23

537

3638

Diseases of inner ear

899

7086

1.23

8.28

1.9

2.2

38.31

37.54

g/l

3.78

754

6091

Retinal vascular disorders

232

1548

1.52

8.27

2.3

2.2

36.48

37.20

g/l

0.96

202

1310

Fall on same level involving ice and snow

876

7124

1.24

8.26

1.9

2.2

37.88

37.76

g/l

0.24

736

6180

Melanoma in situ

509

1.94

8.25

2.4

2.6

37.19

37.27

g/l

0.04

445

Alcohol dependence

416

3080

1.36

8.22

1.5

2.3

37.01

37.94

g/l

2.02

352

2742

Angina pectoris

977

5331

1.23

8.21

2.2

2.4

37.13

37.74

g/l

2.36

858

4549

Mental disorders, not otherwise specified

106

578

1.86

8.21

1.7

2.1

38.50

38.56

g/l

0.04

100

527

Deviated nasal septum

500

3799

1.32

8.20

2.8

2.3

38.69

37.69

g/l

3.78

444

3367

Abnormality of white blood cells, not elsewhere classified

3.85

8.19

2.2

1.7

37.44

38.78

g/l

0.56

Trigger finger

206

1341

1.55

8.17

1.6

2.1

38.32

37.79

g/l

0.65

185

1188

Hypothyreosis and Thyroxine purchase for inclusion criteria

1431

7958

1.18

8.17

2.0

2.2

37.93

37.77

g/l

0.41

1238

6886

Cyst of kidney

138

818

1.72

8.13

2.5

2.4

37.75

37.82

g/l

0.06

130

721

Other symptoms and signs involving the circulatory and respiratory systems

102

552

1.88

8.11

1.6

2.2

37.95

38.00

g/l

0.03

481

Golimumab

218

2.44

8.07

1.2

1.8

37.71

38.92

g/l

0.72

209

Other infective otitis externa

101

549

1.88

7.97

2.1

2.2

39.30

37.74

g/l

2.02

490

Exfoliative dermatitis

3.39

7.96

1.6

2.6

37.11

37.50

g/l

0.12

Coronary artery bypass grafting

493

2789

1.33

7.94

1.6

2.4

36.02

37.28

g/l

4.56

435

2336

Superficial injury of ankle and foot

142

851

1.69

7.92

1.6

2.1

37.59

38.24

g/l

0.59

119

771

Mantle cell lymphoma, including Hilmo

122

3.01

7.91

2.9

1.3

37.13

37.09

g/l

0.01

103

Disorders of optic nerve and visual pathways

139

830

1.70

7.91

2.3

38.21

38.04

g/l

0.11

122

744

Inflammatory diseases of female pelvic organs

790

4672

1.25

7.91

1.6

2.2

38.39

38.12

g/l

0.64

671

4040

therapeutic use

324

2.17

7.89

1.6

2.3

37.00

37.44

g/l

0.20

284

Attention to artificial openings

392

2.04

7.81

1.9

34.71

38.00

g/l

4.05

349

Other specified/unspecified bacterial intestinal infections

118

678

1.77

7.77

2.6

2.2

36.77

37.79

g/l

0.77

604

Fentanyl

166

1040

1.61

7.77

5.3

1.7

35.91

37.35

g/l

2.23

129

865

Urolithiasis

535

4145

1.30

7.72

2.0

2.2

37.52

37.56

g/l

0.05

470

3602

Personal history of other diseases and conditions

123

712

1.74

7.67

3.2

1.9

38.08

38.92

g/l

0.91

103

640

Malignant neoplasm of kidney, except renal pelvis

158

986

1.63

7.62

1.8

1.4

35.99

37.70

g/l

2.80

139

831

Familial hypercholesterolemia

255

1764

1.46

7.59

2.4

2.1

37.17

37.40

g/l

0.22

209

1472

Other and unspecified psoriasis

118

683

1.76

7.59

2.1

2.4

37.40

37.86

g/l

0.42

106

609

Dementia in Alzheimer disease

172

2239

0.64

7.58

1.4

2.2

36.70

36.58

g/l

0.07

103

1875

Malignant melanoma of skin, including Hilmo

239

1634

1.48

7.57

2.1

1.4

38.19

37.68

g/l

0.69

202

1391

Other disorders of bladder

203

1343

1.53

7.56

2.2

2.4

37.43

37.65

g/l

0.19

171

1157

Nummular dermatitis

136

819

1.69

7.55

2.2

2.4

38.64

37.73

g/l

1.13

118

719

Melanocytic naevi of lower limb, including hip

363

2.06

7.51

2.4

2.3

37.88

38.01

g/l

0.06

326

Suicide or other Intentional self-harm

303

2163

1.41

7.51

1.9

2.1

38.46

38.33

g/l

0.13

262

1951

Fracture at wrist and hand level

470

3587

1.32

7.45

2.1

2.2

38.33

38.09

g/l

0.35

400

3161

Melanocytic naevi

403

3017

1.35

7.44

2.4

2.1

38.09

38.06

g/l

0.03

374

2643

Left bundle-branch block

124

733

1.72

7.38

1.7

2.1

37.07

38.27

g/l

1.33

618

Other superficial mycoses

128

762

1.70

7.37

1.6

2.2

38.03

38.11

g/l

0.05

110

686

Symptoms and signs involving emotional state

197

2.44

7.33

1.4

1.9

37.89

38.79

g/l

0.53

175

Malignant neoplasm of urinary organs

170

1090

1.58

7.33

1.7

1.4

36.06

37.65

g/l

2.66

150

919

Carcinoma in situ of skin of trunk

389

2.02

7.32

2.5

2.2

36.24

36.90

g/l

0.49

332

Other specified/unspecified soft tissue disorders

443

1.93

7.31

2.4

1.9

38.12

37.32

g/l

0.65

380

Procreative management

373

2299

1.36

7.28

1.7

2.0

39.36

38.52

g/l

1.99

349

2069

Superficial injury of shoulder and upper arm

165

1053

1.59

7.22

2.0

2.1

38.25

37.75

g/l

0.51

137

941

Arterial embolism and thrombosis

107

611

1.78

7.22

1.4

2.3

34.93

37.45

g/l

3.47

525

Other obstetric conditions, not elsewhere classified

229

980

1.49

7.22

1.3

1.7

39.72

39.74

g/l

0.02

209

915

Other noninfective disorders of lymphatic vessels and lymph nodes

315

2.11

7.20

1.5

2.4

34.78

38.32

g/l

3.78

281

Alzheimer’s disease (Late onset), excluding more controls

276

1268

1.44

7.20

2.2

36.78

36.67

g/l

0.10

207

1076

Fracture of neck

113

657

1.76

7.19

3.3

2.1

37.80

37.42

g/l

0.26

576

Other disorders of optic [2nd] nerve and visual pathways

102

575

1.81

7.19

2.3

2.4

37.65

37.74

g/l

0.05

514

Cryoglobulinemia

13.37

7.19

4.6

1.0

38.18

37.08

g/l

0.21

Bacterial, viral and other infectious agents

115

671

1.74

7.16

2.7

2.2

37.11

38.16

g/l

0.96

104

613

Benign neoplasm of mouth and pharynx

182

1192

1.55

7.14

2.7

2.2

37.30

37.69

g/l

0.32

151

1054

Retinal detachment with retinal break

226

1549

1.48

7.11

2.3

2.1

36.74

37.66

g/l

1.33

194

1348

Complications of cardiac and vascular prosthetic devices, implants and grafts

220

2.36

7.10

1.8

2.8

34.63

37.26

g/l

1.68

189

Suggestive for eosinophilic asthma

154

973

1.61

7.08

2.0

2.2

36.90

37.75

g/l

1.04

142

861

Unspecified nephritic syndrome

208

2.39

7.04

1.9

2.6

36.74

37.72

g/l

0.44

184

Other and unspecified injuries of lower leg

106

608

1.77

7.02

2.2

2.3

37.00

38.10

g/l

0.89

545

Dissociative [conversion] disorders

220

2.31

6.99

1.2

1.8

39.56

38.31

g/l

0.69

198

Other and unspecified erythematous conditions

293

2.14

6.95

2.4

2.3

38.33

37.94

g/l

0.23

259

Superficial injury of wrist and hand

251

1759

1.44

6.95

1.8

2.0

38.30

38.27

g/l

0.03

217

1575

Barrett oesophagus

524

1.84

6.94

2.0

2.6

36.36

37.93

g/l

1.64

468

Organic, including symptomatic, mental disorders

943

5584

1.21

6.91

2.0

2.3

36.72

37.19

g/l

1.46

736

4780

Panniculitis affecting regions of neck and back

300

2.11

6.90

1.9

2.0

39.32

37.67

g/l

1.47

268

Pneumothorax

119

710

1.70

6.89

2.2

2.1

37.50

37.80

g/l

0.20

106

628

Other symptoms and signs involving the urinary system

172

1122

1.55

6.88

2.5

2.2

37.43

37.53

g/l

0.07

159

972

Dermatophytosis

211

1437

1.49

6.87

2.4

2.1

37.35

37.70

g/l

0.38

187

1254

Postviral fatigue syndrome

6.34

6.87

1.0

2.2

39.86

40.20

g/l

0.09

Artificial joint operation, meniscal resection

1507

8455

1.16

6.85

2.0

2.3

37.46

37.69

g/l

0.75

1297

7330

Otalgia

119

711

1.70

6.83

1.7

2.0

38.55

37.78

g/l

0.70

634

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

370

2.00

6.83

2.5

37.99

37.55

g/l

0.29

330

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

229

2.27

6.82

1.6

1.7

36.48

39.28

g/l

3.07

217

Idiopathic pulmonary fibrosis

151

962

1.60

6.77

2.1

2.3

35.92

37.38

g/l

2.47

135

826

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

218

936

1.48

6.74

1.3

1.6

39.61

39.79

g/l

0.18

200

875

Acute peritonitis

110

647

1.73

6.73

2.0

2.3

35.48

37.59

g/l

2.69

104

572

Acute pharyngitis

160

1021

1.57

6.73

2.7

1.9

38.42

38.40

g/l

0.01

147

928

Dermatitis due to substances taken internally

463

1.87

6.72

3.3

2.6

37.36

37.62

g/l

0.16

410

Inguinal hernia

912

5062

1.21

6.72

2.7

2.1

37.86

37.61

g/l

0.57

800

4395

Speech and linguistic disorders

408

1.90

6.72

2.5

2.0

38.42

38.44

g/l

0.01

360

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

100

3.03

6.71

6.3

1.3

38.95

38.37

g/l

0.26

Blepharochalasis

491

3838

1.29

6.71

1.9

2.2

37.97

37.40

g/l

1.36

414

3283

Follicular lymphoma, hilmo

487

1.86

6.70

1.5

2.7

36.93

37.54

g/l

0.42

429

Thiazolidinediones

210

1439

1.48

6.67

1.5

2.2

35.32

37.62

g/l

5.46

181

1241

Other congenital malformations of skin

107

625

1.73

6.67

1.8

2.3

38.77

38.12

g/l

0.51

560

Xerosis cutis

158

2.58

6.67

1.7

2.5

37.04

37.98

g/l

0.43

140

Acute and subacute iridocyclitis

277

1993

1.40

6.66

2.6

2.1

38.02

37.84

g/l

0.19

245

1756

Exophthalmic conditions

3.14

6.63

6.3

1.9

37.27

38.56

g/l

0.79

Crohn's disease NAS

501

1.82

6.63

1.8

2.3

36.53

38.21

g/l

1.24

452

Arthropathic psoriasis

171

1124

1.54

6.62

1.7

2.2

37.43

37.90

g/l

0.43

148

1013

Open wound of hip and thigh

239

2.22

6.60

1.3

2.7

38.00

37.90

g/l

0.04

219

Other specified/unspecified hearing loss

153

983

1.58

6.59

1.9

2.2

37.72

37.31

g/l

0.40

139

858

Anterior Iridocyclitis

296

2157

1.38

6.59

2.5

2.1

37.95

37.82

g/l

0.14

262

1894

Other congenital malformations

567

1.76

6.58

1.6

2.2

39.33

38.31

g/l

0.93

514

Viral and other specified intestinal infections

284

1980

1.39

6.55

1.6

1.9

37.69

38.58

g/l

1.57

260

1752

Other chondrocalcinosis

148

2.64

6.54

1.6

2.2

35.08

37.09

g/l

1.14

129

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

142

2200

0.64

6.53

1.9

1.4

36.63

37.76

g/l

1.20

120

1873

Arthropathy in hypersensitivity reactions classified elsewhere

21.52

6.53

1.8

1.0

39.79

42.28

g/l

—

Chronic laryngitis and laryngotracheitis

218

1509

1.46

6.53

1.6

2.1

36.95

37.59

g/l

0.64

178

1313

Portal vein thrombosis

136

2.67

6.49

1.7

2.6

35.82

38.05

g/l

1.09

125

Follicular cysts of skin and subcutaneous tissue

269

1937

1.40

6.45

2.5

2.1

37.36

37.88

g/l

0.79

244

1708

Postmenopausal bleeding

445

1819

1.32

6.45

2.1

37.51

37.21

g/l

0.45

371

1555

Mantle cell lymphoma

3.33

6.44

1.9

1.3

37.10

36.69

g/l

0.12

Persons encountering health services in other circumstances

518

4073

1.27

6.41

2.2

37.65

37.98

g/l

0.61

464

3491

Thrombotic microangiopathy

4.08

6.40

4.6

1.6

35.31

38.42

g/l

1.01

Palmar fascial fibromatosis [Dupuytren]

256

1832

1.41

6.39

2.5

2.1

37.64

37.19

g/l

0.55

216

1567

Alcohol abuse, main dg

210

1449

1.46

6.39

1.2

2.2

37.27

37.93

g/l

0.63

180

1308

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

409

3142

1.31

6.38

1.4

2.4

37.03

38.32

g/l

4.15

364

2798

Glucagon-like peptide-1 (GLP-1) analogues

409

3142

1.31

6.38

1.4

2.4

37.03

38.32

g/l

4.15

364

2798

Eating disorders

557

1.75

6.37

2.0

1.8

38.82

38.89

g/l

0.04

508

Amenorrhoea

371

1.93

6.35

2.0

1.7

39.49

38.69

g/l

0.53

338

Other disorders of patella

187

1264

1.49

6.29

1.9

2.3

39.38

38.35

g/l

1.55

165

1137

Other erythematous conditions

326

2.01

6.25

2.4

2.3

37.95

37.86

g/l

0.04

289

Hernia of abdominal wall

710

5833

1.22

6.23

2.3

2.2

37.42

37.68

g/l

0.53

633

5060

Other symptoms and signs involving general sensations and perceptions

354

1.96

6.22

2.0

2.4

37.18

37.69

g/l

0.30

313

Congenital malformations and deformations of the musculoskeletal system

116

702

1.66

6.20

1.5

2.1

38.27

38.56

g/l

0.18

108

636

Cervicocranial syndrome

150

974

1.56

6.15

1.8

2.1

38.81

37.49

g/l

2.39

136

844

Later onset COPD

549

3494

1.26

6.15

1.6

2.3

35.36

37.14

g/l

9.79

462

2926

Injuries to the wrist and hand

1485

8961

1.15

6.14

2.0

2.2

38.03

37.86

g/l

0.50

1297

7821

Diseases of peritoneum

168

1120

1.52

6.14

1.9

2.2

36.20

37.54

g/l

1.79

148

977

Assault

137

871

1.59

6.13

1.7

2.1

37.81

38.50

g/l

0.51

119

808

Disorders of oesophagus in diseases classified elsewhere

215

2.26

6.13

3.5

3.0

34.15

37.43

g/l

2.49

185

Haemorrhoids and perianal venous thrombosis

478

3758

1.28

6.12

2.1

2.2

37.60

37.52

g/l

0.11

408

3228

Cerebral cysts

456

1.83

6.10

1.3

2.2

37.01

37.90

g/l

0.40

410

Other/unspecified enthesopathies, not elsewhere classified

132

835

1.60

6.09

1.6

1.8

38.29

37.55

g/l

0.73

117

734

Viral warts

262

1897

1.39

6.08

2.2

2.1

38.54

38.22

g/l

0.39

229

1692

Disorders of psychological development

523

1.73

6.06

2.2

1.9

38.37

38.74

g/l

0.21

471

Vascular diseases of the intestine

422

1.87

6.06

2.5

2.1

34.77

37.30

g/l

2.40

364

Acute gastritis

126

790

1.62

6.05

1.8

2.3

37.10

37.53

g/l

0.34

105

697

Visual impairment including blindness (binocular or monocular)

117

721

1.65

6.04

2.2

2.1

37.08

37.29

g/l

0.14

622

Other and/or unspecified nontoxic goitre

139

893

1.58

6.03

2.3

38.50

37.62

g/l

1.04

125

778

Background retinopathy and retinal vascular changes

197

2.31

6.03

2.0

3.0

38.22

37.68

g/l

0.28

175

Childhood asthma (age<16), excluding more controls

321

1.87

6.02

1.5

1.4

39.63

40.88

g/l

1.09

302

Hepatic failure, not elsewhere classified

359

1.94

6.01

2.0

2.7

33.17

37.64

g/l

5.13

315

Gonarthrosis, primary, with knee surgery

999

6753

1.18

5.98

2.0

2.4

37.01

37.49

g/l

1.69

856

5786

Misadventures to patients during surgical and medical care

217

1528

1.43

5.97

1.8

2.1

36.26

37.61

g/l

2.27

185

1330

Congenital malformations of the circulatory system

178

1169

1.49

5.97

1.4

2.2

37.85

38.01

g/l

0.12

154

1046

Bronchitis, not specified as acute or chronic

130

824

1.60

5.95

1.9

2.2

38.60

37.94

g/l

0.59

110

709

Inflammatory disease of uterus

159

1053

1.52

5.95

1.8

2.0

38.28

38.44

g/l

0.14

137

938

Superficial injury of forearm

124

777

1.61

5.94

2.3

2.1

38.37

37.94

g/l

0.37

104

702

Diseases of the ear and mastoid process

1749

7726

1.14

5.93

2.1

2.2

38.55

37.72

g/l

6.90

1502

6808

Sleep disorders, other/unspecified

224

2.18

5.89

1.2

1.8

38.87

38.22

g/l

0.33

207

Malignant neoplasm of other connective and soft tissue, including Hilmo

412

1.86

5.87

4.4

1.4

37.74

37.81

g/l

0.03

354

Sulfonylureas

646

4204

1.23

5.85

1.7

2.3

35.60

37.17

g/l

8.24

544

3526

Injury of eye and orbit

180

1228

1.48

5.84

1.4

2.0

37.77

38.26

g/l

0.46

153

1114

Ectropion of eyelid

479

1.79

5.83

1.5

2.3

36.58

36.66

g/l

0.04

397

Respiratory disorders in diseases classified elsewhere

132

2.61

5.82

1.6

2.1

36.46

38.00

g/l

0.99

118

Benign neoplasm: Other and unspecified parts of mouth

335

1.96

5.82

2.7

2.5

37.26

37.85

g/l

0.28

297

MS-disease / Multiple Sclerosis

507

1.76

5.81

1.6

2.0

40.06

38.58

g/l

1.42

459

severe traumatic brain injury, does not include concussion

369

2836

1.31

5.81

2.3

2.1

37.21

37.20

g/l

0.01

299

2414

Other or ill-defined heart diseases

427

1.83

5.79

2.1

37.28

38.38

g/l

0.76

374

Diabetic retinopathy, strict definition

270

1749

1.38

5.77

1.6

1.9

35.48

37.00

g/l

3.64

230

1507

Umbilical hernia

394

3057

1.30

5.76

2.0

2.2

36.89

37.80

g/l

2.08

359

2709

Childhood asthma (age<16)

327

1.84

5.71

1.5

1.4

39.63

40.78

g/l

0.96

307

Hyperkinetic disorders, excluding more controls

313

1.94

5.71

1.3

1.6

39.36

40.09

g/l

0.33

291

Congenital malformations of cardiac septa

459

1.77

5.63

1.4

2.3

37.89

38.49

g/l

0.33

413

Other/unspecified synovitis and tenosynovitis

157

1051

1.51

5.63

1.7

1.9

37.75

37.85

g/l

0.07

140

923

Other aneurysm

589

1.69

5.62

2.0

2.4

36.28

37.55

g/l

1.17

516

Chronic hepatitis, not elsewhere classified

297

2.00

5.62

1.5

2.7

38.17

38.57

g/l

0.19

271

Ulcerative colitis, NAS

182

1255

1.46

5.62

2.1

2.2

38.09

38.06

g/l

0.02

163

1121

Psoriatic arthropathies, ICD10

155

1037

1.51

5.60

1.8

2.3

37.44

37.85

g/l

0.33

134

927

Disorders of purine and pyrimidine metabolism

3.57

5.60

1.5

1.3

36.42

37.05

g/l

0.17

Benign paroxysmal vertigo

460

3654

1.27

5.59

2.0

2.2

38.26

37.47

g/l

2.44

385

3140

Plantar fascial fibromatosis

134

869

1.56

5.58

2.7

1.9

39.38

37.94

g/l

2.86

121

774

Other sleep disorders

161

1086

1.50

5.57

1.5

2.2

38.03

37.52

g/l

0.50

126

967

Acidosis

198

2.24

5.54

2.0

2.4

33.14

37.47

g/l

2.95

177

Use of antiglaucoma preparations and miotics

151

1009

1.52

5.53

2.3

36.46

37.09

g/l

0.61

123

841

Atypical facial pain

472

1.77

5.50

2.0

2.4

38.08

37.79

g/l

0.18

412

Polycythaemia vera

335

1.93

5.49

2.9

1.4

38.72

37.53

g/l

0.77

278

Other diseases of oesophagus

156

1051

1.50

5.46

1.8

2.3

37.57

37.42

g/l

0.11

138

919

Cluster headache, strict

238

2.09

5.46

1.8

2.8

41.42

38.26

g/l

3.07

216

Extreme obesity with alveolar hypoventilation

386

1.85

5.44

1.5

2.5

35.79

38.08

g/l

2.83

343

Other hearing loss

511

4034

1.25

5.42

2.2

2.1

37.53

37.03

g/l

1.14

418

3445

Autoimmune hyperthyroidism

466

1.76

5.41

2.0

2.5

38.26

38.45

g/l

0.12

416

Peroneal tendinitis

101

2.75

5.40

2.0

1.8

40.25

38.38

g/l

1.16

Cholecystectomy

1113

8296

1.16

5.39

2.1

2.2

37.36

37.71

g/l

1.11

962

7132

Acute generalized exanthematous pustulosis

409

1.82

5.38

3.5

2.5

37.86

37.69

g/l

0.09

361

Right bundle-branch block

337

1.91

5.38

2.8

2.2

36.65

38.41

g/l

1.63

291

Crohn disease

161

1094

1.48

5.38

1.6

2.2

37.13

38.13

g/l

0.99

146

979

Ventral hernia

372

2894

1.30

5.37

2.6

2.1

37.55

37.65

g/l

0.11

323

2487

Other Crohn's disease

497

1.73

5.36

1.3

2.1

36.04

38.42

g/l

2.01

448

Other and unspecified iridocyclitis

402

1.82

5.36

3.1

2.3

37.32

38.11

g/l

0.57

359

Pustular psoriasis

439

1.79

5.35

2.0

2.3

37.56

37.98

g/l

0.25

393

Adenomyosis (Endometriosis of uterus)

199

1410

1.43

5.34

2.3

2.1

38.38

37.32

g/l

1.76

177

1217

Melanocytic naevi of trunk

164

1123

1.48

5.29

2.0

2.2

38.38

37.96

g/l

0.50

151

1008

Unstable angina pectoris

647

4221

1.22

5.25

2.2

2.3

36.92

37.42

g/l

1.33

561

3550

Hypothyroidism, strict autoimmune, 3 medication purchases required

1253

7372

1.15

5.25

1.8

2.2

37.91

37.79

g/l

0.28

1078

6368

Disorders of myoneural junction and muscle in diseases classified elsewhere

3.00

5.22

1.9

2.3

36.99

38.06

g/l

0.29

Somnolence, stupor and coma

391

1.82

5.21

1.2

2.7

35.72

37.72

g/l

1.60

343

Disorders of synovium and tendon in diseases classified elsewhere

158

2.34

5.19

1.7

2.2

37.33

37.42

g/l

0.03

143

Maternal care for other conditions predominantly related to pregnancy

177

1208

1.44

5.18

1.6

1.8

39.32

39.39

g/l

0.05

161

1118

Other follicular disorders

563

1.67

5.18

2.0

2.3

38.74

38.24

g/l

0.37

509

IBD patients in KELA-register

276

2071

1.34

5.17

2.3

2.0

37.69

38.32

g/l

0.89

248

1860

Pulmonary oedema

191

2.22

5.16

3.5

2.6

34.13

37.00

g/l

2.17

159

Hyperaldosteronism

265

2.01

5.16

2.3

2.6

36.24

37.46

g/l

0.76

237

Gluteal tendinitis

328

1.89

5.13

2.0

2.1

39.29

37.58

g/l

1.23

294

Nontoxic goitre/thyroid nodule

456

3658

1.26

5.13

2.1

2.2

38.18

37.50

g/l

1.67

389

3118

Carcinoma in situ of skin of ear and external auricular canal

173

2.29

5.11

1.7

2.6

36.41

36.86

g/l

0.17

143

Other disorders of penis

138

921

1.51

5.08

1.7

2.3

37.37

37.62

g/l

0.16

120

806

Thyrotoxicosis with diffuse goitre

183

1290

1.43

5.07

2.0

2.2

38.26

38.16

g/l

0.10

167

1148

Congenital malformations and deformations of the musculoskeletal system

518

1.69

5.04

1.5

1.9

38.37

38.57

g/l

0.09

473

Periapical abscess

619

5133

1.21

5.03

1.8

2.3

37.76

38.07

g/l

0.63

549

4537

Follow-up examination after treatment for malignant neoplasms

153

1045

1.48

5.03

2.2

2.1

37.20

37.14

g/l

0.04

132

907

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

342

2655

1.29

5.02

1.6

2.1

38.62

38.22

g/l

0.61

303

2379

Malignant neoplasm of bladder, including Hilmo

196

1393

1.41

5.02

2.1

1.4

36.88

37.41

g/l

0.51

161

1176

Other disorders of nervous system

109

694

1.59

5.00

2.2

38.44

37.76

g/l

0.66

619

Deficiency of other B group vitamins

207

2.14

4.99

3.6

2.1

36.69

37.90

g/l

0.83

183

Other psoriatic arthropathies

148

1007

1.49

4.97

1.8

2.3

37.39

37.89

g/l

0.42

128

900

Adrenocortical insufficiency

304

1.91

4.94

1.9

2.5

37.51

37.81

g/l

0.13

278

Presence of other functional implants

989

5913

1.16

4.89

2.3

2.2

37.21

37.56

g/l

1.03

807

5126

Cluster headache, wide

270

1.96

4.86

1.8

2.7

41.56

38.17

g/l

3.80

243

Lactose intolerance

229

2.05

4.85

1.4

1.6

38.73

37.81

g/l

0.49

207

Bursitis of shoulder

196

2.14

4.83

2.7

1.6

38.23

37.18

g/l

0.57

174

Disorders of ocular muscles, binocular movement, accommodation and refraction

587

4820

1.21

4.83

2.1

38.48

38.12

g/l

0.76

523

4221

Event of undetermined intent

491

1.69

4.80

1.9

2.3

37.94

38.17

g/l

0.12

443

Scabies

144

981

1.48

4.78

1.4

2.2

39.17

38.35

g/l

0.95

134

895

Use of donepezil

228

2923

0.74

4.78

1.8

2.1

37.10

36.65

g/l

0.48

162

2406

Diffuse brain injury

230

2.03

4.78

2.7

1.6

37.41

37.64

g/l

0.11

207

Acute laryngitis and tracheitis

104

649

1.59

4.78

1.5

1.8

39.56

38.46

g/l

1.13

588

Other and unspecified parapsoriasis

3.47

4.77

1.5

2.0

37.28

36.28

g/l

0.26

Duodenal ulcer

181

1291

1.42

4.75

1.9

2.3

35.90

37.29

g/l

2.11

162

1113

Rosacea

161

1124

1.45

4.75

1.9

2.2

37.94

38.03

g/l

0.06

147

998

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

3.57

4.73

1.4

1.3

36.25

36.70

g/l

0.10

Urethral stricture

610

1.62

4.72

2.3

2.5

37.64

37.60

g/l

0.02

527

Chondrocostal junction syndrome [Tietze]

331

1.85

4.70

1.8

2.0

37.98

37.97

g/l

0.01

292

Presence of other devices

256

3352

0.76

4.70

2.3

2.2

37.55

37.20

g/l

0.44

204

2863

Acute bronchiolitis

201

2.03

4.67

5.6

2.0

37.19

39.05

g/l

1.14

180

Ovarian cyst

444

2056

1.25

4.60

1.7

2.0

38.27

37.62

g/l

1.55

390

1785

Other specified and unspecified retinal disorders

356

1.81

4.59

2.8

2.6

36.71

37.73

g/l

0.63

315

Specific development disorders of speech and language

306

1.84

4.58

1.9

2.2

37.92

37.83

g/l

0.03

266

Other disorders of adrenal gland

363

1.79

4.57

1.8

2.5

37.49

37.85

g/l

0.17

330

Viral infections of the central nervous system

622

1.59

4.57

2.3

2.2

37.59

37.90

g/l

0.16

554

Medical abortion

831

3843

1.18

4.56

1.7

2.2

38.14

37.93

g/l

0.42

710

3288

Disorders of optic nerve, not elsewhere classified

215

2.06

4.55

2.5

3.0

37.76

37.83

g/l

0.02

190

Pediculosis, acariasis and other infestations

179

1283

1.40

4.54

1.5

2.2

38.92

38.31

g/l

0.69

165

1162

Other disorders of ear

1440

8376

1.13

4.52

2.1

2.2

38.19

37.63

g/l

3.07

1193

7339

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

2.59

4.51

5.5

1.7

36.32

39.37

g/l

1.31

Hypopituitarism

515

1.65

4.50

3.0

2.3

37.14

37.78

g/l

0.33

473

Viral and other specified intestinal infections

197

1402

1.38

4.48

1.5

1.9

37.35

38.53

g/l

1.93

177

1238

Senility

2.83

4.48

1.6

1.5

36.53

35.50

g/l

0.31

Bell's palsy

166

1179

1.42

4.48

2.3

2.1

38.00

37.79

g/l

0.16

140

1033

Benign neoplasm: Descending colon

123

827

1.51

4.47

2.1

2.3

36.29

37.65

g/l

1.43

100

737

Seborrhoeic keratosis

355

2817

1.27

4.47

2.2

37.41

37.69

g/l

0.39

304

2399

Drug-induced neutropenia

114

754

1.53

4.47

3.1

2.4

34.73

37.84

g/l

6.10

107

668

Mental and behavioural disorders due to tobacco

123

826

1.51

4.46

1.7

2.3

37.22

38.01

g/l

0.72

745

Pneumonia due to Streptococcus pneumoniae

344

1.80

4.45

5.3

1.7

36.76

38.30

g/l

1.13

295

Entropion and trichiasis of eyelid

154

1082

1.44

4.45

2.4

2.3

37.53

37.04

g/l

0.46

130

919

Tinnitus

351

2785

1.27

4.42

2.2

38.55

37.69

g/l

2.18

308

2460

Maternal care for known or suspected fetal abnormality and damage

122

701

1.50

4.39

1.7

40.18

39.64

g/l

0.55

117

655

Viral infections of the central nervous system

103

669

1.56

4.36

2.3

2.2

37.69

37.89

g/l

0.10

595

Spontaneous abortion

350

2967

0.79

4.34

1.9

2.2

39.22

38.25

g/l

2.76

310

2599

Triptan medication for migraine, min. 3 purchases

592

3775

1.20

4.33

2.1

2.0

39.35

38.61

g/l

2.53

533

3380

Disorders of speech understanding and production

255

1.91

4.32

2.0

2.4

37.44

37.54

g/l

0.04

221

Benign neoplasm: Duodenum

284

1.88

4.28

2.8

2.6

36.24

37.24

g/l

0.49

250

Smoking dependency

123

834

1.49

4.27

1.7

2.3

37.22

38.00

g/l

0.71

752

Nail disorders

110

729

1.53

4.26

1.7

2.3

37.75

38.10

g/l

0.27

653

Abnormal blood-pressure reading, without diagnosis

379

1.74

4.25

2.0

2.4

37.14

38.22

g/l

0.64

336

Benign neoplasm: Spinal meninges

109

2.49

4.25

1.3

2.0

37.74

37.37

g/l

0.08

Other deformities of toe(s)

313

1.82

4.24

1.7

1.9

37.86

37.36

g/l

0.24

265

Pure hyperglyceridaemia

200

2.05

4.24

1.3

2.3

38.71

37.18

g/l

0.71

179

Infection due to other mycobacteria

147

2.24

4.22

1.7

2.4

33.51

37.90

g/l

2.14

122

Benign neoplasm of major salivary glands

153

1085

1.43

4.21

1.9

2.2

37.89

37.53

g/l

0.25

136

951

Ulcerative enterocolitis

228

1.96

4.20

1.9

2.3

37.03

38.19

g/l

0.51

202

Cholecystitis

226

1706

1.34

4.19

2.0

2.2

36.50

37.41

g/l

1.43

189

1446

Visual field defects

133

920

1.46

4.19

2.0

36.91

37.60

g/l

0.70

114

809

Aortic valve malfunction, age under 60 years

121

821

1.49

4.19

1.8

2.2

36.38

38.14

g/l

2.19

111

748

Postprocedural disorders of nervous system

448

1.67

4.19

2.1

2.0

40.32

38.46

g/l

2.06

413

Benign neoplasm: Pancreas

308

1.83

4.19

2.6

2.8

37.45

37.38

g/l

0.03

270

Benign neoplasm: Kidney

337

1.79

4.18

2.3

2.6

38.72

37.75

g/l

0.68

295

Other salmonella infections

322

1.80

4.17

2.7

2.0

38.34

38.24

g/l

0.04

281

Bicipital tendinitis

427

1.69

4.16

2.4

2.1

38.64

37.85

g/l

0.54

386

Psychotic depression

480

1.64

4.16

1.7

2.4

37.69

38.06

g/l

0.17

427

Meralgia paraesthetica

286

1.85

4.16

1.5

2.2

38.96

37.87

g/l

0.71

252

Central retinal artery occlusion

251

1.93

4.16

3.0

2.3

37.28

37.15

g/l

0.05

218

Atopic conjunctivitis

293

1.83

4.14

1.4

1.7

38.43

38.25

g/l

0.08

262

Other disorders of iris and ciliary body

258

1.90

4.14

2.1

2.7

36.12

37.63

g/l

0.85

225

Other and unspecified vascular occlusions

162

1165

1.41

4.13

2.3

36.27

37.19

g/l

1.03

142

992

Inflammatory bowel disease, strict (require KELA)

276

2144

1.29

4.13

2.3

2.0

37.69

38.25

g/l

0.74

248

1929

Other keratitis

143

1005

1.44

4.12

2.2

2.1

37.91

37.90

g/l

0.01

125

896

Thyroiditis

647

1.55

4.11

2.2

2.3

38.98

37.95

g/l

0.94

574

Hordeolum and other deep inflammation of eyelid

490

1.63

4.10

2.5

39.11

37.98

g/l

0.82

451

Malignant melanoma of skin

167

1208

1.40

4.10

2.2

1.4

38.19

37.70

g/l

0.51

140

1024

Benign neoplasm: salivary glands, exclude unknown (D119)

137

958

1.45

4.09

2.0

2.2

37.83

37.72

g/l

0.06

121

851

Obsessive-compulsive disorder

294

1.82

4.08

2.0

2.1

38.62

38.88

g/l

0.12

275

Atrial septal defect

257

1.88

4.07

1.5

2.1

37.64

38.29

g/l

0.24

234

Alzheimer’s disease (undefined)

104

0.00

4.06

0.0

2.1

—

35.64

—

Other and unspecified mononeuropathies of upper limb

231

1.94

4.06

1.4

2.1

39.81

38.30

g/l

0.82

210

Focal brain injury

538

1.60

4.05

1.7

2.1

37.09

37.35

g/l

0.14

477

Other and unspecified rosacea

123

844

1.47

4.05

1.9

2.3

38.09

38.04

g/l

0.03

113

754

Lactose intolerance, other/unspecified

204

2.00

4.01

1.4

1.6

38.69

37.84

g/l

0.38

185

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

387

3141

1.24

4.01

2.5

2.1

37.43

37.98

g/l

0.97

343

2771

Left ventricular outflow tract obstruction (LVOTO), broad definition

126

870

1.46

4.01

1.8

2.2

36.43

38.16

g/l

2.19

116

791

Undefined dementia

105

1429

0.67

4.00

1.4

2.2

35.40

36.25

g/l

0.60

1149

Other specified/unspecified spondylopathies

247

1.90

3.99

1.3

2.0

37.38

37.25

g/l

0.05

213

Lichen ruber planus, wide definition including periferal and oral lichen planus

322

2564

1.26

3.98

2.2

38.45

37.76

g/l

1.31

281

2228

Testicular dysfunction

261

1.87

3.98

1.5

2.7

38.48

38.07

g/l

0.15

234

Carrier of infectious disease

198

2.01

3.97

1.2

2.1

37.31

38.27

g/l

0.36

181

Glucosamine medication

834

5774

1.16

3.97

2.3

2.2

37.24

37.36

g/l

0.21

721

4868

Complications of labour and delivery

555

3677

0.84

3.97

2.2

2.1

38.64

38.24

g/l

0.90

499

3206

Other benign neoplasms of skin

560

4717

1.19

3.96

3.0

2.2

37.72

37.52

g/l

0.33

465

4058

Clear cell adenocarcinoma of kidney

465

1.64

3.95

1.5

1.3

36.53

37.79

g/l

0.95

403

Other otitis externa (chronic)

615

1.55

3.91

2.1

2.4

37.51

37.89

g/l

0.22

546

Delivery

415

2677

0.81

3.91

2.1

2.0

37.76

37.70

g/l

0.08

369

2274

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

151

2.14

3.89

1.8

1.7

37.28

39.15

g/l

0.86

140

Impingement syndrome of shoulder

323

2581

1.26

3.87

2.5

2.2

38.22

37.84

g/l

0.51

262

2265

Chondropathies

190

1416

1.35

3.87

1.8

2.0

37.82

38.08

g/l

0.23

160

1272

Benign neoplasm: Parotid gland

122

845

1.46

3.86

2.0

2.3

37.75

37.63

g/l

0.06

109

751

Diseases of tongue

585

1.56

3.86

2.3

2.0

39.26

37.48

g/l

2.21

498

Hepatocellular carcinoma, including Hilmo

294

1.81

3.84

2.8

1.4

36.58

36.97

g/l

0.18

247

Other obstructive and reflux uropathy

308

1.78

3.83

1.5

2.1

35.71

38.58

g/l

1.95

277

Delivery, wide proxy

343

2265

0.80

3.83

2.0

37.38

37.42

g/l

0.04

303

1888

Pain associated with micturition

163

1189

1.38

3.82

2.5

2.2

38.45

37.58

g/l

1.10

131

1039

Single spontaneous delivery

414

2674

0.82

3.82

2.1

2.0

37.78

37.70

g/l

0.09

368

2271

Corneal scars and opacities

251

1.87

3.81

1.7

2.7

37.61

37.36

g/l

0.09

219

Other salmonella infections

369

1.70

3.81

2.6

2.2

38.07

38.23

g/l

0.07

326

Other abnormal uterine and vaginal bleeding

319

1818

1.26

3.80

2.0

37.64

37.31

g/l

0.38

229

1551

Necrosis of pulp, including avohilmo

724

6229

1.16

3.80

1.9

2.2

37.89

38.23

g/l

0.81

646

5525

Other and unspecified disorders of vitreous body

653

5516

1.17

3.79

2.0

2.3

38.10

37.65

g/l

1.16

560

4775

Other neurotic disorders

454

1.63

3.79

1.5

2.6

37.27

37.86

g/l

0.33

397

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

484

1.60

3.79

1.7

2.3

37.91

38.20

g/l

0.13

438

Other epidermal thickening

408

1.67

3.78

2.1

2.6

36.92

37.84

g/l

0.63

362

Wet age-related macular degeneration

322

2506

1.26

3.76

2.5

2.1

36.84

36.88

g/l

0.03

258

2059

Benign neoplasm: Small intestine

464

1.63

3.75

2.5

36.65

37.25

g/l

0.35

406

Disorders of refraction and accommodation

298

2360

1.26

3.73

2.1

2.0

38.67

38.22

g/l

0.63

267

2090

Disorders of tooth development and eruption

172

1023

1.37

3.72

1.9

2.0

38.44

38.27

g/l

0.13

150

901

Acute alcohol intoxication, ICD10

255

1992

1.29

3.71

1.3

2.2

37.70

38.06

g/l

0.35

222

1793

Unspecified lump in breast

212

1617

1.32

3.71

1.8

2.2

38.68

37.87

g/l

1.23

186

1394

Type 1 diabetes, definitions combined

533

1.56

3.69

2.2

2.0

37.63

39.11

g/l

1.42

497

Diabetic maculopathy

186

1313

1.35

3.67

1.3

1.9

35.41

37.16

g/l

3.61

163

1126

Other and unspecified nonorganic psychotic disorders

200

1514

1.33

3.67

1.5

2.1

37.99

38.51

g/l

0.60

172

1373

Unspecified urinary incontinence

138

988

1.41

3.66

1.4

2.1

37.02

37.39

g/l

0.26

847

Epiphora

219

1.92

3.65

2.7

2.2

38.00

37.65

g/l

0.13

193

Premature rupture of membranes

924

0.66

3.65

1.7

39.98

39.28

g/l

0.64

854

Type1 diabetes, definitions combined, early onset

238

1.85

3.65

1.5

1.4

37.19

40.02

g/l

2.17

225

Graves ophthalmopathy, strict

198

1.96

3.63

1.2

1.8

38.38

38.80

g/l

0.19

180

Coeliac disease

156

1140

1.38

3.63

2.6

2.1

38.16

37.96

g/l

0.17

136

1004

Sequelae of injuries of neck and trunk

248

1.85

3.62

3.4

2.8

37.43

38.13

g/l

0.28

225

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

185

1389

1.34

3.61

2.6

2.1

38.00

38.10

g/l

0.08

167

1249

Iridocyclitis in diseases classified elsewhere

164

2.06

3.60

1.9

2.3

38.28

37.66

g/l

0.28

150

Benign neoplasm: Skin of ear and external auricular canal

422

1.64

3.60

2.3

2.4

37.91

37.36

g/l

0.32

375

All dysplastic lesions of the cervix uteri, vagina or vulva

264

2047

1.28

3.59

1.7

1.9

38.78

38.75

g/l

0.03

237

1837

Other and unspecified trigeminal disorders

111

2.31

3.59

1.4

2.0

38.64

38.08

g/l

0.17

Disorders of lacrimal system and orbit in diseases classified elsewhere

213

1.92

3.59

1.2

1.8

38.39

38.60

g/l

0.09

194

Cardiac murmurs and other cardiac sounds

102

684

1.48

3.57

1.7

2.1

38.55

37.90

g/l

0.55

596

Dissection of aorta

331

1.72

3.57

1.7

2.7

35.19

37.39

g/l

1.83

291

Other disorders of pigmentation

431

1.63

3.55

2.3

2.2

38.14

37.71

g/l

0.25

383

Astigmatism

461

1.60

3.54

2.3

39.43

38.01

g/l

1.31

406

Generalized skin eruption due to drugs and medicaments

362

1.68

3.54

3.6

2.6

37.36

37.75

g/l

0.21

321

Seborrhoeic dermatitis

131

936

1.41

3.51

2.0

2.3

38.61

37.69

g/l

1.11

108

831

Cluster headache, strict, including avohilmo

347

1.69

3.51

1.7

2.3

41.48

38.52

g/l

3.58

317

Type 1 diabetes, strict (exclude DM2)

532

1.55

3.50

2.2

2.0

37.55

39.13

g/l

1.56

496

Ulcerative colitis (strict definition, require KELA)

190

1439

1.33

3.50

2.6

2.1

38.05

38.08

g/l

0.03

171

1297

Septal defects

430

1.61

3.50

1.4

2.3

38.12

38.41

g/l

0.13

388

Unspecified/other endometriosis

590

1.52

3.50

2.0

1.7

39.29

38.24

g/l

1.03

521

Allergic contact dermatitis

155

1140

1.37

3.48

1.4

2.2

37.65

38.17

g/l

0.45

135

1007

Open wound of abdomen, lower back and pelvis

215

1.89

3.48

1.6

2.1

36.85

38.00

g/l

0.47

197

Other disorders of cornea

139

1006

1.40

3.47

1.7

2.0

38.29

37.74

g/l

0.49

121

889

Ulcerative colitis (strict definition, all Crohn cases excluded)

166

1235

1.35

3.46

2.8

2.2

38.38

38.04

g/l

0.32

148

1116

Polycystic ovarian syndrome, consortium definition

884

4594

1.14

3.46

1.8

2.1

38.04

38.10

g/l

0.10

712

4001

Single delivery by forceps and vacuum extractor

549

0.60

3.45

1.3

1.6

39.22

39.41

g/l

0.09

507

Benign neoplasm: Pituitary gland, craniopharyngeal duct

458

1.59

3.44

3.1

2.4

38.23

38.09

g/l

0.07

409

Colitis, primary sclerosing, strict definition

2.64

3.43

2.3

2.2

37.57

39.55

g/l

0.76

Other renal tubulo-interstitial diseases

167

2.01

3.42

1.9

34.61

39.09

g/l

2.09

152

Achilles tendinitis

132

949

1.40

3.42

2.8

2.0

38.05

37.65

g/l

0.28

114

857

Other sexually transmitted chlamydial diseases

230

1.84

3.42

1.4

1.3

40.30

39.57

g/l

0.35

216

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

255

1989

1.27

3.42

2.0

1.9

38.78

38.53

g/l

0.25

227

1788

Ulcer of oesophagus

110

767

1.45

3.41

1.9

2.5

37.33

37.45

g/l

0.07

675

Occupational exposure to risk-factors

330

0.36

3.40

1.3

2.7

40.88

37.51

g/l

—

296

Postprocedural disorders of digestive system, not elsewhere classified

314

1.72

3.36

1.8

2.7

36.34

37.61

g/l

0.63

278

Orchitis and epididymitis

129

927

1.40

3.36

1.6

2.2

37.69

37.52

g/l

0.11

111

806

Contusion of other and unspecified parts of foot

306

1.72

3.35

2.2

2.3

38.03

38.91

g/l

0.45

279

Malignant neoplasm of mesothelium and soft tissue

399

1.63

3.35

3.1

1.3

36.59

37.73

g/l

0.69

342

Endometriosis

419

2036

1.21

3.35

1.8

2.0

38.47

37.59

g/l

2.30

359

1762

Cluster headache, wide,, including avohilmo

375

1.64

3.34

1.7

2.3

41.60

38.41

g/l

4.35

340

Other and unspecified follicular disorders

322

1.70

3.34

2.3

2.5

39.13

38.08

g/l

0.71

296

Other and unspecified tonsillitis

308

2090

1.24

3.34

1.5

1.9

38.52

38.73

g/l

0.22

286

1915

Injury of other and unspecified intrathoracic organs

639

1.49

3.33

1.5

2.2

36.66

37.67

g/l

0.90

566

Coxarthrosis, primary, with hip surgery

794

6523

1.14

3.32

2.1

2.3

37.74

37.32

g/l

1.24

673

5556

Drug-induced hypoglycaemia without coma

142

2.09

3.32

1.1

2.5

35.19

37.99

g/l

1.07

126

Other arterial embolism and thrombosis

293

1.74

3.31

1.4

2.6

34.96

37.20

g/l

1.40

254

Unspecified dementia

104

1331

0.70

3.31

1.4

2.3

35.49

36.42

g/l

0.68

1109

Glaucoma suspect

421

5015

0.84

3.30

1.9

2.3

37.87

37.36

g/l

1.03

351

4277

Alzheimer’s disease (Early onset)

506

0.49

3.30

1.3

2.1

38.51

36.61

g/l

0.93

423

Graves ophthalmopathy

220

1.85

3.28

1.2

1.8

38.39

38.86

g/l

0.23

201

Special screening examination for other diseases and disorders

124

888

1.40

3.28

3.0

2.2

38.69

37.75

g/l

1.04

115

787

Benign neoplasm of urinary organs

496

1.56

3.28

2.2

2.5

38.43

37.33

g/l

0.97

438

Post-traumatic wound infection, not elsewhere classified

220

1.85

3.27

1.7

2.8

35.78

38.50

g/l

1.82

197

Postzoster neuralgia

150

2.05

3.26

3.3

2.1

38.04

37.26

g/l

0.44

127

Melanoma in situ of other and unspecified parts of face

158

2.04

3.24

2.3

2.8

35.89

37.04

g/l

0.44

136

Other and unspecified bullous disorders

104

2.29

3.22

3.2

2.0

38.09

37.98

g/l

0.03

Primary coxarthrosis, bilateral

477

4047

1.19

3.22

2.1

2.2

38.17

37.19

g/l

3.16

403

3421

Disorders of breast

607

4756

1.16

3.21

2.0

2.1

38.68

38.00

g/l

2.00

511

4098

Complications of genitourinary prosthetic devices, implants and grafts

229

1.82

3.20

2.0

1.9

37.55

37.56

g/l

0.01

198

Lichen planus, including avohilmo

271

2177

1.25

3.20

2.2

38.51

37.74

g/l

1.31

236

1888

Other and specified injuries of hip and thigh

215

1.85

3.19

1.4

2.2

36.75

37.25

g/l

0.15

190

Scleritis and episcleritis

515

1.53

3.18

1.8

2.0

38.45

38.19

g/l

0.18

473

540

4029

1.17

3.18

2.3

2.1

36.97

36.84

g/l

0.21

421

3369

Contact with sharp object, undetermined intent

151

2.02

3.18

1.8

1.9

37.12

38.29

g/l

0.37

138

Alzheimer’s disease (undefined), excluding more controls

0.00

3.17

0.0

1.6

—

35.15

—

Recurrent dislocation and subluxation of joint

404

1.60

3.16

1.8

2.2

37.68

38.22

g/l

0.21

371

Subacute thyroiditis

320

1.68

3.15

2.9

2.1

38.61

37.89

g/l

0.36

286

Ulcerative proctitis

492

1.54

3.15

1.3

2.2

38.16

38.08

g/l

0.04

439

Vulvovaginal ulceration/inflammation in other diseases

374

1.62

3.13

1.8

2.0

39.31

38.55

g/l

0.77

345

Contusion of toe(s) without damage to nail

152

2.00

3.12

1.2

2.6

39.95

39.24

g/l

0.27

144

Burns and corrosions

160

1206

1.34

3.10

1.9

2.1

36.66

37.99

g/l

1.85

141

1089

Psoriasis (vulgaris), strict definition

276

1.73

3.10

1.5

2.8

37.05

38.45

g/l

0.66

251

Otitis externa, unspecified

133

975

1.37

3.10

1.7

2.2

39.21

37.97

g/l

1.86

114

869

Ganglion

234

1855

1.27

3.09

2.1

2.0

39.01

38.03

g/l

1.80

202

1627

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

205

1600

1.29

3.08

2.5

2.1

38.05

38.10

g/l

0.04

186

1437

Injury of muscle and tendon at lower leg level

201

1566

1.29

3.07

2.8

2.2

38.41

37.93

g/l

0.53

179

1406

Postpartum care and examination

448

0.58

3.07

1.1

1.6

38.42

39.80

g/l

0.73

417

Melanoma in situ of trunk

168

1.96

3.07

2.0

3.0

37.47

37.52

g/l

0.02

147

Degenerative macular diseases

198

1543

1.29

3.05

2.2

37.58

37.20

g/l

0.39

167

1306

Parkinson's disease, including avohilmo

263

2122

1.25

3.02

1.9

2.1

38.28

37.19

g/l

2.57

214

1800

Nontoxic multinodular goitre

292

2382

1.23

3.02

1.7

2.2

37.72

37.48

g/l

0.28

239

2034

Menorrhagia

433

2018

1.19

3.02

1.8

2.0

38.23

37.48

g/l

1.77

343

1740

Tonsillectomy and adenotomy

402

3329

0.84

3.01

1.7

1.9

39.48

38.77

g/l

1.53

357

3033

Prepatellar bursitis

379

1.60

3.00

2.4

2.0

38.08

37.72

g/l

0.19

334

Malignant neoplasm of bladder

107

762

1.42

2.98

1.7

1.4

36.59

37.23

g/l

0.40

634

Crohn's disease of small intestine

531

1.50

2.98

1.6

2.2

36.19

38.18

g/l

1.52

478

Malignant neoplasm, without specification of site, including Hilmo

491

1.53

2.98

2.7

1.4

35.38

37.20

g/l

1.33

405

Use of disulfiram, acamprosate or naltrexone

103

729

1.42

2.97

1.4

2.2

38.37

38.12

g/l

0.15

666

Other sexually transmitted chlamydial diseases

363

1.60

2.97

1.3

1.5

40.36

40.02

g/l

0.17

340

Hyperfunction of pituitary gland

325

1.65

2.97

3.1

2.0

38.10

38.11

g/l

0.01

301

Procedures for purposes other than remedying health state

198

1.85

2.97

2.3

1.4

38.72

39.12

g/l

0.15

184

Dislocation, sprain and strain of joints and ligaments at neck level

157

1189

1.33

2.96

2.3

2.2

39.16

38.30

g/l

0.99

140

1076

Monocytic leukaemia

3.39

2.95

3.8

1.4

35.72

36.54

g/l

0.15

Unspecified misadventure during surgical and medical care

558

1.49

2.94

1.7

2.4

36.58

37.76

g/l

0.97

495

Congenital malformations of heart and great arteries

139

1003

1.35

2.94

1.7

2.2

38.02

38.04

g/l

0.01

116

907

Atrophic disorders of skin

192

1498

1.29

2.93

1.7

2.1

38.20

37.91

g/l

0.29

173

1291

Sequelae of injuries of head

437

1.55

2.92

3.0

2.5

37.89

38.28

g/l

0.21

391

Mental and behavioural disorders due to cannabinoids

108

2.15

2.91

1.8

1.5

39.07

39.91

g/l

0.25

101

Secondary parkinsonism, excluding more controls

192

1.85

2.91

2.6

1.6

36.87

37.06

g/l

0.06

167

Other and unspecified mononeuropathies of lower limb

244

1.75

2.90

1.5

2.1

38.88

37.56

g/l

0.75

210

Contact with heat and hot substances

422

1.56

2.89

1.5

2.4

36.02

38.09

g/l

2.07

379

Autonomic disorders

200

1.83

2.89

2.3

2.2

37.18

37.99

g/l

0.25

177

Dementia in other diseases classified elsewhere

528

1.50

2.89

1.7

2.4

37.77

37.18

g/l

0.36

456

Appendectomy

826

7019

1.13

2.88

2.2

2.1

38.27

38.15

g/l

0.23

728

6191

Other noninflammatory disorders of vulva and perineum

109

784

1.40

2.88

1.4

1.9

37.07

37.72

g/l

0.45

686

Enteropathic arthropathies

143

1.99

2.87

1.4

2.3

40.58

37.98

g/l

2.06

129

Other disorders of electrolyte and fluid balance, not elsewhere classified

2.41

2.87

1.6

1.5

39.16

36.88

g/l

0.78

Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia

5.74

2.86

9.3

1.0

40.66

37.26

g/l

—

Other and unspecified primary disorders of muscles

2.63

2.84

1.3

2.7

40.77

38.98

g/l

0.65

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

117

757

1.38

2.83

1.3

1.6

39.61

39.67

g/l

0.03

107

702

Vascular dementia (subcortical)

394

1.58

2.82

2.3

2.1

35.76

36.37

g/l

0.35

328

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

164

1261

1.31

2.79

1.7

2.0

39.26

38.40

g/l

1.27

149

1114

Open wound of shoulder and upper arm

159

1.92

2.79

1.5

2.0

35.19

37.88

g/l

1.23

142

Bitten or struck by other mammals

123

908

1.36

2.78

2.2

2.3

38.70

38.34

g/l

0.30

114

818

Any dementia, excluding more controls

628

3780

1.15

2.76

1.9

2.3

36.47

37.00

g/l

1.26

480

3202

Assault by bodily force

459

1.51

2.75

1.6

2.2

37.10

38.75

g/l

1.09

427

Focal epilepsy, strict definition

264

2154

1.23

2.74

1.9

2.1

37.08

37.65

g/l

0.71

216

1881

Secondary polycythaemia

204

1.80

2.73

3.0

2.8

37.68

37.58

g/l

0.03

180

Graves disease, strict definition

115

844

1.37

2.71

2.2

2.1

38.43

38.25

g/l

0.15

103

756

Ingrowing nail

413

1.54

2.71

2.0

2.4

38.45

38.49

g/l

0.02

372

malignant neoplasm of male genital organs

425

2199

1.18

2.71

2.1

1.5

36.90

37.53

g/l

1.24

367

1912

Other specified/unspecified disorders of bone/cartilage

227

1.75

2.70

1.7

1.9

37.77

37.81

g/l

0.01

207

Corneal ulcer

225

1809

1.25

2.69

2.2

2.1

37.74

38.02

g/l

0.27

197

1602

Viral warts

112

820

1.38

2.69

2.0

2.3

37.56

38.25

g/l

0.57

100

732

Benign neoplasm: Skin of eyelid, including canthus

232

1874

1.25

2.68

3.1

2.1

37.77

37.55

g/l

0.23

196

1626

Crohn's disease of large intestine

390

1.55

2.68

1.4

2.3

38.12

38.28

g/l

0.06

351

Nasal polyp

267

2189

1.23

2.67

2.6

2.3

37.49

37.68

g/l

0.21

240

1919

Ventricular septal defect, a heart condition

112

2.08

2.67

1.3

1.6

37.54

39.13

g/l

0.44

104

Schizophrenia or delusion, excluding more controls

324

2678

1.20

2.66

1.9

2.2

37.58

38.19

g/l

1.01

269

2379

Excessive attrition of teeth

686

6067

1.13

2.66

2.1

2.2

39.05

38.13

g/l

4.17

593

5383

Other disorders of central nervous system

2.20

2.65

1.3

1.8

40.29

37.85

g/l

1.53

Burns and corrosions of external body surface, specified by site

124

925

1.35

2.64

2.0

2.2

36.32

37.96

g/l

2.11

107

838

Other congenital malformations of upper alimentary tract

0.00

2.64

0.0

2.7

—

37.64

—

Salpingitis and oophoritis

215

1725

1.25

2.64

1.5

2.3

37.64

38.10

g/l

0.50

189

1515

Myocardial infarction, with ST-elevation

279

2303

1.22

2.63

1.9

2.1

35.91

37.23

g/l

3.21

241

1957

Parkinson's disease

248

2025

1.23

2.61

2.0

2.1

38.32

37.25

g/l

2.51

204

1726

Benign neoplasm of meninges

156

1207

1.30

2.60

1.9

2.2

37.36

37.59

g/l

0.18

129

1038

Malignant neoplasm of breast, ER-positive, including Hilmo

420

2766

1.18

2.59

1.9

1.4

38.16

38.04

g/l

0.16

346

2342

Viral encephalitis, not elsewhere classified/unspecified

178

1.83

2.59

3.9

2.6

36.83

37.92

g/l

0.29

157

Acute alcohol intoxication

340

2861

1.19

2.59

1.4

2.3

37.37

37.92

g/l

0.73

293

2537

Pneumonitis due to solids and liquids

124

931

1.34

2.56

1.3

2.0

36.46

37.19

g/l

0.69

798

Triptan medication for migraine, single purchase ok

911

5544

1.11

2.56

2.1

39.09

38.28

g/l

4.14

823

4904

Migraine, single triptan purchase ok & required. ICD-code if available is included

911

5544

1.11

2.56

2.1

39.09

38.28

g/l

4.14

823

4904

Burns and corrosions of multiple and unspecified body regions

164

1.86

2.56

2.0

2.7

35.75

38.55

g/l

1.61

150

Maternal care for other known or suspected fetal problems

796

0.71

2.55

1.6

1.7

39.56

39.64

g/l

0.04

741

Malignant neoplasm of breast, HER2-negative, including Hilmo

532

2995

1.15

2.54

2.0

1.4

38.08

38.16

g/l

0.12

450

2555

Colitis, primary sclerosing

2.20

2.54

2.2

2.0

38.13

38.80

g/l

0.19

Malignant neoplasm of breast, including Hilmo

532

2995

1.15

2.53

2.0

1.4

38.08

38.16

g/l

0.12

450

2555

Postpartum haemorrhage

123

1371

0.75

2.53

1.7

1.9

39.97

39.17

g/l

0.88

108

1253

Lichen planus

186

1477

1.27

2.53

2.4

2.2

38.42

37.57

g/l

1.17

160

1288

Malignant neoplasm of bronchus and lung, including Hilmo

329

2313

1.20

2.52

2.1

1.4

36.33

37.48

g/l

2.88

290

1960

Acute suppurative otitis media

212

1591

1.25

2.51

2.7

1.9

38.71

38.77

g/l

0.05

192

1445

Maze procedure for atrial fibrillation

2.69

2.51

1.3

1.7

35.36

37.72

g/l

0.89

Arterial embolism and thrombosis of lower extremity artery

389

1.54

2.51

1.4

2.6

34.23

37.15

g/l

2.92

341

Other retinal artery occlusion

248

1.69

2.51

1.5

2.7

37.41

36.86

g/l

0.25

219

!Aliquae complicationes praecoces traumatis

389

1.53

2.51

2.3

2.5

35.23

38.08

g/l

2.43

350

Early complications of trauma

389

1.53

2.51

2.3

2.5

35.23

38.08

g/l

2.43

350

Other and unspecified mononeuropathies, also in other diseases

271

1.65

2.50

2.0

2.4

38.38

37.53

g/l

0.39

234

Melanocytic naevi of upper limb, including shoulder

195

1.77

2.50

1.7

2.7

37.96

37.77

g/l

0.07

178

Use of levodopa decarboxylase inhibitor

226

1838

1.24

2.49

2.1

2.2

38.49

37.29

g/l

2.80

184

1555

Disorder of external ear, unspecified

303

1.61

2.47

1.7

2.7

38.12

37.85

g/l

0.13

273

Other, unspecified and serous retinal detachments

319

1.59

2.47

2.1

2.7

37.24

37.49

g/l

0.10

280

Other and unspecified disorders of adult personality and behaviour

3.22

2.47

1.4

1.1

38.42

40.53

g/l

—

Abdominal aortic aneurysm (AAA)

159

1232

1.29

2.46

1.7

2.2

35.90

37.15

g/l

1.65

132

1029

Parkinson's disease, strict definition

232

1895

1.23

2.46

1.9

2.2

38.46

37.22

g/l

2.97

192

1610

Blindness, monocular

2.23

2.45

5.3

2.0

36.18

37.46

g/l

—

Right side

0.00

2.44

0.0

1.9

—

37.28

—

Corneal degeneration

160

1.86

2.44

1.2

1.8

36.99

37.82

g/l

0.21

140

Endocrine disorders, other/unspecified

161

0.31

2.43

1.8

2.0

36.90

37.93

g/l

—

148

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

117

2.00

2.42

3.1

2.1

37.01

38.47

g/l

0.49

108

Malignant neoplasm of prostate, including Hilmo

430

2195

1.17

2.42

2.1

1.5

37.09

37.49

g/l

0.66

375

1907

Retinal breaks without detachment

230

1880

1.23

2.42

2.4

2.2

37.99

37.90

g/l

0.08

195

1650

Malignant neoplasm of breast

523

2975

1.15

2.42

1.9

1.4

38.06

38.15

g/l

0.13

440

2535

Injury of muscle and tendon at hip and thigh level

121

914

1.33

2.41

1.8

2.2

38.79

37.90

g/l

1.00

110

831

Oesophageal obstruction

369

1.54

2.41

3.1

2.7

36.60

37.28

g/l

0.33

326

Lung diseases due to external agents

211

1711

1.24

2.40

2.4

2.1

36.36

37.24

g/l

1.42

166

1465

Moderate visual impairment, binocular

306

1.59

2.39

1.7

2.1

36.84

36.64

g/l

0.07

263

Strabismus

308

2584

1.19

2.39

2.1

2.0

38.49

37.95

g/l

0.89

271

2272

Excessive, frequent and irregular menstruation

443

2089

1.17

2.38

1.8

2.0

38.01

37.63

g/l

0.66

365

1808

Diseases of appendix

988

8087

1.10

2.38

2.5

2.1

38.19

37.97

g/l

0.55

868

7117

Type 1 diabetes, strict definition

328

1.56

2.38

1.4

37.46

40.11

g/l

2.28

310

Cholangitis (primary sclerosing, PSC)

609

1.41

2.38

1.8

2.3

36.83

37.60

g/l

0.53

533

Benign neoplasm: Liver/bile ducts

206

1.72

2.36

2.6

1.8

38.10

38.67

g/l

0.23

189

Corns and callosities

661

1.39

2.35

1.7

2.3

37.42

37.98

g/l

0.42

587

Spontaneous rupture of synovium and tendon

108

806

1.35

2.35

2.0

1.9

37.37

37.56

g/l

0.12

707

Malignant neoplasm of thymus, including Hilmo

2.88

2.33

3.9

1.1

34.97

37.88

g/l

0.66

Benign neoplasm: Liver

177

1.78

2.33

2.7

1.9

38.22

38.80

g/l

0.20

161

Crohn disease (strict definition, require KELA)

453

1.47

2.32

1.8

2.1

36.71

38.33

g/l

0.95

411

Crohn disease (strict definition, require KELA, min 2 HDR)

445

1.47

2.32

1.8

2.1

36.55

38.26

g/l

1.01

404

Malignant neoplasm of breast, HER2-negative

517

2958

1.15

2.31

1.9

1.4

37.98

38.14

g/l

0.25

433

2518

Rare circulating lymphoid malignancy

2.65

2.31

5.0

1.3

33.55

35.98

g/l

0.64

Other maternal disorders predominantly related to pregnancy

468

3369

0.87

2.30

2.0

2.1

38.34

38.61

g/l

0.43

415

2996

Malignant neoplasm of breast, HER-positive

409

2748

1.16

2.30

1.9

1.4

38.15

38.02

g/l

0.17

335

2326

Non-small cell lung cancer, including Hilmo

229

1772

1.22

2.30

2.1

1.4

36.50

37.43

g/l

1.49

202

1489

Retrobulbar neuritis in diseases classified elsewhere

4.04

2.28

5.4

1.1

38.83

37.89

g/l

—

Disturbance of activity and attention

397

1.49

2.27

1.3

1.5

39.69

39.85

g/l

0.06

372

Open wound of wrist and hand

548

4725

1.14

2.26

2.3

2.1

37.81

38.07

g/l

0.47

485

4202

Hepatocellular carcinoma

217

1.69

2.26

2.2

1.4

36.22

36.84

g/l

0.22

179

Benign neoplasm of breast

159

1261

1.27

2.22

2.0

39.06

37.81

g/l

1.91

133

1080

Varicose veins

929

6372

1.10

2.22

2.1

2.2

37.09

37.80

g/l

2.95

785

5463

Lichen simplex chronicus

296

1.57

2.21

2.4

2.8

36.89

37.85

g/l

0.63

263

Malignant neoplasm of pancreas

747

0.66

2.21

2.1

1.4

36.78

37.35

g/l

0.26

626

All dysplastic lesions of the cervix uteri

209

1694

1.23

2.20

1.8

1.9

39.06

38.97

g/l

0.08

190

1534

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

704

1.36

2.20

2.1

1.4

35.42

37.30

g/l

2.31

590

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

101

755

1.35

2.18

2.3

37.42

37.45

g/l

0.02

654

Irregular menses

477

3297

1.14

2.17

1.9

2.0

38.40

38.59

g/l

0.28

420

2940

HSIL lesion of the cervix uteri, vagina or vulva

166

1326

1.26

2.17

1.7

1.8

38.27

38.85

g/l

0.59

146

1195

Vascular dementia

152

1160

1.27

2.17

2.0

2.1

35.90

36.32

g/l

0.38

113

968

Alcohol withdrawal state with delirium

690

1.36

2.14

1.2

2.3

35.71

37.81

g/l

1.95

623

Maternal care related to the fetus and amniotic cavity and possible delivery problems

305

2110

0.85

2.14

2.5

1.9

39.63

38.83

g/l

1.86

281

1894

Focal epilepsy

274

2308

1.19

2.13

1.9

2.1

36.93

37.66

g/l

1.01

224

2022

Malignant neoplasm, without specification of site

316

1.54

2.11

2.4

1.4

35.42

36.53

g/l

0.49

257

Complications of other internal prosthetic devices, implants and grafts

414

1.47

2.10

2.4

2.2

38.00

37.30

g/l

0.55

363

Malignant neoplasm of prostate

415

2154

1.16

2.10

2.1

1.5

36.87

37.45

g/l

1.09

356

1869

Glaucoma-related operations

693

1.36

2.10

2.8

2.5

36.06

37.12

g/l

0.88

598

Aneurysms, operations, SAH

228

1893

1.21

2.10

1.9

2.0

37.52

37.80

g/l

0.27

190

1641

Retinal haemorrhage

277

1.58

2.09

4.9

2.7

37.79

37.31

g/l

0.19

242

Combinations of oral blood glucose lowering drugs

416

3630

1.15

2.09

1.6

2.4

37.18

37.73

g/l

1.07

372

3167

Redundant prepuce, phimosis and paraphimosis

237

1955

1.20

2.09

2.0

2.4

37.16

38.12

g/l

1.36

214

1736

Cerebral aneurysm, nonruptured

116

893

1.31

2.08

1.5

2.2

38.08

37.95

g/l

0.08

101

788

Hyperkinetic disorders

429

1.44

2.08

1.3

1.5

39.36

39.87

g/l

0.22

402

Medial epicondylitis

269

1.58

2.07

1.3

1.8

39.28

37.89

g/l

0.78

245

Acute appendicitis

901

7677

1.10

2.07

2.5

2.1

38.17

38.03

g/l

0.27

797

6762

Other specified disorders of external ear

383

1.48

2.06

1.5

2.6

36.97

37.53

g/l

0.30

344

Familial hypercholesterolemia, with ischemic heart disease

152

1213

1.26

2.06

2.0

2.2

36.40

37.31

g/l

1.01

124

1012

Hydrocele

165

1328

1.25

2.06

2.4

2.5

37.33

37.42

g/l

0.06

147

1152

HSIL lesion of the cervix uteri

143

1131

1.27

2.05

1.8

1.9

38.70

39.07

g/l

0.33

128

1028

Other disorders of the genitourinary system

187

1527

1.23

2.05

2.1

2.2

37.30

37.47

g/l

0.14

165

1306

Sudden idiopathic hearing loss

147

1169

1.27

2.05

2.2

2.1

38.12

37.52

g/l

0.61

115

1037

Supplementary factors related to causes of morbidity and mortality classified elsewhere

393

3420

1.15

2.05

1.7

2.1

37.62

37.91

g/l

0.38

308

2987

Hypertrophic disorders of skin

416

1.45

2.04

2.3

37.92

37.98

g/l

0.03

380

Malignant neoplasm of small intestine, including Hilmo

295

1.55

2.03

2.2

1.3

36.87

37.68

g/l

0.38

253

Laparoscopic right hemicolectomy

698

1.35

2.02

2.0

2.4

36.81

37.37

g/l

0.37

613

Atlantoaxial subluxation

2.35

2.01

1.3

1.8

36.68

38.92

g/l

0.81

Other or unspecified paralytic strabismus

2.35

2.01

1.0

2.6

40.50

39.52

g/l

0.44

Gonococcal infection

272

1.56

1.99

2.2

1.7

38.52

38.65

g/l

0.04

248

Alport

4.90

1.99

1.4

3.5

37.48

39.45

g/l

—

Schizophrenia

113

1453

0.77

1.98

2.7

2.1

37.17

38.21

g/l

1.04

1314

Other and unspecified acute skin changes due to ultraviolet radiation

257

1.58

1.98

2.0

2.5

36.54

37.33

g/l

0.30

222

Other acquired deformities of musculoskeletal system and connective tissue

420

1.44

1.97

2.3

35.25

38.11

g/l

2.71

374

Polyp of the female genital tract

393

1961

1.15

1.96

1.9

2.0

38.10

37.44

g/l

1.47

341

1687

Malignant neoplasm of respiratory system and intrathoracic organs

311

2220

1.17

1.95

2.1

1.4

36.39

37.52

g/l

2.50

269

1879

Tracheo-bronchomalasia

3.84

1.95

1.8

2.8

37.38

41.71

g/l

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

496

1.40

1.94

1.7

2.2

36.78

38.28

g/l

0.90

445

Injuries involving multiple body regions

298

1.53

1.94

2.5

2.4

36.51

37.89

g/l

0.74

267

Appendicitis, broad definition

967

8027

1.09

1.93

2.5

2.1

38.19

37.98

g/l

0.49

851

7064

Other predominantly sexually transmitted diseases, not elsewhere classified

142

1132

1.26

1.93

1.7

1.9

38.54

38.70

g/l

0.10

124

1032

Use of anticholinesterases

489

4342

0.88

1.93

1.9

2.2

37.23

36.76

g/l

1.00

367

3612

N06DA Anticholinesterases

489

4342

0.88

1.93

1.9

2.2

37.23

36.76

g/l

1.00

367

3612

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

506

1.39

1.91

1.5

2.2

38.64

38.17

g/l

0.25

457

Congenital obstruction of the pelviureteric junction

2.21

1.91

4.4

2.4

37.70

38.37

g/l

0.19

Disorders of parathyroid gland, other and/or unspecified

2.15

1.90

1.3

1.8

35.69

36.85

g/l

0.27

276

1.55

1.90

1.9

2.6

34.17

37.40

g/l

2.89

234

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

499

1.40

1.90

1.8

1.4

35.05

37.17

g/l

1.90

420

Lesion of radial nerve

316

1.50

1.90

1.8

2.3

36.93

37.68

g/l

0.34

276

UC patients in KELA-register (code 208), prior to 1994

424

1.43

1.89

2.0

2.6

37.62

37.86

g/l

0.12

380

Other strabismus

227

1898

1.20

1.89

2.1

39.06

38.04

g/l

1.91

202

1691

Trigeminal neuralgia

559

1.37

1.88

2.4

2.3

37.93

37.71

g/l

0.13

493

Leiomyoma of uterus

801

4126

1.10

1.88

2.1

37.77

38.01

g/l

0.52

670

3549

Focal epilepsy, mode (most common among epilepsy diagnosis)

237

1998

1.19

1.87

2.0

2.1

37.66

37.67

g/l

0.01

192

1742

Benign neoplasm of eye and adnexa

142

1139

1.26

1.87

1.4

2.2

37.72

37.74

g/l

0.01

121

1003

Other acute skin changes due to ultraviolet radiation

343

1.48

1.84

1.8

2.3

36.98

37.79

g/l

0.38

301

Paralytic strabismus

752

1.31

1.84

2.1

2.3

37.14

37.63

g/l

0.37

667

Other predominantly sexually transmitted diseases, not elsewhere classified

160

1301

1.23

1.84

1.6

1.9

38.48

38.94

g/l

0.40

140

1189

Abnormal findings in secretions and smears from cervix uteri vagina vulva

493

3311

1.13

1.83

2.0

38.46

38.54

g/l

0.11

439

2906

Primary open-angle glaucoma, strict

338

3867

0.87

1.82

2.1

2.2

37.34

37.13

g/l

0.28

270

3225

Acute appendicitis, no complications

663

5974

1.11

1.82

2.4

2.1

38.49

38.18

g/l

0.69

587

5318

Hereditary sideroblastic anaemia

2.86

1.82

2.8

1.6

38.15

37.42

g/l

—

Degeneration of the brain due to alcohol

223

1.60

1.82

1.3

2.8

38.86

37.42

g/l

0.72

197

Benign neoplasm: Prostate

2.10

1.79

1.2

3.8

36.71

37.19

g/l

—

Degeneration of nervous system due to alcohol

224

1.59

1.79

1.3

2.8

38.86

37.47

g/l

0.69

197

Campylobacter enteritis

224

1.58

1.78

2.3

2.4

38.10

37.48

g/l

0.33

198

Other secondary coxarthrosis

330

1.47

1.76

1.6

2.3

38.72

37.57

g/l

0.65

294

Ulcerative rectosigmoiditis

687

1.32

1.76

1.8

2.2

38.86

38.05

g/l

0.66

623

Cytomegaloviral hepatitis

3.06

1.76

1.7

2.2

35.53

38.70

g/l

—

Gonococcal infection

265

1.53

1.75

2.2

1.7

38.36

38.69

g/l

0.11

243

Contact with machinery

1122

0.76

1.74

2.0

2.1

37.93

37.76

g/l

0.09

1005

Brachial plexus disorders

671

1.32

1.73

2.0

2.2

40.19

38.35

g/l

3.39

613

Vascular dementia (sudden onset)

0.00

1.73

0.0

2.6

—

35.47

—

Other blood glucose lowering drugs, excl. Insulins

247

2109

1.18

1.73

1.6

2.2

35.85

37.51

g/l

3.40

214

1787

Contraceptive management

318

2565

0.87

1.73

2.2

2.0

38.91

38.70

g/l

0.29

287

2335

Benign neoplasm of middle ear and respiratory system

108

848

1.28

1.72

2.5

2.2

38.04

37.66

g/l

0.28

749

Alzheimer’s disease (Atypical or mixed)

109

1365

0.79

1.71

1.3

2.2

35.45

36.35

g/l

0.73

1120

Other and unspecified nerve root and plexus disorders, also in other diseases

240

2047

1.18

1.70

2.5

2.1

38.86

37.97

g/l

1.98

195

1816

Single delivery by caesarean section

724

0.77

1.69

2.1

1.5

39.11

39.13

g/l

0.01

673

Pedal cyclist injured in noncollision transport accidents

127

1019

1.25

1.69

1.7

2.1

38.73

37.93

g/l

0.67

105

920

Alkalosis

3.30

1.69

2.0

2.6

39.65

38.20

g/l

—

Thyroiditis, unspecified

134

1.75

1.68

1.3

1.7

39.58

38.08

g/l

0.46

123

Tongue abnormality

658

1.32

1.68

2.3

2.4

39.13

37.68

g/l

1.58

576

Malignant neoplasm of small intestine

212

1.58

1.67

2.6

1.3

36.37

37.81

g/l

0.65

181

Viral haemorrhagic fevers, not elsewhere classified/unspecified

772

0.72

1.66

2.5

2.2

37.87

37.96

g/l

0.04

694

Alzheimer’s disease (Early onset), excluding more controls

381

0.61

1.66

1.3

2.0

38.51

36.85

g/l

0.76

318

Unspecified jaundice

513

1.36

1.64

1.6

2.3

35.00

37.53

g/l

2.26

449

Inguinal hernia, bilateral

153

1258

1.22

1.64

3.0

2.2

37.32

37.56

g/l

0.19

132

1091

Other facial nerve disorders

229

1.55

1.64

2.3

2.2

39.29

38.08

g/l

0.60

198

Vascular dementia (other)

1.97

1.63

1.5

2.8

36.78

35.88

g/l

0.33

Chronic iridocyclitis

445

1.38

1.63

2.3

38.79

37.75

g/l

0.86

396

Dislocation of lens

143

1.71

1.63

3.2

2.5

37.62

36.93

g/l

0.25

130

Type of accident

362

3194

1.14

1.62

1.7

2.1

37.57

37.85

g/l

0.34

279

2797

Hereditary lymphedema

3.17

1.61

1.0

1.2

38.23

37.37

g/l

—

Asthma mixed form (mode), excluding more controls

361

1.42

1.61

2.3

1.5

39.50

38.42

g/l

0.64

307

Polypectomy (DHB20)

680

1.30

1.61

2.4

2.3

37.49

37.67

g/l

0.11

609

Pilonidal cyst

558

1.33

1.60

2.0

2.1

37.01

38.63

g/l

1.33

516

Use of peginterferon beta-1a

3.08

1.60

1.0

1.1

41.38

40.10

g/l

—

Mouth breathing

511

4601

1.11

1.58

2.4

2.2

37.68

38.03

g/l

0.69

454

4091

Foreign body entering into or through eye or natural orifice

699

1.30

1.58

2.9

2.2

37.75

37.88

g/l

0.07

632

Neovascular glaucoma

414

1.39

1.58

2.6

2.4

36.56

37.34

g/l

0.42

358

Respiratory tuberculosis, confirmed

184

1.60

1.56

1.3

2.6

36.81

36.77

g/l

0.01

156

Contact with and exposure to communicable diseases

177

2097

0.84

1.56

1.8

1.9

39.16

38.94

g/l

0.21

165

1917

Erythema intertrigo

216

1.55

1.56

1.8

3.2

36.43

37.85

g/l

0.59

190

Inguinal or femoral hernia, bilateral

155

1284

1.21

1.56

3.0

2.2

37.35

37.52

g/l

0.13

134

1112

Other changes in lacrimal passages

3.57

1.56

3.0

1.9

38.90

38.01

g/l

—

Primary open-angle glaucoma

430

4640

0.89

1.55

2.1

2.2

37.53

37.05

g/l

0.96

346

3879

Deep endometriosis

876

0.75

1.55

1.3

2.1

39.45

37.90

g/l

1.60

767

Congenital varicose veins

2.66

1.53

2.6

2.1

40.17

39.07

g/l

—

Benign neoplasm: Cerebral meninges

134

1097

1.23

1.53

2.0

2.3

37.04

37.45

g/l

0.35

113

948

Macular cyst

333

1.43

1.52

2.3

2.7

37.41

37.25

g/l

0.06

296

Benign neoplasm of brain and other parts of central nervous system

643

1.30

1.51

2.1

2.4

38.94

37.87

g/l

0.82

571

Pregnancy, childbirth and the puerperium

326

1937

0.88

1.51

1.6

2.1

37.27

37.25

g/l

0.01

283

1590

Other diseases of gallbladder

478

1.35

1.51

2.6

2.4

37.80

37.44

g/l

0.19

413

Glaucoma secondary to other eye disorders

418

1.38

1.51

2.6

36.56

37.27

g/l

0.38

363

Allergic contact dermatitis due to drugs in contact with skin

202

1.56

1.50

1.5

2.0

36.15

38.16

g/l

0.73

183

Other disorders of breast

144

1189

1.22

1.50

2.3

2.1

39.23

38.13

g/l

1.46

117

1038

Burn and corrosion of wrist and hand

259

1.48

1.49

1.2

2.2

36.96

38.53

g/l

0.87

233

Myopia

111

892

1.25

1.49

2.1

2.2

38.90

38.36

g/l

0.42

104

806

Injury of nerves and spinal cord at neck level

211

1.54

1.48

3.2

3.0

37.98

37.71

g/l

0.06

186

Brain meningioma

489

1.34

1.47

2.4

1.4

36.03

37.74

g/l

1.23

409

Colorectal neuroendocrine tumor and carcinoma

102

1.79

1.46

3.7

1.3

40.82

38.49

g/l

1.39

Flat foot [pes planus] (acquired)

103

823

1.26

1.46

1.5

2.5

37.99

37.95

g/l

0.02

716

Meningitis

420

1.37

1.46

2.0

2.4

37.07

38.12

g/l

0.56

379

Other drug-induced secondary parkinsonism

1.83

1.46

1.3

2.2

38.21

37.83

g/l

—

Spinal enthesopathy

260

1.47

1.45

2.9

1.8

36.30

36.43

g/l

0.04

205

Status epilepticus

319

1.42

1.45

1.4

2.6

36.03

37.02

g/l

0.46

283

Benign neoplasm of other and unspecified female genital organs

437

0.66

1.45

1.9

2.1

38.16

37.96

g/l

0.04

386

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

286

1.45

1.44

1.6

2.2

39.65

38.11

g/l

1.16

263

Other puerperal infections

344

1.40

1.44

1.3

1.6

40.09

39.23

g/l

0.52

326

Presbycusis

240

2061

1.16

1.44

2.4

2.1

37.02

36.51

g/l

0.70

189

1723

Recurrent dislocation of patella

204

1.53

1.43

1.2

1.7

38.74

38.88

g/l

0.05

190

Excessive earwax

809

7310

1.08

1.42

2.2

37.81

37.51

g/l

0.76

659

6317

Right hemicolectomy

676

1.28

1.42

3.0

2.3

35.78

37.29

g/l

1.42

592

Non-small cell lung cancer, squamous, helper endpoint

553

0.70

1.42

1.8

2.4

36.21

36.84

g/l

0.27

468

Malignant neoplasm of colon, including Hilmo

260

2267

1.15

1.42

2.4

1.4

36.28

37.43

g/l

1.98

214

1904

Erectile dysfunction

120

981

1.23

1.41

2.2

2.3

37.34

37.32

g/l

0.02

106

846

Other condition

162

1362

1.19

1.41

2.0

2.1

37.94

37.93

g/l

0.01

144

1212

Use of memantine

386

3569

0.89

1.41

1.7

2.2

36.75

36.72

g/l

0.03

265

2965

Use of other anti-dementia drugs

386

3569

0.89

1.41

1.7

2.2

36.75

36.72

g/l

0.03

265

2965

Noninflammatory disorders of female genital tract

464

2095

1.11

1.40

2.0

38.29

37.63

g/l

1.51

400

1814

Peritonsillar abscess

208

1787

1.17

1.40

2.5

2.1

38.43

38.27

g/l

0.15

189

1599

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

457

0.67

1.39

1.7

2.1

39.90

38.28

g/l

1.41

412

Impotence

547

1.31

1.37

1.9

2.2

36.61

37.56

g/l

0.57

475

Carcinoma in situ of skin of lip

2.25

1.37

1.1

1.5

33.98

37.32

g/l

—

Dementia due to Parkinsons disease, excluding more controls

207

1.52

1.37

1.3

2.1

36.44

36.61

g/l

0.04

179

Transient global amnesia

1146

0.80

1.36

2.9

2.2

39.49

37.42

g/l

3.17

1004

Type 1 diabetes, strict definition, subgroup 1

297

1.42

1.35

1.4

37.21

40.25

g/l

2.19

280

Postpartum hemorraghe, all women as controls

123

1466

0.82

1.35

1.7

1.8

39.97

39.27

g/l

0.73

108

1353

Other and unspecified degenerative diseases of nervous system

291

1.43

1.34

1.7

2.6

37.29

36.89

g/l

0.16

253

conjunctival haemorrhage

106

861

1.24

1.34

2.1

37.94

37.66

g/l

0.17

753

Other and unspecified injuries of wrist and hand

283

1.42

1.32

1.2

1.8

38.70

38.33

g/l

0.17

255

Other and unspecified disorders of orbit

2.15

1.32

1.3

2.9

38.79

38.06

g/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

965

0.78

1.32

2.9

2.3

37.08

37.82

g/l

0.48

864

Other intracranial haemorrhages

326

1.39

1.31

1.8

2.3

37.34

37.16

g/l

0.07

275

Tobacco use

446

1.33

1.31

1.5

2.5

35.86

38.25

g/l

2.36

406

Respiratory tuberculosis, bacteriologically and histologically confirmed

193

1.52

1.31

1.3

2.6

36.81

36.82

g/l

0.00

164

Congenital iodine-deficiency syndrome/hypothyroidism

301

1.41

1.31

2.7

2.1

37.08

37.34

g/l

0.11

260

Disturbances of smell and taste

412

1.35

1.31

3.0

2.9

37.55

38.13

g/l

0.25

366

Other diseases of spinal cord

259

1.44

1.30

2.7

36.43

37.90

g/l

0.66

234

Chromophobe cell carcinoma of kidney

2.15

1.30

1.9

1.1

38.28

37.41

g/l

—

Acute nasopharyngitis (common cold)

118

965

1.22

1.30

1.8

1.9

39.10

38.29

g/l

0.75

107

874

Convergent concomitant strabismus

378

1.36

1.29

2.0

39.29

38.30

g/l

0.55

339

Arthropathy in ulcerative colitis

1.74

1.28

1.5

1.8

39.80

38.88

g/l

0.34

Other diseases of peritoneum

448

1.33

1.28

1.7

2.4

37.62

37.65

g/l

0.01

394

Other symptoms and signs involving the digestive system and abdomen

201

1737

1.16

1.28

1.7

2.2

37.51

37.71

g/l

0.18

156

1497

LSIL lesion of the cervix uteri, vagina or vulva

119

983

1.21

1.28

2.0

1.9

38.90

38.85

g/l

0.03

109

890

FESS (DNB20)

1192

0.81

1.27

1.8

2.2

38.68

37.90

g/l

0.55

1072

Suppurative and unspecified otitis media

330

2610

1.12

1.27

2.5

1.9

38.86

38.42

g/l

0.67

300

2332

Other sideroblastic anaemias

2.29

1.26

1.1

1.5

34.45

36.45

g/l

—

Other lesions of median nerve

278

1.42

1.26

1.2

2.2

38.28

37.21

g/l

0.44

235

Congenital malformations of genital organs

551

1.29

1.25

1.5

1.9

38.98

38.83

g/l

0.08

511

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

349

1.36

1.24

2.7

1.9

38.90

38.86

g/l

0.02

320

Pregnancy with abortive outcome

802

3887

1.08

1.24

1.7

2.2

38.30

37.90

g/l

1.03

695

3317

Malignant neoplasm of liver and intrahepatic bile ducts

296

1.40

1.24

1.7

1.3

35.41

37.10

g/l

0.90

247

Benign neoplasm of male genital organs

205

1.48

1.21

1.3

2.8

38.16

37.07

g/l

0.36

179

Acute drug-induced interstitial lung disorder

1.79

1.21

9.7

2.1

37.03

37.73

g/l

0.19

Contact with other hot fluids

213

1.47

1.21

1.1

2.2

36.50

38.64

g/l

1.14

195

Other disorders of bone density and structure

181

1.50

1.19

1.6

2.2

38.80

38.39

g/l

0.11

166

Other peripheral vertigo

123

1029

1.20

1.19

1.9

2.4

39.06

37.78

g/l

1.55

101

905

Other disorders of Eustachian tube

256

1.42

1.19

1.5

2.1

37.41

38.07

g/l

0.21

232

Antepartum haemorrhage, not elsewhere classified

445

1.31

1.18

2.3

1.7

40.14

39.50

g/l

0.39

417

Macular hole

704

1.25

1.18

2.1

2.4

36.68

37.54

g/l

0.68

616

Endometriosis of rectovaginal septum and vagina

759

0.77

1.17

1.3

1.9

39.31

37.08

g/l

2.52

662

Other congenital malformations of respiratory system

2.62

1.17

1.0

35.38

39.18

g/l

—

Postpartum hemorraghe, parous women as controls

123

1248

0.84

1.17

1.7

1.9

39.97

39.35

g/l

0.62

108

1147

Presbyopia

552

1.28

1.17

1.5

2.2

38.27

38.15

g/l

0.05

501

Nontoxic single thyroid nodule

741

1.24

1.16

2.6

2.2

39.07

37.67

g/l

1.41

654

Status post-ami

412

2853

1.10

1.16

1.7

2.3

36.23

37.27

g/l

2.90

347

2383

Other and unspecified disease of Bartholin gland

283

1.39

1.16

1.3

2.3

37.34

38.01

g/l

0.22

256

Dementia, including avohilmo

785

5035

1.07

1.15

2.0

2.3

37.04

36.99

g/l

0.08

590

4286

Use of rasagiline

292

1.39

1.15

1.4

2.9

38.75

37.46

g/l

0.80

257

Pleural plaque without asbestos

466

1.30

1.15

1.7

2.3

37.09

36.79

g/l

0.17

400

Benign neoplasm: Conjunctiva

310

1.37

1.13

1.3

2.8

36.81

37.94

g/l

0.63

281

Abrasion of teeth

404

3680

1.10

1.12

2.5

2.2

38.88

37.99

g/l

2.32

350

3234

Other fall from one level to another

249

2209

1.13

1.11

2.0

2.2

38.04

37.93

g/l

0.10

217

1957

Dislocation, sprain and strain of joints and ligaments of knee

684

5866

1.08

1.11

1.8

2.2

38.50

38.34

g/l

0.29

595

5225

Sixth [abducent] nerve palsy

337

1.35

1.11

2.8

2.6

35.87

37.43

g/l

0.90

291

Benign neoplasm: Parathyroid gland

112

1.64

1.11

1.2

1.9

37.51

37.38

g/l

0.03

102

Vascular dementia (mixed)

210

1.45

1.10

2.0

36.15

36.56

g/l

0.15

177

Haemangioma, any site

819

1.21

1.09

2.8

2.2

38.17

37.86

g/l

0.20

729

Oral lichen planus, including avohilmo , including avohilmo

684

1.24

1.09

2.0

2.4

38.76

37.89

g/l

0.90

602

Malignant neoplasm of bronchus and lung

262

1938

1.13

1.09

2.0

1.4

36.35

37.45

g/l

2.08

226

1628

Other diseases of biliary tract

119

1003

1.19

1.08

2.3

36.83

37.44

g/l

0.51

104

864

Non-small cell lung cancer, adenocarcinoma

712

1.23

1.08

1.8

1.4

36.71

37.64

g/l

0.70

600

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

326

2909

1.11

1.08

2.6

1.4

35.79

37.61

g/l

5.47

281

2491

Dronedarone medication

296

1.37

1.07

1.7

2.4

35.73

38.04

g/l

1.45

256

Brain meningioma, including Hilmo

515

1.27

1.07

2.4

1.4

36.03

37.78

g/l

1.28

428

Outcome of delivery

110

566

1.20

1.07

1.6

1.8

39.46

39.32

g/l

0.09

103

530

Benign neoplasm: Lip

220

1.43

1.06

1.8

2.3

36.98

38.08

g/l

0.36

190

Lesion of sciatic nerve

499

0.74

1.06

1.4

2.3

38.80

37.16

g/l

0.87

422

Disorders of eyelid in diseases classified elsewhere

288

1.37

1.06

1.2

2.4

38.38

37.59

g/l

0.38

255

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

805

1.21

1.05

2.1

2.4

36.60

37.61

g/l

0.83

710

Other disorders of conjunctiva

190

1666

1.14

1.05

2.4

2.1

38.06

37.43

g/l

0.76

164

1440

Benign neoplasm: Orbit, unspecified

1.88

1.04

1.5

2.1

37.66

39.51

g/l

0.50

Malignant neoplasm of digestive organs

531

3875

1.08

1.04

2.2

1.4

36.52

37.50

g/l

2.92

449

3275

Schizoaffective disorder

571

1.25

1.03

1.7

2.2

37.68

38.27

g/l

0.35

521

Abnormalities of forces of labour

643

1.23

1.03

1.4

1.9

40.14

39.13

g/l

1.12

605

Frontotemporal dementia

1.81

1.03

2.4

2.1

42.07

37.28

g/l

—

Asthma mixed form (mode)

394

1.30

1.02

2.3

1.5

39.50

38.33

g/l

0.74

335

Other mental disorders due to brain damage and dysfunction and to physical disease

168

1466

1.15

1.01

2.4

2.3

38.43

37.40

g/l

1.61

126

1275

Crohn disease (strict definition, all UC cases excluded)

369

1.31

1.00

1.4

2.3

35.58

38.28

g/l

1.76

335

All dysplastic lesions of the vagina

214

1.41

1.00

1.2

1.7

38.02

38.18

g/l

0.05

197

Cysts of oral region, not elsewhere classified

529

1.25

1.00

2.7

2.4

36.96

37.93

g/l

0.70

474

Pyoderma

156

1.49

0.99

1.3

2.5

37.15

38.12

g/l

0.23

141

All dysplastic lesions of the vulva

370

1.31

0.99

1.3

2.2

35.76

38.23

g/l

1.41

338

Other noninflammatory disorders of uterus, except cervix

293

1779

1.11

0.99

2.5

2.1

37.67

37.19

g/l

0.69

246

1517

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

1.90

0.98

1.6

2.6

39.53

38.01

g/l

—

Benign neoplasm: Scrotum

1.99

0.98

1.3

40.60

38.32

g/l

—

Frontotemporal dementia, wide, incl. Pick's disease

1.73

0.97

2.3

2.0

41.96

37.18

g/l

—

Postprocedural musculoskeletal disorders, not elsewhere classified

804

1.20

0.97

2.3

37.41

37.55

g/l

0.07

711

Malignant neoplasm of other and unspecified major salivary glands

0.00

0.96

0.0

1.1

—

37.12

—

Infections of genitourinary tract in pregnancy

748

0.80

0.96

2.0

38.51

38.39

g/l

0.05

670

L02BA Anti-estrogens

198

1754

1.13

0.96

2.0

2.2

38.16

37.89

g/l

0.29

169

1513

Benign neoplasm: Endocrine pancreas

1.76

0.94

1.9

2.6

40.39

38.11

g/l

1.09

Hereditary corneal dystrophies

365

1.30

0.94

1.4

2.5

38.78

37.51

g/l

0.89

322

Ménière disease

123

1056

1.17

0.94

1.6

2.4

38.06

37.64

g/l

0.32

106

924

Haemangioma and lymphangioma, any site

103

871

1.19

0.94

2.8

2.2

38.09

37.82

g/l

0.17

774

Other noninflammatory disorders of vagina

706

1.21

0.94

2.4

1.9

38.56

37.62

g/l

0.89

613

Lateral epicondylitis

132

1140

1.16

0.93

1.7

1.9

38.76

38.02

g/l

0.80

114

1021

Recurrent and persistent haematuria

1.69

0.93

1.5

2.3

36.85

38.27

g/l

0.32

Lack of expected normal physiological development

2.19

0.92

1.0

1.1

37.87

42.05

g/l

—

Malignant neoplasm of ovary, including Hilmo

632

0.79

0.92

2.9

1.4

36.29

37.79

g/l

1.07

527

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

1113

0.84

0.92

2.7

1.4

37.20

37.73

g/l

0.34

943

Changes in corneal membranes

2.13

0.91

1.5

2.5

37.95

38.01

g/l

—

Polyhydramnios

219

0.64

0.90

1.4

1.8

41.51

39.27

g/l

4.07

205

Hydatidiform mole

101

0.49

0.90

1.0

2.0

43.18

38.17

g/l

—

Orthopaedic devices associated with adverse incidents

211

1.39

0.90

1.2

2.3

37.97

37.59

g/l

0.06

183

Suppurative otitis media, unspecified

194

0.61

0.90

1.8

2.3

37.42

38.22

g/l

0.26

171

Ethmoidectomy

106

1240

0.85

0.89

2.4

2.2

38.67

37.89

g/l

0.59

1114

Granuloma annulare

119

1.53

0.89

2.4

1.8

37.82

38.52

g/l

0.18

109

Gastrointestinal stromal tumor and sarcoma

103

1.58

0.89

1.3

36.57

37.57

g/l

0.19

Mild mental retardation

156

0.57

0.88

1.8

2.0

36.70

38.75

g/l

—

147

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

597

5045

0.94

0.88

2.1

38.13

38.17

g/l

0.06

528

4417

Pedal cyclist injured in transport accident

243

2192

1.11

0.88

2.0

2.1

38.68

37.95

g/l

0.99

207

1952

Radial styloid tenosynovitis [de Quervain]

422

1.26

0.87

2.3

1.9

37.18

38.15

g/l

0.52

386

Pedestrian injured in transport accident

630

1.21

0.87

1.4

2.2

37.95

37.75

g/l

0.11

560

Unspecified mental disorder

450

4175

1.08

0.87

2.0

2.1

37.93

38.24

g/l

0.52

387

3685

Small plaque parapsoriasis

1.99

0.86

1.7

2.4

38.08

36.52

g/l

—

Contact with other hot metals

112

1.53

0.85

1.1

2.6

35.87

38.41

g/l

1.22

Other and unspecified injuries of thorax

145

1.46

0.85

2.6

2.3

34.50

38.48

g/l

1.43

128

Oral lichen planus

265

1.33

0.85

1.3

2.2

37.79

37.98

g/l

0.08

239

Malnutrition

196

1.39

0.85

2.0

2.1

32.46

37.63

g/l

1.69

168

Malignant neoplasm of nasal cavity and sinuses

1.79

0.85

7.6

1.2

40.65

38.22

g/l

—

Nonsuppurative otitis media

192

1483

1.12

0.83

1.9

37.98

38.26

g/l

0.26

172

1324

Accidental poisoning by and exposure to alcohol

114

0.52

0.83

1.3

3.0

36.47

38.68

g/l

—

104

Exposure to other specified electric current

140

0.57

0.83

2.4

2.0

42.25

39.06

g/l

—

130

Retained placenta and membranes, without haemorrhage

1005

0.84

0.83

2.2

2.0

37.90

38.60

g/l

0.53

902

Adenocarcinoma and papilloma adenocarcinoma of rectum

1068

0.85

0.82

2.8

1.4

37.33

37.69

g/l

0.20

904

Acute lymphadenitis

417

1.25

0.82

2.8

2.4

37.33

38.09

g/l

0.34

374

Whooping cough

1.90

0.82

1.0

3.4

39.18

40.07

g/l

—

Obstructed labour due to malposition and malpresentation of fetus

124

1327

0.87

0.82

1.6

1.9

39.47

39.20

g/l

0.26

118

1220

Other and unspecified abdominal hernia

427

1.25

0.81

1.3

1.8

37.94

37.27

g/l

0.37

377

Endometriosis diagnosis and infertility diagnosis occurring together

681

1.19

0.81

1.3

2.0

39.09

39.03

g/l

0.03

628

Conductive hearing loss, unspecified

829

1.17

0.81

1.9

2.1

37.56

37.88

g/l

0.21

740

Typhoid and paratyphoid fevers

1.73

0.81

1.3

1.4

38.06

39.01

g/l

—

Perforation of oesophagus

1.77

0.81

1.1

2.6

37.25

37.92

g/l

—

Malignant neoplasm of rectum

1076

0.85

0.80

2.3

1.4

37.82

37.75

g/l

0.04

911

Any dementia

662

4336

1.06

0.79

1.9

2.2

36.30

36.94

g/l

1.75

504

3649

Varicose veins of other sites

592

1.20

0.79

2.2

2.3

38.43

38.46

g/l

0.01

530

Labour and delivery complicated by fetal stress [distress]

110

833

0.86

0.79

1.7

1.6

39.36

39.71

g/l

0.28

104

773

Examination and encounter for administrative purposes

393

1.25

0.78

3.1

2.7

37.12

37.15

g/l

0.01

350

Other specified disorders of kidney and ureter

313

1.29

0.78

2.9

2.7

37.75

37.79

g/l

0.01

279

Embolic stroke

511

1.22

0.77

1.8

2.4

34.84

37.21

g/l

2.31

437

Fistulae involving female genital tract

157

1.42

0.77

2.3

2.0

36.86

37.46

g/l

0.16

138

Burn and corrosion confined to eye and adnexa

157

1.41

0.77

1.7

2.3

36.50

39.14

g/l

1.02

147

Long labour

145

1402

0.88

0.77

2.3

1.9

38.90

39.03

g/l

0.09

135

1281

Obstructed labour due to maternal pelvic abnormality

122

1391

0.87

0.76

2.3

2.1

38.82

38.32

g/l

0.45

106

1232

Systemic sclerosis,strict definition

1.59

0.76

1.3

1.8

37.21

38.43

g/l

0.39

Malignant neoplasm of thyroid gland, including Hilmo

687

1.18

0.76

2.8

1.4

38.64

37.93

g/l

0.54

586

Foreign body in alimentary tract

504

1.22

0.75

1.5

2.3

37.65

37.71

g/l

0.03

451

Malignant neoplasm of peripheral nerves and autonomic nervous system, including Hilmo

1.89

0.75

1.1

36.67

37.79

g/l

—

Malignant neoplasm of other endocrine glands and related structures, including Hilmo

1.88

0.74

3.3

1.1

41.87

38.21

g/l

—

Malignant neoplasm of hypopharynx, including Hilmo

1.66

0.74

1.4

1.2

36.78

36.53

g/l

—

Car occupant injured in other and unspecified transport accidents

182

1636

1.11

0.74

1.9

2.1

38.44

38.09

g/l

0.33

157

1463

Bacterial meningitis

298

1.28

0.74

2.3

2.7

36.32

38.30

g/l

0.94

268

Tuberculosis, IBD comorbidity

819

1.16

0.74

2.0

2.2

37.12

37.20

g/l

0.04

701

970

0.85

0.74

1.3

2.2

33.65

37.30

g/l

3.95

850

Dentofacial anomalies [including malocclusion]

778

5936

1.05

0.73

2.1

39.11

38.28

g/l

3.95

673

5264

Specific developmental disorder of motor function

2.04

0.73

1.0

2.2

40.54

41.07

g/l

—

Infective dermatitis

129

1137

1.14

0.73

1.6

2.3

37.64

37.67

g/l

0.02

111

1002

Malignant neoplasm of accessory sinuses, including Hilmo

1.83

0.73

5.0

1.2

35.49

38.25

g/l

—

Amblyopia ex anopsia

281

1.29

0.73

1.2

2.1

39.62

38.05

g/l

0.78

254

Malignant neoplasm of colon

194

1753

1.11

0.73

2.7

1.4

36.84

37.39

g/l

0.58

161

1461

Other problems related to primary support group, including family circumstances

644

1.18

0.72

2.0

38.03

38.73

g/l

0.37

589

Dystonia

507

1.21

0.72

1.2

2.3

40.12

37.84

g/l

2.33

454

Gender identity disorders

1.76

0.71

1.0

1.9

41.54

40.17

g/l

—

Nontoxic diffuse goitre

318

1.27

0.71

3.7

2.1

38.47

37.84

g/l

0.33

280

Maltreatment syndromes

282

1.28

0.71

2.1

1.8

38.82

39.10

g/l

0.09

265

Aggressive periodontitis

186

1.36

0.70

1.3

2.8

36.11

38.04

g/l

0.68

168

Burns and corrosions confined to eye and internal organs

186

1.35

0.70

1.6

2.2

37.05

39.09

g/l

0.81

172

Nonspecific lymphadenitis

463

1.21

0.70

1.9

2.1

39.12

38.57

g/l

0.35

424

Acute appendicitis, with complications

238

2178

1.10

0.70

2.6

2.1

37.27

37.85

g/l

0.72

210

1929

Tuberculosis, wide

861

1.15

0.70

2.0

2.3

37.18

37.09

g/l

0.05

739

Other female pelvic inflammatory diseases

173

1559

1.11

0.69

1.5

2.2

37.79

38.05

g/l

0.21

127

1353

Palindromic rheumatism

1.58

0.69

1.5

1.4

36.31

38.53

g/l

0.87

Pleural plaque

141

1257

1.13

0.69

2.0

2.1

37.27

37.09

g/l

0.17

117

1064

Benign neoplasm of bone and articular cartilage

722

1.17

0.69

1.6

2.4

38.94

38.04

g/l

0.68

648

Motor disorders

1.85

0.68

1.0

2.1

40.54

41.17

g/l

—

Benign mammary dysplasia

176

1591

1.11

0.67

2.7

2.1

38.27

37.60

g/l

0.74

146

1362

Diseases of middle ear and mastoid

623

4829

1.06

0.67

2.3

2.1

38.48

38.11

g/l

0.80

554

4242

Cholesteatoma of middle ear

572

0.82

0.67

1.8

2.3

38.00

37.36

g/l

0.33

502

Impacted teeth

836

0.86

0.66

1.2

1.8

39.65

39.45

g/l

0.11

771

Sequelae of other and unspecified infectious and parasitic diseases

421

1.22

0.66

2.7

2.0

37.62

38.27

g/l

0.24

380

Chalazion

123

1091

1.13

0.66

3.1

2.2

38.64

37.69

g/l

1.13

105

970

Malignant neoplasm of oral cavity, including Hilmo

440

1.21

0.65

2.6

1.3

37.69

37.89

g/l

0.12

378

Use of selegiline

514

1.19

0.65

2.3

2.4

38.81

37.17

g/l

1.50

450

Acute poliomyelitis

128

0.62

0.65

1.4

2.2

33.90

37.85

g/l

—

113

Calcaneal spur

1.49

0.64

1.1

1.5

38.59

38.14

g/l

—

Secondary parkinsonism

278

1.27

0.64

2.6

2.5

36.87

37.40

g/l

0.18

244

Pre-eclampsia or eclampsia

188

1710

1.10

0.64

1.8

2.0

38.18

38.75

g/l

0.62

169

1527

Family history of malignant neoplasm

946

0.86

0.64

3.0

1.9

38.94

38.61

g/l

0.26

846

Acute and transient psychotic disorders

113

1000

1.13

0.63

2.2

37.42

38.08

g/l

0.51

904

Dysplasia of cervi uteri

220

1458

1.09

0.63

1.9

39.06

38.19

g/l

1.39

196

1280

Separation of retinal layers (serosa)

378

1.22

0.63

2.0

2.6

37.47

38.06

g/l

0.29

341

Secondary parkinsonism+Parkinsonism in other disease

288

1.26

0.63

2.6

36.95

37.46

g/l

0.19

253

Communicating hydrocephalus

217

1.30

0.62

1.5

2.9

38.16

37.79

g/l

0.11

192

Other abnormal products of conception

221

1340

1.09

0.62

1.7

1.9

40.07

39.01

g/l

2.22

205

1228

Medical treatment for female infertility

1118

0.88

0.62

1.6

1.7

39.49

39.52

g/l

0.02

1035

Non-allergic asthma

823

1.14

0.62

2.1

2.3

37.77

37.72

g/l

0.03

724

Other helminthiases

0.00

0.62

0.0

2.6

—

39.26

—

Other obstructed labour

576

0.83

0.61

1.4

2.1

38.43

38.71

g/l

0.15

531

LSIL lesion of the cervix uteri

694

1.16

0.60

2.4

2.0

39.52

38.98

g/l

0.34

643

Carcinoma in situ of middle ear and respiratory system

1.56

0.60

2.1

3.4

41.73

37.42

g/l

—

Contact with other and unspecified heat and hot substances

1.56

0.60

4.3

1.8

34.46

39.11

g/l

—

Injury of muscle and tendon at shoulder and upper arm level

479

4532

1.06

0.60

2.3

2.2

37.98

37.72

g/l

0.43

421

3984

Benign neoplasm of thyroid gland

322

0.77

0.60

1.1

2.1

41.02

38.15

g/l

1.49

290

Oligomenorrhoea

236

1.28

0.60

1.6

2.0

38.88

37.72

g/l

0.54

210

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

159

1443

1.10

0.59

2.6

2.2

38.10

37.90

g/l

0.16

134

1289

Haemorrhage in early pregnancy

207

2191

0.92

0.59

2.2

2.0

38.99

38.72

g/l

0.27

186

1956

Enterobiasis

0.00

0.59

0.0

1.0

—

39.12

—

Disorders of globe

264

1.26

0.58

1.8

2.6

38.31

37.58

g/l

0.32

227

Neuroendocrine tumor and carcinoma of rectum

1.75

0.58

3.8

1.1

40.18

38.58

g/l

—

Malignant neoplasm of hypopharynx

1.74

0.58

1.0

1.1

35.83

36.85

g/l

—

Universal erythroderma, KELA reimbursement

123

1.39

0.58

1.4

2.4

40.40

37.59

g/l

—

109

Non-small cell lung cancer, squamous

475

0.82

0.58

1.8

1.4

36.21

37.09

g/l

0.40

397

Ovarian dysfunction, other/unspecified

1.73

0.58

2.7

2.4

38.67

39.11

g/l

—

Use of galantamine

1030

0.88

0.57

1.4

2.2

37.65

36.53

g/l

1.30

852

Toxic effects of substances chiefly nonmedicinal as to source

988

0.88

0.56

1.8

2.2

37.82

37.89

g/l

0.03

888

Heterophoria

624

1.16

0.56

2.8

2.3

39.80

38.01

g/l

2.26

562

Foreign body on external eye

123

1367

0.90

0.56

2.2

2.1

38.68

38.09

g/l

0.54

109

1241

Respiratory tuberculosis, not confirmed

461

0.82

0.55

2.3

2.5

38.49

37.05

g/l

0.96

393

Lichen sclerosus et atrophicus

121

1088

1.12

0.55

1.5

2.1

38.61

37.77

g/l

0.90

106

920

Melanocytic naevi of lip

1.50

0.54

1.2

2.2

38.44

38.19

g/l

0.05

Von Willebrand disease

1.44

0.53

2.3

2.1

40.44

38.86

g/l

0.66

Additional codes for the location of defect, injury or illness

535

1.16

0.53

1.5

2.4

36.41

37.61

g/l

0.92

478

Melanocytic naevi, other sites/unspecified

727

0.86

0.53

2.0

2.3

36.82

38.06

g/l

0.84

662

Non-small cell lung cancer

132

1187

1.11

0.52

1.8

1.4

36.38

37.42

g/l

1.11

114

982

Myocardial infarction, unclassifiable

300

2853

0.94

0.52

1.7

2.1

35.62

36.86

g/l

2.86

253

2368

Vascular syndromes of brain in cerebrovascular disorders

522

0.84

0.52

2.2

2.5

38.46

37.23

g/l

0.85

457

Use of dimethyl fumarate

1.51

0.52

1.0

2.5

41.52

40.91

g/l

—

Embedded teeth, including avohilmo

480

1.17

0.51

1.8

39.03

38.86

g/l

0.08

442

Embedded and impacted teeth

136

1232

0.91

0.50

1.4

1.9

39.63

39.03

g/l

0.57

123

1134

Malignant neoplasm of stomach, including Hilmo

623

1.14

0.49

1.2

1.4

35.39

37.25

g/l

1.56

521

Benign neoplasm: Larynx

326

1.20

0.49

3.0

2.5

38.85

37.62

g/l

0.64

287

Circumscribed brain atrophy

235

1.24

0.48

1.7

2.8

39.99

37.09

g/l

2.26

206

Seminoma of testis, including Hilmo

1.53

0.48

1.9

1.2

36.03

38.99

g/l

—

Malignant neoplasm of nasal cavity and middle ear

1.51

0.48

7.1

1.2

40.69

37.57

g/l

—

Degenerative diseases of the nervous system

584

4108

1.05

0.48

1.8

2.2

36.65

36.88

g/l

0.36

439

3431

Puerperal sepsis

106

1173

0.90

0.47

2.3

2.1

38.45

38.40

g/l

0.04

1054

Other benign neoplasm of uterus: Other parts/unspecified

532

1.15

0.47

2.9

2.1

36.90

36.93

g/l

0.01

437

Dementia

724

4794

1.04

0.47

1.9

2.3

36.96

37.02

g/l

0.09

540

4074

Subarachnoid haemorrhage

128

1168

1.10

0.46

2.1

37.10

37.44

g/l

0.24

104

1003

Non-small cell lung cancer, adenocarcinoma, helper endpoint

778

1.12

0.46

1.8

2.4

36.71

37.30

g/l

0.38

685

Calcific tendinitis of shoulder

494

0.85

0.46

2.2

2.0

37.66

38.06

g/l

0.15

451

Tuberculosis of other organs, strict

273

1.22

0.46

1.9

2.5

35.53

36.79

g/l

0.54

233

Other and unspecified injuries of shoulder and upper arm

255

1.22

0.46

1.1

2.7

36.91

37.61

g/l

0.18

224

Endometriosis of pelvic peritoneum

141

1233

1.09

0.45

1.5

2.0

39.40

38.09

g/l

1.94

118

1088

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

684

0.87

0.45

3.2

2.3

39.11

37.81

g/l

1.10

609

Pre-eclampsia or poor fetal growth

234

2184

1.07

0.45

1.8

2.0

38.41

38.91

g/l

0.61

211

1963

L01XE Protein kinase inhibitors

610

1.14

0.45

3.1

2.5

35.06

37.61

g/l

2.55

544

Use of levodopa decarbox-comt-inhibitor

376

1.18

0.45

1.1

2.8

38.24

37.00

g/l

0.75

332

Alzheimer’s disease (Late onset)

375

2998

1.05

0.44

1.9

2.1

36.26

36.63

g/l

0.51

278

2479

Malignant neoplasm of head and neck

866

1.11

0.44

2.4

1.4

38.14

37.77

g/l

0.25

738

339

3022

1.06

0.44

2.1

37.03

36.84

g/l

0.25

256

2483

Benign neoplasm: Choroid

678

1.12

0.43

1.4

2.4

38.56

37.69

g/l

0.53

599

Unequal limb length (acquired)

1.62

0.43

1.0

2.4

39.32

40.48

g/l

—

Dental pulpitis, including avohilmo

1094

6895

1.03

0.42

1.9

2.2

38.73

38.18

g/l

2.37

991

6118

Sequelae of injuries of upper limb

100

907

1.11

0.42

2.5

2.3

37.70

37.93

g/l

0.13

813

Postmenopausal atrophic vaginitis

344

1800

1.06

0.42

2.2

2.1

39.39

37.32

g/l

11.22

298

1550

Obstetric embolism

0.00

0.42

0.0

1.1

—

36.63

—

Renal cell carcinoma of kidney

332

1.18

0.42

2.1

1.4

35.09

36.94

g/l

0.88

272

Malignant neoplasm of other and unspecified urinary organs

1.54

0.42

1.0

1.2

38.72

35.84

g/l

—

Cyst of spleen

0.00

0.41

0.0

3.8

—

37.95

—

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

1.37

0.41

1.1

2.2

35.32

38.13

g/l

—

Maternal care for known or suspected abnormality of pelvic organs

153

1125

0.92

0.41

2.7

1.9

39.67

39.08

g/l

0.77

139

1029

Leisure time condition

205

1921

1.07

0.41

1.4

2.1

37.34

37.60

g/l

0.21

143

1682

Vertigo of central origin

159

1.27

0.40

1.8

2.7

38.78

37.43

g/l

0.27

136

Ill-defined and unknown causes of mortality

1024

0.91

0.40

1.7

2.2

35.38

37.04

g/l

1.73

873

Benign neoplasm of ovary

202

1894

1.07

0.40

2.0

2.1

37.37

37.78

g/l

0.45

180

1616

Intermittent heterotropia

352

1.17

0.39

2.3

2.0

40.51

38.12

g/l

1.57

316

Discharge from other and unspecified firearms

0.00

0.39

0.0

2.5

—

39.19

—

Vertical strabismus

288

1.19

0.39

1.7

2.6

36.70

38.09

g/l

0.61

255

Lesion of plantar nerve

633

0.88

0.39

2.7

2.2

38.36

37.80

g/l

0.32

547

Divergent concomitant strabismus

617

1.12

0.39

1.9

2.2

39.16

38.01

g/l

1.12

551

Carcinoma in situ of other and unspecified genital organs

170

0.76

0.38

1.3

2.1

34.24

37.94

g/l

—

156

Endometriosis ASRM stages 3,4

208

2211

0.94

0.38

1.6

2.0

38.64

38.04

g/l

0.80

170

1916

Sequelae of infectious and parasitic diseases

694

1.11

0.38

2.9

2.1

37.00

37.58

g/l

0.30

612

Chondromalacia

243

1.20

0.38

1.5

2.1

38.09

38.24

g/l

0.05

227

Other factor of the environment

107

1.32

0.37

3.4

1.7

40.05

38.01

g/l

0.91

Pathological resorption of teeth

299

1.18

0.37

1.1

2.6

38.24

38.13

g/l

0.03

273

Other bursal cyst

125

1.29

0.37

2.5

1.8

40.64

37.62

g/l

1.45

107

Persistent delusional disorders

767

0.90

0.37

1.5

2.2

36.17

37.81

g/l

1.53

670

Tuberculosis of other organs

235

1.20

0.36

2.1

2.4

35.04

36.85

g/l

0.72

200

Oral leukoplakia, including avohilmo

272

1.18

0.36

1.3

2.3

37.63

37.88

g/l

0.10

244

Colorectal adenocarcinoma

228

2404

0.94

0.36

2.5

1.4

36.83

37.41

g/l

0.67

177

2029

Female genital prolapse

323

1915

0.95

0.36

2.4

2.0

38.40

37.34

g/l

2.58

275

1645

Nontraumatic intracranial haemmorrhage

269

2555

1.05

0.36

2.4

2.1

36.18

37.32

g/l

2.38

228

2164

Congenital malformations of breast

1.34

0.36

1.0

2.0

42.61

39.15

g/l

2.15

Papillary adenocarcinoma of thyroid gland

451

1.13

0.35

1.6

1.3

38.32

38.28

g/l

0.02

393

Other ulcerative colitis

451

1.13

0.35

1.2

2.4

39.11

38.26

g/l

0.47

403

Vascular dementia (undefined)

475

1.13

0.35

1.5

2.2

35.74

35.93

g/l

0.07

387

Other rupture of muscle

1.37

0.34

1.0

1.8

36.30

39.02

g/l

—

False labour

169

1124

0.94

0.34

1.6

1.7

40.47

39.25

g/l

2.25

161

1046

Schizophrenia or delusion

324

3098

1.05

0.34

1.9

2.1

37.58

38.25

g/l

1.16

269

2754

Other complications of labour and delivery, not elsewhere classified

459

0.88

0.34

1.3

1.5

41.53

40.09

g/l

1.50

426

Other benign neoplasms of uterus

662

1.11

0.34

2.7

2.1

36.25

37.36

g/l

0.71

553

Vestibular neuronitis

104

960

1.09

0.33

2.2

2.4

39.23

37.76

g/l

2.21

850

Malignant neoplasm of pancreas, including Hilmo

949

0.91

0.33

2.3

1.4

37.07

37.62

g/l

0.37

802

Malignant neoplasm of penis, including Hilmo

1.31

0.33

4.0

1.2

36.85

37.56

g/l

—

Tooth eruption problems

656

1.10

0.32

1.6

1.8

39.17

39.01

g/l

0.09

604

Malignant neoplasm of gallbladder

1.29

0.32

1.2

1.1

34.75

37.63

g/l

—

Malignant neoplasm of other and ill-defined digestive organs

1.36

0.32

1.4

1.3

34.69

36.84

g/l

—

Torsion of ovary, ovarian pedicle and fallopian tube

155

1.23

0.32

1.4

2.1

39.85

37.66

g/l

1.21

140

Benign neoplasm: Skin of other and unspecified parts of face

115

1237

0.93

0.32

3.8

2.3

36.61

37.61

g/l

0.92

1081

Glaucoma, exfoliation

140

1494

0.93

0.32

2.4

2.2

37.71

36.91

g/l

0.86

112

1234

Dislocation, sprain and strain of joints and ligaments of elbow

455

1.12

0.32

1.9

2.0

39.55

38.42

g/l

0.82

412

Pleural plaque with presence of asbestos

966

0.92

0.31

2.3

37.28

37.03

g/l

0.18

818

Benign leiomyoma with endometriosis

189

1788

1.06

0.31

2.1

37.91

37.66

g/l

0.23

155

1537

Benign neoplasm: Skin of trunk

399

1.13

0.31

3.0

2.4

39.09

37.97

g/l

0.65

356

Congenital malformations of aortic and mitral valves

314

1.15

0.31

1.3

2.5

37.54

38.13

g/l

0.20

286

Convalescence

475

1.12

0.31

2.2

2.1

37.58

38.37

g/l

0.39

421

Anxious personality disorder

100

0.70

0.30

3.0

1.7

40.91

40.02

g/l

—

Other appendicitis

782

1.09

0.30

2.9

2.3

38.53

37.92

g/l

0.56

705

Other benign neoplasm of uterus: Corpus uteri

1.35

0.30

1.6

2.2

32.94

37.71

g/l

—

Melanocytic naevi of eyelid, including canthus

1.30

0.30

1.3

2.2

39.40

37.54

g/l

0.68

Disorders of acoustic nerve

287

1.15

0.30

2.9

2.1

38.68

37.92

g/l

0.31

253

malignant neoplasm of female genital organs

158

1665

0.94

0.30

1.7

1.4

36.94

37.52

g/l

0.63

135

1380

Malignant neoplasm of stomach

524

1.11

0.30

1.1

1.4

35.54

37.07

g/l

0.99

440

Hypertrophy of breast in women and men

187

1773

1.06

0.29

2.0

2.2

38.09

38.29

g/l

0.17

162

1575

Motorcycle rider injured in noncollision transport accidents

185

1.19

0.29

2.0

1.8

39.87

39.08

g/l

0.27

171

Other vitreous opacities

392

1.13

0.29

2.3

2.5

39.20

37.77

g/l

1.01

346

Pterygium

307

1.14

0.29

2.3

2.5

38.00

37.39

g/l

0.25

272

Cyst of Bartholin Gland

288

1.15

0.29

1.9

37.82

38.28

g/l

0.13

267

Pre-eclampsia

162

1533

1.06

0.28

1.8

2.0

38.04

38.74

g/l

0.72

144

1374

Pedal cyclist injured in collision with motor vehicle

237

0.84

0.28

1.1

2.1

37.01

38.23

g/l

0.27

218

Schizophrenia, schizotypal and delusional disorders

324

3121

1.04

0.27

1.9

2.1

37.62

38.24

g/l

1.03

269

2774

Other ill-defined and unspecified causes of mortality

936

0.93

0.26

1.5

2.2

35.32

37.04

g/l

1.66

801

Fall on and from ladder

808

1.08

0.26

3.9

2.4

38.50

37.69

g/l

0.74

723

Periodontal disease, other/unspecified

225

0.84

0.26

4.5

2.3

38.92

37.91

g/l

0.40

203

Mental retardation, excluding more controls

191

1.17

0.26

1.4

2.5

38.62

38.52

g/l

0.03

172

Other benign neoplasms of connective and other soft tissue

106

993

1.07

0.26

2.4

2.2

37.51

37.81

g/l

0.20

878

Endometriosis of ovary

166

1540

1.05

0.25

1.7

2.0

38.46

37.73

g/l

0.85

137

1347

Foreign body or object entering through skin

502

1.10

0.25

2.9

2.3

39.24

38.02

g/l

1.02

455

Endometriosis ASRM stages 1,2

146

1384

1.06

0.25

1.5

1.8

39.33

38.56

g/l

0.90

121

1243

Complications following abortion and ectopic and molar pregnancy

359

1.12

0.25

1.3

2.3

39.39

37.76

g/l

0.93

318

Normotensive glaucoma

107

1138

0.94

0.25

2.3

37.23

37.28

g/l

0.03

975

Injury of nerves at forearm level

1.26

0.24

1.3

2.4

41.13

39.10

g/l

0.80

Antenatal screening

149

792

1.06

0.24

1.8

39.40

39.11

g/l

0.26

144

739

Diabetes mellitus in pregnancy

180

1209

0.95

0.24

1.5

1.8

38.96

39.55

g/l

0.72

163

1123

Foreign body in respiratory tract

445

1.10

0.24

2.9

2.3

37.35

37.78

g/l

0.19

395

Congenital malformations of breast

1.27

0.24

1.0

1.5

42.40

39.19

g/l

1.76

L02BX Other hormone antagonists and related agents

667

1.08

0.24

1.3

2.3

35.25

37.21

g/l

2.09

583

Other specified and unspecified disorders of lens

115

1.23

0.24

1.9

2.6

38.74

36.47

g/l

—

102

Other infective (teno)synovitis

1.36

0.24

1.0

1.2

40.64

38.75

g/l

—

Other acantholytic disorders

1.33

0.23

1.6

3.0

34.96

37.81

g/l

—

Hypothermia

171

1.17

0.23

1.3

3.3

36.98

37.78

g/l

0.21

149

541

1.09

0.23

1.8

2.2

38.22

36.99

g/l

0.79

436

Cauda equina syndrome

106

1.23

0.23

2.3

1.7

34.92

38.44

g/l

1.40

Inflammatory disease of cervix uteri

671

0.92

0.23

1.3

2.1

39.18

37.87

g/l

0.91

587

Supervision of normal pregnancy

125

755

0.94

0.23

2.1

1.8

40.01

39.17

g/l

1.18

117

705

Perforation of tympanic membrane

106

999

1.06

0.23

2.0

2.1

37.62

37.77

g/l

0.09

879

L02BB Anti-androgens

115

1216

0.94

0.23

1.5

2.3

37.14

37.01

g/l

0.09

1022

Effects of foreign body entering through natural orifice

259

2498

1.04

0.22

2.1

2.2

38.16

38.06

g/l

0.09

229

2229

Cellulitis of external ear

0.73

0.22

1.7

39.89

38.10

g/l

—

Calculus of lower urinary tract

612

1.08

0.22

2.3

2.5

37.08

37.40

g/l

0.16

536

Follow-up care involving plastic surgery

333

1.11

0.22

1.6

1.8

39.81

38.74

g/l

0.49

295

Carcinoma in situ of breast, intraductal

923

1.06

0.22

1.7

2.0

38.55

37.85

g/l

0.65

806

Secondary sideroblastic anaemia due to drugs and toxins

0.00

0.22

0.0

1.0

—

37.03

—

Toxic effect of pesticides

0.00

0.22

0.0

1.0

—

38.64

—

Other congenital malformations of spinal cord

0.00

0.21

0.0

1.0

—

38.25

—

Disorders of adrenal gland, other and/or unspecified

1.20

0.21

1.0

2.4

34.14

38.45

g/l

—

Supernumerary ureter

0.00

0.21

0.0

1.0

—

37.36

—

Seminoma of testis

1.19

0.21

2.2

1.2

35.72

39.17

g/l

—

Spinal instabilities

220

0.86

0.21

1.3

2.0

41.40

37.89

g/l

2.04

202

Birth injury to peripheral nervous system

0.00

0.21

0.0

3.5

—

43.15

—

Constitutional tall stature

0.00

0.21

0.0

1.0

—

41.65

—

Caught, crushed, jammed or pinched in or between objects

382

1.10

0.21

1.4

2.3

38.80

38.11

g/l

0.28

347

Benign neoplasm: Pineal gland

0.00

0.21

0.0

1.0

—

40.35

—

Unicornuate uterus

0.00

0.21

0.0

1.0

—

42.12

—

Other congenital musculoskeletal deformities

0.00

0.21

0.0

1.0

—

40.65

—

Femoral hernia

481

0.91

0.21

2.5

2.0

39.57

37.29

g/l

2.29

427

Primary angle-closure glaucoma

512

0.92

0.21

2.7

2.5

37.99

37.21

g/l

0.40

439

Congenital malformations of nose

0.00

0.21

0.0

1.0

—

40.15

—

Malignant neoplasm of eye, brain and central nervous system

373

1.10

0.21

1.5

1.3

38.07

38.10

g/l

0.01

322

Residual foreign body in soft tissue

373

1.10

0.21

2.3

2.1

37.05

37.78

g/l

0.30

334

Mental and behavioural disorders due to use of volatile solvents

0.00

0.21

0.0

3.2

—

40.08

—

Hypertrophy of breast

155

1482

1.05

0.21

1.5

2.1

38.44

38.42

g/l

0.01

133

1319

Isolated growth hormone deficiency

0.00

0.21

0.0

4.1

—

43.58

—

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

1.26

0.20

1.6

3.0

34.88

37.93

g/l

—

Vasomotor rhinitis (mode)

703

1.07

0.20

2.1

2.5

38.82

37.81

g/l

0.87

624

Bicuspidal aortic valve syndrome

288

1.11

0.20

1.3

2.5

37.51

38.29

g/l

0.28

263

Other and unspecified disorders of skin and subcutaneous tissue

634

0.93

0.19

1.4

2.5

36.88

37.77

g/l

0.47

563

Malignant neoplasm of renal pelvis

1.18

0.19

1.0

1.2

36.75

37.36

g/l

—

Chronic diseases of tonsils and adenoids

885

5689

0.98

0.19

1.7

2.2

38.74

38.04

g/l

2.89

796

5023

Guttate psoriasis

122

0.82

0.19

1.4

1.8

39.65

38.08

g/l

—

113

Malignant neoplasm of rectum, including Hilmo

134

1401

0.96

0.19

2.9

1.4

37.06

37.59

g/l

0.43

110

1181

Other menopausal disorders

316

1729

1.03

0.19

1.9

2.0

39.11

37.62

g/l

5.11

284

1510

Left ventricular outflow tract obstruction, narrow definition

366

1.09

0.19

1.3

2.4

37.35

38.23

g/l

0.37

332

Coarctation of the aorta

1.13

0.18

10.3

1.6

41.28

39.33

g/l

—

Benign neoplasm: Cranial nerves

299

1.11

0.18

2.9

2.3

38.09

37.94

g/l

0.05

260

Colorectal cancer

296

2812

1.03

0.18

2.5

1.4

37.05

37.40

g/l

0.44

242

2373

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

764

1.06

0.18

2.0

37.27

38.37

g/l

0.88

680

Malignant neoplasm of brain, including Hilmo

434

1.08

0.18

2.7

1.4

37.93

g/l

0.00

374

Other specified/unspecified diseases of inner ear

1.21

0.18

1.9

2.0

42.03

36.93

g/l

—

Lifestyle-related condition

100

1.21

0.18

3.8

1.7

40.17

38.71

g/l

0.51

Uterine polyps

101

960

1.05

0.18

1.7

2.0

38.58

37.71

g/l

0.97

837

Pedal cyclist injured in collision with pedestrian or animal

1.19

0.18

2.6

2.1

41.90

38.66

g/l

—

Sensorineural hearing loss

1107

7621

0.99

0.18

2.2

37.92

37.43

g/l

1.95

893

6644

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

400

3559

0.98

0.17

1.9

2.1

38.19

38.58

g/l

0.69

365

3131

Benign neoplasm: Skin of upper limb, including shoulder

167

1.14

0.17

4.3

2.7

39.68

37.81

g/l

1.68

151

Alzheimer’s disease, strict definition

395

3180

1.02

0.16

1.9

2.1

36.37

36.70

g/l

0.45

296

2638

Arthropathy in Crohn disease

1.16

0.16

1.1

2.4

43.15

39.38

g/l

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

225

1.11

0.16

3.8

2.6

38.38

38.08

g/l

0.10

200

Simple and mucopurulent chronic bronchitis

432

0.92

0.16

1.7

2.3

34.79

37.43

g/l

1.39

368

Malignant neoplasm of corpus uteri, including Hilmo

109

1043

1.05

0.16

1.5

1.4

36.83

37.42

g/l

0.53

862

Use of ropinirole

399

1.08

0.16

2.4

2.8

37.66

37.33

g/l

0.15

354

Osteitis due to dental implant

0.78

0.16

6.2

1.9

36.28

36.72

g/l

—

Exposure to excessive heat of man-made origin

0.75

0.15

5.7

3.2

36.85

37.68

g/l

—

Gestational diabetes (for exclusion)

214

1533

0.97

0.15

1.7

1.8

38.68

39.57

g/l

1.47

193

1420

Helminthiases

139

0.86

0.14

3.7

2.0

38.77

38.03

g/l

0.42

123

Gestational [pregnancy-induced] hypertension

178

1830

0.97

0.14

2.2

1.9

38.17

38.93

g/l

1.09

169

1629

Medicines for HER+ breast cancer

437

4217

0.98

0.14

1.9

2.2

38.20

37.76

g/l

0.92

362

3590

Unspecific neurodegenerative disorder

674

4674

0.98

0.14

1.9

2.3

36.65

36.95

g/l

0.59

493

3958

Infliximab

1.19

0.14

1.1

1.7

35.90

39.90

g/l

—

Carcinoma in situ of cervix uteri

548

1.06

0.14

1.9

2.0

38.47

38.67

g/l

0.09

505

Conductive and sensorineural hearing loss

1170

7805

1.01

0.14

2.2

37.98

37.47

g/l

2.17

944

6812

Malignant neoplasm of endocrine gland

647

1.05

0.13

2.1

1.4

38.38

38.00

g/l

0.21

551

Fourth [trochlear] nerve palsy

211

0.90

0.13

1.3

2.8

36.53

37.58

g/l

0.30

186

Glaucoma

847

7197

1.01

0.13

2.1

2.3

37.62

37.35

g/l

0.66

704

6151

Contact with sharp glass

248

1.09

0.12

1.2

2.0

40.79

38.41

g/l

1.23

227

Other corneal oedema

1.18

0.12

3.0

1.9

39.36

37.84

g/l

—

Crossbite

337

1.07

0.12

1.1

2.1

38.79

38.62

g/l

0.06

316

Malignant neoplasm of corpus uteri

904

1.04

0.12

1.6

1.4

36.85

37.34

g/l

0.37

744

Dislocation, sprain and strain of joints and ligaments of head

268

1.08

0.12

1.2

1.9

38.12

38.54

g/l

0.12

242

Normal-pressure hydrocephalus

610

1.05

0.12

2.4

38.31

37.11

g/l

1.06

520

Dementia due to Parkinson's disease

288

1.08

0.12

1.3

2.4

36.44

36.69

g/l

0.07

245

Benign neoplasm: Bladder

1.16

0.11

2.4

3.2

38.49

37.51

g/l

0.24

Anomalies of dental arch relationship, including avohilmo

142

1318

0.97

0.11

1.7

2.2

39.07

38.46

g/l

0.66

113

1198

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS